k141_113045_11	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	25.5	196	491	307	6.57e-08	53.1
k141_113045_11	SARG|gi|500448961|gb|EOP61695.1|	27.4	201	491	306	1.15e-06	49.3
k141_113045_11	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	24.7	215	491	461	1.29e-06	49.7
k141_113045_11	SARG|gi|446026113|ref|WP_000103968.1|	26.8	194	491	306	1.53e-06	48.9
k141_113045_11	SARG|gi|507044560|ref|WP_016115614.1|	27.0	200	491	306	2.04e-06	48.5
k141_113045_11	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.6	168	491	655	2.67e-06	48.9
k141_113045_11	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.6	168	491	655	2.67e-06	48.9
k141_113045_11	SARG|gi|500465078|gb|EOP76697.1|	26.9	201	491	306	8.51e-06	46.6
k141_113045_11	NCBI|WP_172065992.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	24.4	197	491	461	9.07e-06	47.0
k141_113045_16	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	30.9	194	353	255	5.16e-24	98.2
k141_113045_16	SARG|gb|WP_104671188.1|ARO:3003948|efrA	27.3	216	353	575	1.57e-14	73.6
k141_113045_16	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	27.9	197	353	343	1.22e-12	67.0
k141_113045_28	SARG|gb|AAG07064.1|ARO:3003693|mexK	32.5	1027	1022	1025	9.79e-172	528
k141_113045_28	CARD|gb|AAG03548.1|ARO:3003681|TriC	31.4	1016	1022	1015	9.19e-159	494
k141_113045_28	SARG|ZP_02371789	23.5	1051	1022	1061	3.96e-66	241
k141_113045_28	SARG|ABC36050	23.5	1051	1022	1061	5.32e-66	240
k141_113045_28	SARG|YP_001025938	23.5	1051	1022	1061	1.29e-65	239
k141_113045_28	SARG|ZP_02405550	23.5	1051	1022	1061	1.74e-65	239
k141_113045_28	SARG|ZP_02465589	23.3	1051	1022	1061	1.02e-64	236
k141_113045_28	SARG|YP_001116031	23.5	1056	1022	1066	1.90e-64	236
k141_113045_28	SARG|YP_371056	23.1	1062	1022	1066	8.24e-64	234
k141_113045_28	SARG|ZP_02357857	23.2	1055	1022	1061	1.07e-63	233
k141_113045_46	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	28.7	216	241	574	5.75e-14	69.7
k141_113045_46	SARG|gb|ADZ12699.1|ARO:3005091|RanA	21.4	229	241	258	1.20e-10	58.9
k141_113045_46	SARG|gb|AYV52072.1|ARO:3002882|lmrD	26.6	158	241	664	3.20e-06	46.6
k141_113045_50	CARD|gb|ATC67679.1|ARO:3000838|arlR	36.1	219	224	219	2.15e-38	131
k141_113045_50	CARD|gb|AAG06465.1|ARO:3005063|cprR	37.9	219	224	223	9.47e-38	130
k141_113045_50	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	35.8	229	224	231	2.82e-35	124
k141_113045_50	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	36.2	229	224	231	2.82e-35	124
k141_113045_50	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	35.8	229	224	231	2.82e-35	124
k141_113045_50	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	33.2	220	224	225	3.41e-35	123
k141_113045_50	CARD|gb|AAC73788.1|ARO:3003841|kdpE	33.2	220	224	225	3.41e-35	123
k141_113045_50	NCBI|WP_011029105.1|1|1|vanR-Sc|vanR-Sc|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-Sc|AMR|glycopeptide	34.1	217	224	231	1.22e-33	119
k141_113045_50	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	32.1	218	224	228	2.24e-33	119
k141_113045_50	NCBI|WP_063856729.1|1|1|vanR-O|vanR-O|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-O|AMR|glycopeptide	33.0	224	224	233	1.08e-31	114
k141_113045_51	SARG|gb|BAE78116.1|ARO:3003576|eptA	71.0	538	547	547	9.86e-285	783
k141_113045_51	NCBI|WP_042649073.1|1|1|mcr-3_set|mcr-3_set||2|COLISTIN|COLISTIN|MCR-3-related_phosphoethanolamine--lipid_A_transferase|AMR|peptide	44.6	457	547	541	2.23e-142	421
k141_113045_51	SARG|gb|AVZ47168.1|ARO:3004693|MCR-3.12	42.5	494	547	541	2.52e-141	418
k141_113045_51	NCBI|WP_094308975.1|1|1|mcr-3.22|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.22|AMR|peptide	42.5	494	547	541	2.52e-141	418
k141_113045_51	SARG|gb|AUN87920.1|ARO:3004500|MCR-3.11	42.5	494	547	541	3.56e-141	417
k141_113045_51	SARG|WP_065804663.1	42.5	494	547	541	5.03e-141	417
k141_113045_51	NCBI|WP_136512112.1|1|1|mcr-3.29|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.29|AMR|peptide	42.5	494	547	541	5.03e-141	417
k141_113045_51	NCBI|WP_150823496.1|1|1|mcr-3.28|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.28|AMR|peptide	42.5	494	547	541	7.11e-141	417
k141_113045_51	SARG|gb|ATQ63376.1|ARO:3004504|MCR-3.10	42.3	494	547	541	7.11e-141	417
k141_113045_51	SARG|gb|AST36141.1|ARO:3004510|MCR-3.7	42.5	494	547	541	7.11e-141	417
k141_113045_65	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	39.0	236	580	343	2.11e-51	179
k141_113045_65	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	36.2	221	580	307	2.04e-42	153
k141_113045_65	SARG|gi|510143239|gb|AGN36970.1|	32.5	252	580	313	8.63e-42	152
k141_113045_65	SARG|P42332	32.4	247	580	306	3.66e-41	150
k141_113045_65	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	32.4	247	580	306	3.66e-41	150
k141_113045_65	SARG|ABB80128	32.4	247	580	306	5.06e-41	149
k141_113045_65	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	36.4	231	580	325	5.79e-41	150
k141_113045_65	SARG|gi|445996719|ref|WP_000074574.1|	32.4	247	580	309	7.52e-41	149
k141_113045_65	SARG|gb|AAA26793|ARO:3003748|oleC	39.1	207	580	325	1.10e-40	149
k141_113045_65	SARG|gi|542061059|gb|ERI11611.1|	31.1	251	580	316	2.34e-40	148
k141_113045_69	SARG|WP_000345069.1	23.6	428	444	434	7.59e-27	110
k141_113045_82	SARG|gi|498115003|ref|WP_010429159.1|	41.5	234	241	646	1.17e-46	162
k141_113045_82	SARG|gi|1016095642|ref|WP_062938108.1|	41.0	239	241	646	4.30e-46	161
k141_113045_82	SARG|gi|654544841|ref|WP_028012549.1|	41.5	234	241	646	1.14e-45	160
k141_113045_82	SARG|gi|895898290|ref|WP_048999361.1|	41.0	234	241	646	1.57e-45	159
k141_113045_82	SARG|gi|896106549|ref|WP_049136608.1|	41.0	234	241	646	1.57e-45	159
k141_113045_82	SARG|gi|983405167|ref|WP_060572706.1|	41.0	234	241	646	2.17e-45	159
k141_113045_82	SARG|gi|896325272|ref|WP_049294291.1|	44.2	217	241	648	2.21e-45	159
k141_113045_82	SARG|gi|1016942913|ref|WP_063144441.1|	41.0	234	241	646	3.00e-45	159
k141_113045_82	SARG|gi|754493745|ref|WP_041910640.1|	41.0	234	241	646	3.00e-45	159
k141_113045_82	SARG|gi|493862656|ref|WP_006809409.1|	40.6	239	241	646	3.00e-45	159
k141_113045_96	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.0	532	531	655	5.17e-81	265
k141_113045_96	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.0	532	531	655	5.17e-81	265
k141_113045_96	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.8	532	531	655	1.98e-80	263
k141_113045_96	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.8	532	531	655	2.77e-80	263
k141_113045_96	SARG|gb|AKA86814|ARO:3003746|optrA	31.8	532	531	655	2.77e-80	263
k141_113045_96	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.8	532	531	655	7.57e-80	261
k141_113045_96	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.8	532	531	655	7.57e-80	261
k141_113045_96	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.8	532	531	655	7.57e-80	261
k141_113045_96	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.8	532	531	655	7.57e-80	261
k141_113045_96	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.6	532	531	655	2.89e-79	260
k141_54163_20	SARG|YP_001571041	30.2	245	530	648	3.47e-22	99.4
k141_54163_20	SARG|gi|960873409|ref|WP_058345546.1|	30.2	245	530	648	3.47e-22	99.4
k141_54163_20	SARG|gi|974672242|ref|WP_059256507.1|	30.6	235	530	648	4.61e-22	99.0
k141_54163_20	SARG|gi|974641719|ref|WP_059227752.1|	30.6	235	530	648	4.61e-22	99.0
k141_54163_20	SARG|gi|643601187|ref|WP_025237288.1|	30.6	235	530	648	4.61e-22	99.0
k141_54163_20	SARG|gi|974628291|ref|WP_059215695.1|	30.6	235	530	648	4.61e-22	99.0
k141_54163_20	SARG|gi|446110298|ref|WP_000188153.1|	30.6	235	530	648	4.61e-22	99.0
k141_54163_20	SARG|gi|446110299|ref|WP_000188154.1|	30.6	235	530	648	4.61e-22	99.0
k141_54163_20	SARG|ZP_02903696	30.6	235	530	648	4.61e-22	99.0
k141_54163_20	SARG|gi|974633183|ref|WP_059219858.1|	30.6	235	530	648	4.61e-22	99.0
k141_54163_22	SARG|gb|ALV80601.1|ARO:3003801|bcr-1	38.6	316	399	402	1.64e-64	210
k141_54163_22	NCBI|WP_031633255.1|1|1|cmlA_floR|cmlA_floR|efflux|2|CHLORAMPHENICOL|PHENICOL|CmlA/FloR_family_phenicol_efflux_MFS_transporter|AMR|phenicol	29.9	381	399	395	1.37e-31	122
k141_54163_22	SARG|AF313472.2.gene8.p01	29.6	385	399	419	2.49e-30	119
k141_54163_22	megares|MEG_1764|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	29.6	385	399	419	2.49e-30	119
k141_54163_22	SARG|gi|487586482|ref|WP_001724981.1|	29.4	385	399	419	4.69e-30	119
k141_54163_22	SARG|CAI43343	30.3	386	399	419	6.44e-30	118
k141_54163_22	SARG|U12338.3.gene8.p01	29.4	385	399	419	6.44e-30	118
k141_54163_22	SARG|ACC95408	30.3	386	399	419	6.44e-30	118
k141_54163_22	megares|MEG_1762|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	29.4	385	399	419	6.44e-30	118
k141_54163_22	megares|MEG_1754|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	29.4	385	399	419	6.44e-30	118
k141_54163_27	SARG|gi|942489450|ref|WP_055329626.1|	33.0	188	429	377	4.11e-13	69.3
k141_54163_27	SARG|gi|852260313|ref|WP_048324983.1|	33.0	188	429	378	4.13e-13	69.3
k141_54163_27	SARG|gi|763152412|ref|WP_044032075.1|	33.0	188	429	378	4.13e-13	69.3
k141_54163_27	SARG|gi|742394783|ref|WP_038873908.1|	33.0	188	429	378	4.13e-13	69.3
k141_54163_27	SARG|gi|896175180|ref|WP_049188167.1|	33.0	188	429	378	4.13e-13	69.3
k141_54163_27	SARG|gi|851962897|ref|WP_048233629.1|	33.0	188	429	378	4.13e-13	69.3
k141_54163_27	SARG|gi|665934413|ref|WP_031300463.1|	33.0	188	429	378	4.13e-13	69.3
k141_54163_27	SARG|gb|WP_063864750.1|ARO:3006999|SST-1	33.0	188	429	378	5.51e-13	68.9
k141_54163_27	SARG|AAK64454	32.4	188	429	378	7.36e-13	68.6
k141_54163_27	SARG|gb|WP_033642964.1|ARO:3006853|SRT-3	33.0	188	429	378	7.36e-13	68.6
k141_54163_38	SARG|gb|AAC75271.1|ARO:3003952|yojI	83.9	547	548	547	0.0	905
k141_54163_38	SARG|gi|556476567|ref|WP_023328168.1|	35.3	215	548	641	2.72e-20	93.6
k141_54163_38	SARG|gi|501015807|ref|WP_012068502.1|	33.9	218	548	646	2.74e-20	93.6
k141_54163_38	SARG|gi|647265102|ref|WP_025712979.1|	35.2	219	548	646	2.74e-20	93.6
k141_54163_38	SARG|gi|556477097|ref|WP_023328693.1|	34.7	219	548	646	4.83e-20	92.8
k141_54163_38	SARG|gi|490320210|ref|WP_004209695.1|	34.7	219	548	646	4.83e-20	92.8
k141_54163_38	SARG|gi|782700886|ref|WP_045611431.1|	34.7	219	548	646	4.83e-20	92.8
k141_54163_38	SARG|gi|1044080358|emb|SBY45576.1|	34.7	219	548	646	4.83e-20	92.8
k141_54163_38	SARG|gi|544902100|ref|WP_021313340.1|	34.7	219	548	646	4.83e-20	92.8
k141_54163_38	SARG|gi|895895864|ref|WP_048997630.1|	34.7	219	548	644	6.39e-20	92.4
k141_54163_42	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	69.0	374	365	374	2.21e-182	509
k141_54163_42	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	51.7	362	365	357	6.99e-119	347
k141_54163_45	CARD|gb|AAC75429.1|ARO:3000833|evgS	30.1	552	947	1197	1.91e-57	214
k141_54163_57	SARG|WP_000345069.1	37.4	431	431	434	3.13e-84	263
k141_54163_101	SARG|gi|585358510|ref|WP_024240108.1|	41.5	212	258	648	5.92e-37	136
k141_54163_101	SARG|gi|851934663|ref|WP_048223926.1|	41.5	212	258	648	1.11e-36	135
k141_54163_101	SARG|gi|921979807|ref|WP_053271336.1|	41.0	212	258	648	1.11e-36	135
k141_54163_101	SARG|gb|AYV52072.1|ARO:3002882|lmrD	27.2	228	258	664	1.64e-12	65.9
k141_54163_101	SARG|AAG08983	25.4	228	258	524	2.64e-07	50.1
k141_54163_101	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	23.2	194	258	461	3.43e-06	46.6
k141_54163_101	SARG|KC539823.1.gene1.p01	24.6	211	258	522	4.81e-06	46.2
k141_54163_101	NCBI|WP_063856937.1|1|1|vga(A)|vga(A)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(A)|AMR|lincosamide	24.6	211	258	522	6.42e-06	45.8
k141_54163_101	NCBI|WP_032492560.1|1|1|vga(A)|vga(A)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(A)|AMR|lincosamide	24.3	210	258	522	8.58e-06	45.4
k141_54163_101	SARG|DQ823382.1.gene1.p01	24.3	210	258	522	8.58e-06	45.4
k141_54163_134	megares|MEG_2421|Drugs|beta-lactam|Class_A_betalactamases|CTX_2	71.0	107	161	107	8.77e-54	164
k141_54163_136	CARD|gb|VWQ00850.1|ARO:3003843|leuO	22.7	286	303	314	1.88e-10	59.7
k141_54163_136	CARD|gb|CAA79966.1|ARO:3003665|NmcR	35.7	126	303	295	1.35e-09	57.0
k141_54163_168	SARG|gi|491270241|ref|WP_005128370.1|	39.0	231	365	648	5.13e-36	137
k141_54163_168	SARG|gi|851902043|ref|WP_048212057.1|	39.0	231	365	648	5.13e-36	137
k141_54163_168	SARG|gi|992380339|ref|WP_061067665.1|	39.0	231	365	648	5.13e-36	137
k141_54163_168	SARG|gi|922960663|ref|WP_053388845.1|	39.9	223	365	648	5.13e-36	137
k141_54163_168	SARG|gi|493734654|ref|WP_006683876.1|	39.1	238	365	648	5.13e-36	137
k141_54163_168	SARG|gi|936194420|ref|WP_054528571.1|	38.5	231	365	648	7.00e-36	137
k141_54163_168	SARG|gi|757799695|ref|WP_043016897.1|	39.9	223	365	648	7.00e-36	137
k141_54163_168	SARG|gi|1045891604|ref|WP_065554100.1|	39.9	223	365	648	7.00e-36	137
k141_54163_168	SARG|gi|507082903|ref|WP_016153652.1|	39.9	223	365	648	7.00e-36	137
k141_54163_168	SARG|gi|754951242|ref|WP_042307417.1|	39.0	231	365	648	7.00e-36	137
k141_54163_201	CARD|gb|BAA16344.1|ARO:3000491|acrD	91.0	1037	1038	1037	0.0	1798
k141_54163_201	CARD|gb|AAC73564.1|ARO:3000216|acrB	66.2	1037	1038	1049	0.0	1278
k141_54163_201	SARG|gi|817600095|ref|WP_046594084.1|	65.0	1032	1038	1037	0.0	1247
k141_54163_201	SARG|gi|817604860|ref|WP_046598079.1|	65.0	1032	1038	1037	0.0	1246
k141_54163_201	SARG|gi|447196024|ref|WP_001273280.1|	65.0	1032	1038	1037	0.0	1246
k141_54163_201	SARG|gi|817600173|ref|WP_046594139.1|	65.0	1032	1038	1037	0.0	1246
k141_54163_201	SARG|gi|487663012|ref|WP_001752778.1|	64.9	1032	1038	1037	0.0	1246
k141_54163_201	SARG|gi|817601660|ref|WP_046595348.1|	65.0	1032	1038	1037	0.0	1245
k141_54163_201	SARG|CP000647.1.gene3710.p01	64.7	1032	1038	1036	0.0	1235
k141_54163_201	SARG|gi|556290479|ref|WP_023291164.1|	64.8	1032	1038	1036	0.0	1233
k141_54163_244	SARG|gb|BAH45481.1|ARO:3002815|clbB	32.8	344	389	343	2.57e-47	163
k141_54163_244	NCBI|WP_111690898.1|1|1|cfr(C)|cfr(C)|target_modification|2|CHLORAMPHENICOL/CLINDAMYCIN/FLORFENICOL/LINEZOLID/STREPTOGRAMIN/TIAMULIN|LINCOSAMIDE/OXAZOLIDINONE/PHENICOL/PLEUROMUTILIN/STREPTOGRAMIN|23S_rRNA_(adenine(2503)-C(8))-methyltransferase_Cfr(C)|AMR|multidrug	34.8	371	389	379	1.63e-46	162
k141_54163_244	SARG|CP001581.1.gene3143.p01	31.1	341	389	344	1.06e-45	159
k141_54163_244	megares|MEG_1680|Drugs|MLS|23S_rRNA_methyltransferases|CFR_1	34.6	356	389	416	1.36e-45	160
k141_54163_244	SARG|gb|CAL84423.1|ARO:3004146|cfrC	30.2	344	389	344	1.16e-43	154
k141_54163_244	SARG|gb|BAD63613.1|ARO:3002816|clbC	31.3	345	389	350	1.38e-42	151
k141_54163_244	SARG|VXQ21601.1	31.6	348	389	344	2.43e-41	147
k141_54163_275	CARD|gb|AAK37618.1|ARO:3005008|TxR	41.1	302	446	318	3.93e-73	231
k141_54163_275	CARD|gb|ATC67679.1|ARO:3000838|arlR	30.9	123	446	219	5.16e-11	61.2
k141_54163_275	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	30.7	101	446	228	3.53e-10	58.9
k141_54163_275	CARD|gb|AAG05188.1|ARO:3005068|ParR	26.4	121	446	235	2.47e-08	53.5
k141_54163_277	CARD|gb|AAC75429.1|ARO:3000833|evgS	29.1	230	474	1197	1.51e-15	78.6
k141_54163_277	CARD|gb|CYF42523.1|ARO:3004047|kdpD	23.2	276	474	885	2.25e-10	62.0
k141_54163_290	SARG|gi|1004359922|gb|AMP42228.1|	25.6	438	600	639	3.26e-27	115
k141_54163_290	SARG|ABN80187	26.2	439	600	640	5.73e-26	111
k141_54163_290	SARG|gb|AMP42147.1|ARO:3004442|tet(W/N/W)	24.8	436	600	639	2.38e-25	109
k141_54163_290	SARG|gi|104303742|gb|ABF72138.1|	25.2	437	600	639	3.17e-25	109
k141_54163_290	SARG|ACI02041	25.2	437	600	639	3.17e-25	109
k141_54163_290	megares|MEG_7170|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	24.9	437	600	629	5.44e-25	108
k141_54163_290	SARG|WP_000691721.1	25.2	437	600	639	5.61e-25	108
k141_54163_290	ResF|tet(O/W)_4_AM889121_1	24.9	437	600	639	5.61e-25	108
k141_54163_290	SARG|ABC18245	25.2	437	600	639	5.61e-25	108
k141_54163_290	SARG|AAL30847	25.2	437	600	639	5.61e-25	108
k141_54163_306	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	29.6	419	433	429	1.47e-53	183
k141_357_9	SARG|gb|AAK76137.1|ARO:3000024|patA	27.6	170	211	564	2.63e-10	58.2
k141_357_83	SARG|gi|445996710|ref|WP_000074565.1|	25.0	244	270	309	1.98e-17	79.3
k141_357_83	SARG|gi|507035724|ref|WP_016107411.1|	24.6	244	270	309	5.11e-17	78.2
k141_357_83	SARG|gi|500194536|ref|WP_011867743.1|	26.0	215	270	306	6.78e-17	77.8
k141_357_83	SARG|gi|445996732|ref|WP_000074587.1|	25.3	245	270	309	6.99e-17	77.8
k141_357_83	SARG|gi|445996698|ref|WP_000074553.1|	24.2	244	270	309	1.31e-16	77.0
k141_357_83	SARG|gi|445996697|ref|WP_000074552.1|	24.6	244	270	309	1.31e-16	77.0
k141_357_83	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	31.2	215	270	579	1.36e-16	78.2
k141_357_83	SARG|gi|445996696|ref|WP_000074551.1|	24.6	244	270	309	1.79e-16	76.6
k141_357_83	SARG|gi|445996719|ref|WP_000074574.1|	24.2	244	270	309	2.45e-16	76.3
k141_357_83	SARG|gb|AET10445.1|ARO:3004033|tetB(46)	27.8	223	270	578	3.34e-16	77.0
k141_357_84	SARG|gi|949718947|ref|WP_057063453.1|	29.3	246	331	648	5.88e-19	86.7
k141_357_84	SARG|gi|754732608|ref|WP_042101370.1|	28.3	251	331	648	5.88e-19	86.7
k141_357_84	SARG|gi|446110297|ref|WP_000188152.1|	28.3	251	331	648	5.88e-19	86.7
k141_357_84	SARG|gi|910140813|ref|WP_050008485.1|	28.3	251	331	648	5.88e-19	86.7
k141_357_84	SARG|gi|851913025|ref|WP_048215946.1|	28.9	246	331	648	1.92e-18	85.1
k141_357_84	SARG|gi|489930965|ref|WP_003834285.1|	28.9	246	331	648	1.92e-18	85.1
k141_357_84	SARG|gi|696368937|ref|WP_032943949.1|	29.0	245	331	648	2.58e-18	84.7
k141_357_84	SARG|gi|851922185|ref|WP_048218206.1|	28.9	246	331	648	2.58e-18	84.7
k141_357_84	SARG|YP_002850060	28.9	246	331	648	2.58e-18	84.7
k141_357_84	SARG|gi|696375069|ref|WP_032949617.1|	28.9	246	331	648	2.58e-18	84.7
k141_357_156	SARG|gi|1005608354|ref|WP_061691305.1|	51.5	458	464	466	1.58e-157	453
k141_357_156	SARG|gi|489822049|ref|WP_003725847.1|	51.3	458	464	466	3.16e-157	452
k141_357_156	SARG|gi|489824904|ref|WP_003728682.1|	51.3	458	464	466	3.16e-157	452
k141_357_156	SARG|gi|1000359761|ref|WP_061107064.1|	51.1	458	464	466	3.16e-157	452
k141_357_156	SARG|gi|489823816|ref|WP_003727600.1|	51.3	458	464	466	4.48e-157	452
k141_357_156	SARG|gi|844765894|ref|WP_047933506.1|	51.1	458	464	466	6.35e-157	452
k141_357_156	SARG|gi|489826943|ref|WP_003730711.1|	51.3	458	464	466	6.35e-157	452
k141_357_156	SARG|gi|504744674|ref|WP_014931776.1|	51.3	458	464	466	6.35e-157	452
k141_357_156	SARG|HE999704.1.gene3170.p01	51.1	458	464	466	9.00e-157	451
k141_357_156	SARG|gi|933593662|ref|WP_054314487.1|	50.9	458	464	466	1.28e-156	451
k141_357_164	megares|MEG_1992|Drugs|beta-lactam|Class_C_betalactamases|CMY_1	30.7	287	300	291	2.81e-30	114
k141_357_166	CARD|gb|AAK37618.1|ARO:3005008|TxR	34.8	293	514	318	9.87e-48	167
k141_3047_6	SARG|gi|2708772|gb|AAB96371.1|	27.9	183	465	391	4.67e-08	53.9
k141_3047_6	SARG|YP_251195	26.7	180	465	391	6.20e-08	53.5
k141_3047_6	SARG|AF024666.2.gene33.p01	26.7	180	465	391	6.20e-08	53.5
k141_3047_6	SARG|NP_044444	26.7	180	465	391	8.22e-08	53.1
k141_3047_6	SARG|gb|AAF40764.1|ARO:3003962|farB	26.6	158	465	508	1.65e-06	49.3
k141_3047_6	NCBI|AAD54074.1|1|1|farB|farB||1|EFFLUX|EFFLUX|fatty_acid_resistance_MFS_efflux_transporter_permease_subunit_FarB|AMR|efflux	26.6	158	465	507	3.80e-06	48.1
k141_3047_21	SARG|gi|959109145|ref|WP_058113944.1|	35.2	250	270	648	5.71e-31	120
k141_3047_21	SARG|gi|446048043|ref|WP_000125898.1|	34.5	249	270	648	2.68e-30	118
k141_3047_21	SARG|gi|446048048|ref|WP_000125903.1|	34.8	250	270	648	2.68e-30	118
k141_3047_21	SARG|gi|555288792|ref|WP_023262971.1|	34.5	249	270	648	2.68e-30	118
k141_3047_21	SARG|gi|1005616587|ref|WP_061695226.1|	34.7	248	270	648	3.65e-30	117
k141_3047_21	SARG|gi|446048041|ref|WP_000125896.1|	34.4	250	270	648	3.65e-30	117
k141_3047_21	SARG|gi|923061916|ref|WP_053445667.1|	34.4	247	270	648	3.65e-30	117
k141_3047_21	SARG|gi|555258323|ref|WP_023240896.1|	34.4	250	270	648	4.97e-30	117
k141_3047_21	SARG|gi|970558766|ref|WP_058820271.1|	34.4	247	270	648	6.77e-30	117
k141_3047_21	SARG|gi|779838942|ref|WP_045343641.1|	34.8	247	270	648	6.77e-30	117
k141_22192_2	CARD|gb|NP_216393.1|ARO:3007662|Rv1877	41.5	479	498	687	8.14e-117	358
k141_22192_2	SARG|AAC15775	36.7	515	498	536	1.72e-98	306
k141_22192_2	SARG|AAD04032	36.7	515	498	563	3.61e-98	306
k141_22192_2	megares|MEG_4380|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|OTRB_1	36.7	515	498	563	3.61e-98	306
k141_22192_2	megares|MEG_4381|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|OTRB_1	36.7	515	498	563	3.61e-98	306
k141_22192_2	SARG|BAA07390	37.4	479	498	512	4.00e-93	291
k141_22192_2	SARG|ZP_03053667	34.9	495	498	506	6.72e-93	290
k141_22192_2	SARG|YP_001486998	34.5	495	498	530	5.57e-91	286
k141_22192_2	SARG|CAB12101	36.9	409	498	512	1.34e-90	285
k141_22192_2	SARG|YP_001419960	34.2	486	498	510	5.46e-89	280
k141_22192_3	CARD|gb|ALH22601.1|ARO:3000620|adeL	36.5	285	305	337	1.38e-41	145
k141_22192_12	CARD|gb|BAA15221.2|ARO:3000263|marA	27.0	111	318	127	1.86e-08	51.2
k141_22192_50	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	37.3	241	306	343	1.30e-49	167
k141_22192_50	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	33.2	295	306	325	2.10e-46	158
k141_22192_50	SARG|gb|AAA26793|ARO:3003748|oleC	33.4	293	306	325	4.14e-46	157
k141_22192_50	megares|MEG_2670|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|DRRA_1	36.6	194	306	293	3.07e-33	122
k141_22192_50	SARG|gb|AAR96051.1|ARO:3002894|otrC	32.3	217	306	351	9.68e-30	114
k141_22192_50	megares|MEG_4383|Drugs|Tetracycline|Tetracycline_resistance_ABC_efflux_pumps|OTRC_1	31.8	217	306	351	6.89e-29	112
k141_22192_50	SARG|gi|779793259|ref|WP_045327301.1|	31.4	207	306	646	1.94e-23	99.4
k141_22192_50	SARG|gi|491270241|ref|WP_005128370.1|	29.0	221	306	648	1.94e-23	99.4
k141_22192_50	SARG|gi|851902043|ref|WP_048212057.1|	29.0	221	306	648	1.94e-23	99.4
k141_22192_50	SARG|gi|992380339|ref|WP_061067665.1|	29.0	221	306	648	1.94e-23	99.4
k141_22192_96	SARG|gi|554684122|ref|WP_023184036.1|	27.5	287	379	343	6.39e-19	85.9
k141_22192_96	SARG|gi|740611645|ref|WP_038397166.1|	27.2	287	379	343	3.97e-18	83.6
k141_22192_96	SARG|YP_001572361	26.8	287	379	343	1.34e-17	82.0
k141_22192_96	SARG|gi|759552006|ref|WP_043271822.1|	25.8	229	379	410	1.10e-10	61.6
k141_22192_96	SARG|gi|497308478|ref|WP_009622695.1|	25.8	229	379	410	1.10e-10	61.6
k141_22192_96	SARG|gi|746192777|ref|WP_039250898.1|	26.5	185	379	406	7.99e-09	55.8
k141_22192_96	SARG|gi|490838406|ref|WP_004700481.1|	26.5	185	379	406	7.99e-09	55.8
k141_22192_96	SARG|gi|516086900|ref|WP_017517480.1|	28.2	181	379	411	8.08e-09	55.8
k141_22192_96	SARG|gi|505289665|ref|WP_015476767.1|	27.6	181	379	411	1.07e-08	55.5
k141_22192_96	SARG|gi|639919893|ref|WP_024762275.1|	27.1	181	379	411	1.07e-08	55.5
k141_22192_104	NCBI|AAD44693.1|1|1|mtrA_Ngon|mtrA_Ngon||1|EFFLUX|EFFLUX|efflux_transporter_MtrCDE_transcriptional_activator_MtrA|AMR|efflux	33.3	81	393	301	1.86e-08	54.3
k141_22192_106	SARG|gi|491270241|ref|WP_005128370.1|	33.3	228	514	648	9.82e-23	100
k141_22192_106	SARG|gi|851902043|ref|WP_048212057.1|	33.3	228	514	648	9.82e-23	100
k141_22192_106	SARG|gi|992380339|ref|WP_061067665.1|	33.3	228	514	648	9.82e-23	100
k141_22192_106	SARG|gi|851928815|ref|WP_048221086.1|	33.3	228	514	648	9.82e-23	100
k141_22192_106	SARG|gi|780033092|ref|WP_045444768.1|	33.3	228	514	648	9.82e-23	100
k141_22192_106	SARG|gi|507086196|ref|WP_016156937.1|	33.3	228	514	648	1.74e-22	100
k141_22192_106	SARG|gi|740856590|ref|WP_038641842.1|	32.9	228	514	648	3.09e-22	99.4
k141_22192_106	SARG|gi|922960663|ref|WP_053388845.1|	32.9	228	514	648	4.11e-22	99.0
k141_22192_106	SARG|gi|757799695|ref|WP_043016897.1|	32.9	228	514	648	5.47e-22	98.6
k141_22192_106	SARG|gi|1045891604|ref|WP_065554100.1|	32.9	228	514	648	5.47e-22	98.6
k141_22192_117	SARG|gb|ABX00624.1|ARO:3002881|lmrC	38.3	509	540	550	1.15e-90	287
k141_22192_117	megares|MEG_7256|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|TLRC_1	31.0	525	540	540	1.63e-42	158
k141_22192_117	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.5	515	540	655	1.74e-42	160
k141_22192_117	SARG|gb|AKA86814|ARO:3003746|optrA	28.5	515	540	655	1.74e-42	160
k141_22192_117	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.5	515	540	655	2.37e-42	159
k141_22192_117	megares|MEG_4322|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.2	517	540	655	2.37e-42	159
k141_22192_117	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.5	515	540	655	2.37e-42	159
k141_22192_117	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.5	515	540	655	2.37e-42	159
k141_22192_117	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.5	515	540	655	2.37e-42	159
k141_22192_117	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.5	515	540	655	3.23e-42	159
k141_22192_120	SARG|YP_001419960	27.5	149	452	510	1.08e-09	59.3
k141_22192_120	SARG|CAB12101	27.5	149	452	512	1.44e-09	58.9
k141_22192_120	SARG|ZP_03053667	28.2	149	452	506	2.50e-09	58.2
k141_22192_120	SARG|YP_001486998	28.2	149	452	530	2.59e-09	58.2
k141_22192_120	SARG|GQ244501.1.gene1.p01	29.3	188	452	519	7.83e-09	56.6
k141_22192_120	megares|MEG_6996|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TET43_1	29.3	188	452	519	7.83e-09	56.6
k141_22192_120	SARG|YP_002633439	26.2	122	452	388	7.78e-08	53.1
k141_22192_120	CARD|gb|ABV18113.1|ARO:3001329|mdtG	23.5	358	452	408	8.16e-08	53.1
k141_22192_120	SARG|gi|656016562|ref|WP_029056449.1|	27.0	122	452	386	1.81e-07	52.0
k141_22192_120	SARG|gi|516233382|ref|WP_017637345.1|	27.0	122	452	386	1.81e-07	52.0
k141_22192_122	SARG|AAY52004	30.1	276	324	322	8.51e-28	109
k141_22192_122	SARG|KF478993.1.gene2.p01	31.3	256	324	350	1.85e-27	108
k141_22192_122	NCBI|WP_011029109.1|1|1|vanH-Sc|vanH-Sc|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Sc|AMR|glycopeptide	31.6	256	324	337	2.02e-26	105
k141_22192_122	NCBI|WP_063856700.1|1|1|vanH-Ao2|vanH-Ao2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao2|AMR|glycopeptide	30.6	255	324	343	1.53e-25	103
k141_22192_122	NCBI|WP_063856699.1|1|1|vanH-Ao1|vanH-Ao1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao1|AMR|glycopeptide	30.6	255	324	348	1.65e-25	103
k141_22192_122	NCBI|WP_063856698.1|1|1|vanH-Ac1|vanH-Ac1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ac1|AMR|glycopeptide	31.0	258	324	351	6.20e-25	102
k141_22192_122	megares|MEG_7399|Drugs|Glycopeptide|VanA-type_resistance_protein|VANHA_1	32.0	225	324	237	2.23e-24	98.2
k141_22192_122	SARG|gb|MBY8651254.1|ARO:3007188|vanH_in_vanP_cl	27.8	248	324	314	3.92e-18	82.4
k141_22192_123	SARG|WP_000345069.1	28.0	407	427	434	1.90e-54	186
k141_22192_123	SARG|gi|738114161|ref|WP_036072414.1|	27.9	154	427	469	7.79e-07	50.1
k141_22192_123	SARG|gi|489822049|ref|WP_003725847.1|	27.5	182	427	466	2.38e-06	48.5
k141_22192_123	SARG|gi|1005608354|ref|WP_061691305.1|	27.5	182	427	466	2.38e-06	48.5
k141_22192_123	SARG|gi|489823816|ref|WP_003727600.1|	27.5	182	427	466	2.38e-06	48.5
k141_22192_123	SARG|HE999704.1.gene3170.p01	27.5	182	427	466	3.16e-06	48.1
k141_22192_123	SARG|gi|844765894|ref|WP_047933506.1|	27.5	182	427	466	3.16e-06	48.1
k141_22192_123	SARG|gi|933593662|ref|WP_054314487.1|	27.5	182	427	466	3.16e-06	48.1
k141_22192_123	SARG|gi|489865176|ref|WP_003768773.1|	27.5	182	427	466	3.16e-06	48.1
k141_22192_123	SARG|gi|502716012|ref|WP_012951063.1|	27.5	182	427	466	3.16e-06	48.1
k141_22192_133	megares|MEG_8080|Drugs|Lipopeptide|Colistin_phosphoethanolamine_transferase|EPTB_1	99.5	557	558	574	0.0	1129
k141_22192_133	SARG|gb|CCI79240.1|ARO:3005047|eptB	99.5	557	558	574	0.0	1129
k141_22192_133	SARG|gb|BAE78116.1|ARO:3003576|eptA	25.7	549	558	547	4.27e-33	132
k141_22192_138	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	32.4	222	328	255	9.16e-24	97.1
k141_22192_138	SARG|gi|554685678|ref|WP_023185565.1|	33.1	239	328	648	8.05e-22	95.1
k141_22192_138	SARG|gi|754964360|ref|WP_042320280.1|	32.1	240	328	648	1.46e-21	94.4
k141_22192_138	SARG|gi|817104523|ref|WP_046477871.1|	32.4	238	328	648	1.97e-21	94.0
k141_22192_138	SARG|gi|764278838|ref|WP_044327089.1|	32.4	238	328	648	1.97e-21	94.0
k141_22192_138	SARG|gi|922019548|ref|WP_053299973.1|	33.1	239	328	648	2.65e-21	93.6
k141_22192_138	SARG|gi|446048013|ref|WP_000125868.1|	31.8	239	328	648	2.65e-21	93.6
k141_22192_138	SARG|gi|657888313|ref|WP_029592374.1|	31.8	261	328	648	3.58e-21	93.2
k141_22192_138	SARG|YP_001571041	32.2	239	328	648	3.58e-21	93.2
k141_22192_138	SARG|gi|960873409|ref|WP_058345546.1|	32.2	239	328	648	3.58e-21	93.2
k141_22192_139	SARG|gb|AAK76137.1|ARO:3000024|patA	30.3	234	338	564	8.98e-17	80.1
k141_22192_161	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	37.6	425	441	429	2.89e-83	261
k141_22192_163	CARD|gb|ALH22601.1|ARO:3000620|adeL	41.0	288	300	337	1.18e-73	228
k141_22192_181	SARG|gb|AAK76137.1|ARO:3000024|patA	28.6	238	264	564	1.17e-13	69.3
k141_22192_181	SARG|gi|664317010|ref|WP_030845774.1|	28.8	233	264	605	7.18e-13	67.0
k141_22192_181	SARG|gi|663286402|ref|WP_030292859.1|	28.8	233	264	605	7.18e-13	67.0
k141_22192_181	SARG|gi|663342223|ref|WP_030341347.1|	28.8	233	264	605	7.18e-13	67.0
k141_22192_181	SARG|gi|759527374|ref|WP_043247487.1|	28.8	233	264	605	7.18e-13	67.0
k141_22192_181	SARG|gi|664194237|ref|WP_030727956.1|	28.8	233	264	605	7.18e-13	67.0
k141_22192_181	SARG|gi|926286457|ref|WP_053623344.1|	28.3	233	264	605	1.30e-12	66.2
k141_22192_181	SARG|gi|664244930|ref|WP_030776974.1|	28.7	216	264	601	1.75e-12	65.9
k141_22192_181	SARG|gb|WP_104671188.1|ARO:3003948|efrA	26.8	239	264	575	2.31e-12	65.5
k141_22192_181	SARG|gi|1045390184|ref|WP_065479071.1|	28.4	211	264	605	2.35e-12	65.5
k141_22192_182	SARG|gi|497748188|ref|WP_010062372.1|	27.1	229	255	605	2.19e-11	62.4
k141_22192_182	SARG|gi|764446018|ref|WP_044369325.1|	26.6	229	255	605	9.63e-11	60.5
k141_22192_182	SARG|gi|695865802|ref|WP_032778631.1|	26.6	229	255	605	1.29e-10	60.1
k141_22192_182	SARG|gi|695887424|ref|WP_032788534.1|	26.6	229	255	605	1.74e-10	59.7
k141_22192_182	SARG|gi|664180077|ref|WP_030714054.1|	26.6	229	255	605	1.74e-10	59.7
k141_22192_182	SARG|gi|1045390184|ref|WP_065479071.1|	26.6	229	255	605	3.14e-10	58.9
k141_22192_182	SARG|gi|662129758|ref|WP_030081404.1|	26.2	229	255	605	5.67e-10	58.2
k141_22192_182	SARG|gi|664085850|ref|WP_030624018.1|	26.2	229	255	605	7.61e-10	57.8
k141_22192_182	SARG|gi|951183771|ref|WP_057661487.1|	25.8	229	255	603	1.37e-09	57.0
k141_22192_182	SARG|gi|827013130|ref|WP_047175495.1|	26.2	229	255	603	1.37e-09	57.0
k141_22192_189	SARG|gb|AAC75314.1|ARO:3003578|pmrF	86.5	310	328	322	3.70e-196	540
k141_22192_190	SARG|gi|851899656|ref|WP_048211088.1|	80.4	657	662	660	0.0	1103
k141_22192_190	SARG|gi|1002399350|ref|WP_061382108.1|	80.5	657	662	660	0.0	1101
k141_22192_190	SARG|gi|765458296|ref|WP_044714032.1|	80.5	657	662	660	0.0	1101
k141_22192_190	SARG|gi|489117806|ref|WP_003027650.1|	80.5	657	662	660	0.0	1100
k141_22192_190	SARG|gi|696375142|ref|WP_032949690.1|	80.5	657	662	660	0.0	1100
k141_22192_190	SARG|gi|391316952|gb|EIQ74337.1|	80.4	657	662	660	0.0	1100
k141_22192_190	SARG|gi|507079934|ref|WP_016150692.1|	80.4	657	662	660	0.0	1100
k141_22192_190	SARG|gi|851917461|ref|WP_048217311.1|	80.5	657	662	660	0.0	1099
k141_22192_190	SARG|gi|757799830|ref|WP_043017032.1|	80.2	657	662	660	0.0	1096
k141_22192_190	SARG|gi|851981245|ref|WP_048240645.1|	80.4	657	662	660	0.0	1096
k141_22192_192	SARG|gb|CDO12042.1|ARO:3005053|ArnT	98.9	551	552	551	0.0	1066
k141_22192_195	NCBI|AKA30736.1|1|1|cxpE|cxpE||1|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_transporter_CxpE|AMR|phenicol	28.3	127	350	397	1.55e-08	54.7
k141_22192_206	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	34.8	221	223	255	2.79e-41	140
k141_22192_206	SARG|gi|694064328|ref|WP_032410816.1|	34.7	219	223	646	5.18e-37	135
k141_22192_206	SARG|gi|507055561|ref|WP_016126482.1|	27.8	216	223	309	2.34e-20	86.3
k141_22192_206	SARG|gi|488053456|ref|WP_002124853.1|	27.8	216	223	309	3.24e-20	85.9
k141_22192_206	SARG|gi|488068784|ref|WP_002140181.1|	28.3	219	223	309	3.24e-20	85.9
k141_22192_206	SARG|gi|447057510|ref|WP_001134766.1|	28.3	219	223	309	3.24e-20	85.9
k141_22192_206	SARG|gi|447057509|ref|WP_001134765.1|	28.3	219	223	309	4.47e-20	85.5
k141_22192_206	SARG|gi|488067981|ref|WP_002139378.1|	27.3	216	223	309	6.19e-20	85.1
k141_22192_206	SARG|gi|487936534|ref|WP_002010000.1|	27.3	216	223	309	6.19e-20	85.1
k141_22192_206	SARG|gi|488130770|ref|WP_002201978.1|	27.3	216	223	309	8.55e-20	84.7
k141_22192_217	SARG|gb|AYV52072.1|ARO:3002882|lmrD	24.7	231	256	664	2.13e-12	65.5
k141_22192_217	SARG|gb|CDO61516.1|ARO:3003949|efrB	24.7	174	256	362	3.23e-10	58.5
k141_22192_217	SARG|gb|AAK76136.1|ARO:3000025|patB	21.8	225	256	588	6.24e-08	52.0
k141_22192_217	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	28.2	110	256	461	1.83e-07	50.4
k141_22192_217	NCBI|WP_172065992.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	27.3	110	256	461	4.38e-07	49.3
k141_22192_218	SARG|gi|446048013|ref|WP_000125868.1|	28.8	222	238	648	4.46e-21	90.5
k141_22192_218	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	23.4	239	238	579	2.18e-11	62.0
k141_22192_218	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	23.0	239	238	579	7.20e-11	60.5
k141_22192_218	SARG|gb|CDO61516.1|ARO:3003949|efrB	29.1	203	238	362	1.86e-10	58.9
k141_22192_260	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	45.7	232	240	252	2.65e-63	197
k141_22192_260	CARD|gb|AAG05188.1|ARO:3005068|ParR	42.0	231	240	235	9.71e-57	179
k141_22192_260	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	40.4	225	240	232	4.57e-54	172
k141_22192_260	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	40.4	225	240	232	4.57e-54	172
k141_22192_260	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	39.8	226	240	231	1.60e-51	166
k141_22192_260	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	39.8	226	240	231	1.60e-51	166
k141_22192_260	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	40.3	226	240	231	9.06e-51	164
k141_22192_260	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	40.3	226	240	231	1.28e-50	164
k141_22192_260	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	39.4	226	240	231	2.56e-50	163
k141_22192_260	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	39.9	228	240	225	1.21e-49	161
k141_22192_261	CARD|gb|BAB38260.1|ARO:3000830|cpxA	31.7	268	452	457	1.63e-35	135
k141_22192_292	CARD|gb|BAE77933.1|ARO:3000518|CRP	99.0	210	211	210	1.93e-150	415
k141_22192_297	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.1	508	635	655	9.36e-91	293
k141_22192_297	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.1	508	635	655	9.36e-91	293
k141_22192_297	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.9	508	635	655	2.57e-90	292
k141_22192_297	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.9	508	635	655	5.03e-90	291
k141_22192_297	SARG|gb|AKA86814|ARO:3003746|optrA	33.9	508	635	655	5.03e-90	291
k141_22192_297	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.9	508	635	655	1.38e-89	290
k141_22192_297	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.9	508	635	655	1.38e-89	290
k141_22192_297	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.9	508	635	655	1.38e-89	290
k141_22192_297	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.9	508	635	655	1.38e-89	290
k141_22192_297	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.9	508	635	655	1.38e-89	290
k141_22192_299	SARG|ZP_04615639	31.1	527	602	543	1.10e-56	199
k141_22192_299	SARG|gi|740410309|ref|WP_038243756.1|	31.1	527	602	563	1.60e-56	199
k141_22192_299	SARG|YP_001401994	31.2	525	602	563	5.68e-55	194
k141_22192_299	SARG|AAS61092	31.2	525	602	563	5.68e-55	194
k141_22192_299	SARG|ZP_04631861	31.1	527	602	543	7.51e-55	194
k141_22192_299	SARG|ZP_04630103	31.1	527	602	543	1.99e-54	192
k141_22192_299	SARG|ZP_04612557	31.3	527	602	543	2.75e-54	192
k141_22192_299	SARG|ZP_04635128	31.1	527	602	543	2.75e-54	192
k141_22192_299	SARG|ZP_04638974	31.1	527	602	563	2.86e-54	192
k141_22192_299	SARG|YP_001605795	30.9	524	602	562	3.88e-54	192
k141_22192_310	SARG|YP_002850805	26.4	701	705	652	1.29e-73	249
k141_22192_310	SARG|NP_348076	27.2	691	705	652	1.78e-73	249
k141_22192_310	SARG|ZP_02952732	26.2	701	705	652	1.77e-72	246
k141_22192_310	SARG|ZP_02632674	26.2	701	705	660	2.08e-72	246
k141_22192_310	SARG|L20800.gene.p01	26.2	701	705	652	4.73e-72	245
k141_22192_310	SARG|L42544.gene.p01	27.9	685	705	651	6.43e-72	245
k141_22192_310	SARG|AAV80410	27.7	685	705	651	8.79e-71	242
k141_22192_310	megares|MEG_7163|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	27.8	683	705	629	3.57e-65	226
k141_22192_310	ResF|tet(O/W)_5_AM889122_1	27.8	683	705	639	4.31e-65	226
k141_22192_310	NCBI|WP_063856409.1|1|1|tet(Q)|tet(Q)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(Q)|AMR|tetracycline	26.0	665	705	641	1.18e-64	225
k141_22192_311	NCBI|WP_050824634.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	34.2	79	90	639	7.84e-08	47.0
k141_66717_15	SARG|gb|AAC74000.1|ARO:3003950|msbA	91.9	582	583	582	0.0	1016
k141_66717_15	SARG|gi|1045390184|ref|WP_065479071.1|	33.9	570	583	605	1.55e-89	287
k141_66717_15	SARG|gi|948137056|ref|WP_056795395.1|	34.3	571	583	602	5.57e-89	286
k141_66717_15	SARG|gi|695865802|ref|WP_032778631.1|	33.9	570	583	605	6.38e-88	283
k141_66717_15	SARG|gi|664317010|ref|WP_030845774.1|	33.9	570	583	605	2.46e-87	281
k141_66717_15	SARG|gi|648667297|ref|WP_026359044.1|	33.3	570	583	605	2.46e-87	281
k141_66717_15	SARG|gi|663286402|ref|WP_030292859.1|	33.9	570	583	605	2.46e-87	281
k141_66717_15	SARG|gi|663342223|ref|WP_030341347.1|	33.9	570	583	605	2.46e-87	281
k141_66717_15	SARG|gi|759527374|ref|WP_043247487.1|	33.9	570	583	605	2.46e-87	281
k141_66717_15	SARG|gi|664194237|ref|WP_030727956.1|	33.9	570	583	605	2.46e-87	281
k141_66717_29	SARG|gb|WP_122630825.1|ARO:3006873|EAM-1	29.9	87	216	318	7.94e-09	53.5
k141_66717_29	NCBI|WP_043245728.1|1|1|blaPAM-1|blaPAM|hydrolase|2|CARBAPENEM|beta-lactam|subclass_B3_metallo-beta-lactamase_PAM-1|AMR|beta-lactam	32.8	116	216	287	2.40e-08	52.0
k141_66717_29	NCBI|WP_420354156.1|1|1|blaPAM-6|blaPAM|hydrolase|2|CARBAPENEM|beta-lactam|subclass_B3_metallo-beta-lactamase_PAM-6|AMR|beta-lactam	32.8	116	216	287	2.40e-08	52.0
k141_66717_29	NCBI|WP_184489348.1|1|1|blaPAM-5|blaPAM|hydrolase|2|CARBAPENEM|beta-lactam|subclass_B3_metallo-beta-lactamase_PAM-5|AMR|beta-lactam	32.8	116	216	287	2.40e-08	52.0
k141_66717_31	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	58.5	378	360	374	7.00e-149	424
k141_66717_31	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	52.4	359	360	357	1.45e-119	348
k141_66717_40	SARG|gi|895865878|ref|WP_048974758.1|	35.7	230	258	646	2.70e-26	106
k141_66717_40	SARG|gi|507044560|ref|WP_016115614.1|	32.1	212	258	306	2.87e-24	97.8
k141_66717_40	SARG|gi|446026113|ref|WP_000103968.1|	31.6	212	258	306	2.84e-23	95.1
k141_66717_40	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	33.2	202	258	574	4.71e-19	85.1
k141_66717_40	SARG|gb|AAC74000.1|ARO:3003950|msbA	29.6	203	258	582	2.18e-15	74.3
k141_66717_40	SARG|gi|953808775|ref|WP_058042812.1|	31.2	205	258	608	8.07e-14	69.7
k141_66717_40	SARG|AF170880.4.gene1.p01	30.2	205	258	615	1.09e-13	69.3
k141_66717_40	SARG|gi|558888514|ref|WP_023543283.1|	30.2	205	258	615	1.09e-13	69.3
k141_66717_40	SARG|gi|764446018|ref|WP_044369325.1|	30.8	201	258	605	1.46e-13	68.9
k141_66717_40	SARG|gi|695865802|ref|WP_032778631.1|	30.8	201	258	605	1.46e-13	68.9
k141_66717_48	SARG|gb|APB03216.1|ARO:3003982|LlmA	31.3	112	702	287	7.20e-08	53.5
k141_66717_49	SARG|gb|AVI44920.1|ARO:3004470|poxtA	31.6	525	636	542	1.47e-71	239
k141_66717_49	NCBI|WP_209691075.1|1|1|poxtA2|poxtA|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA2|AMR|multidrug	31.6	525	636	544	1.54e-71	239
k141_66717_49	ResF|poxtA-Ef_1_WP094899500.1_1	31.2	523	636	538	1.87e-71	239
k141_66717_49	megares|MEG_8639|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT_1	31.2	523	636	543	2.10e-71	239
k141_66717_49	NCBI|WP_094899500.1|1|1|poxtA-Ef|poxtA-Ef|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA-Ef|AMR|multidrug	31.2	523	636	543	2.10e-71	239
k141_66717_49	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.4	514	636	655	1.14e-66	229
k141_66717_49	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.4	514	636	655	2.20e-66	228
k141_66717_49	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.2	514	636	655	4.22e-66	228
k141_66717_49	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.2	514	636	655	8.11e-66	227
k141_66717_49	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.2	514	636	655	8.11e-66	227
k141_66717_56	megares|MEG_8288|Drugs|beta-lactam|Mutant_porin_proteins|OMPA_1	99.7	356	357	374	1.66e-258	701
k141_66717_56	CARD|gb|CDO13836.1|ARO:3005044|OmpA	99.7	356	357	374	1.66e-258	701
k141_66717_79	CARD|gb|ALH22601.1|ARO:3000620|adeL	32.1	290	314	337	8.12e-37	133
k141_66717_116	NCBI|WP_063856710.1|1|1|vanH-Pt2|vanH-Pt2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Pt2|AMR|glycopeptide	30.8	159	313	322	4.52e-12	64.7
k141_66717_116	SARG|gb|MBY8651254.1|ARO:3007188|vanH_in_vanP_cl	29.7	155	313	314	2.16e-09	56.6
k141_66717_127	CARD|gb|ABV18113.1|ARO:3001329|mdtG	86.8	394	409	408	4.66e-241	660
k141_66717_127	SARG|WP_000136147.1	44.9	392	409	399	4.43e-113	335
k141_66717_127	NCBI|EHE72460.1|1|1|pmrA|pmrA|efflux|1|quinolone|quinolone|multidrug_efflux_MFS_transporter_PmrA|AMR|quinolone	42.6	392	409	371	5.88e-101	303
k141_66717_127	SARG|gi|446964022|ref|WP_001041278.1|	26.2	390	409	388	1.70e-18	85.5
k141_66717_127	SARG|gi|446964023|ref|WP_001041279.1|	26.2	390	409	388	2.30e-18	85.1
k141_66717_127	SARG|gi|686391947|ref|WP_031906419.1|	26.2	390	409	388	2.30e-18	85.1
k141_66717_127	SARG|gi|686115864|ref|WP_031765718.1|	26.2	390	409	388	3.09e-18	84.7
k141_66717_127	SARG|gi|446964030|ref|WP_001041286.1|	25.9	390	409	388	4.17e-18	84.3
k141_66717_127	SARG|gi|446964071|ref|WP_001041327.1|	25.2	385	409	388	4.17e-18	84.3
k141_66717_127	SARG|gi|872477686|ref|WP_048520687.1|	25.6	390	409	388	5.61e-18	84.0
k141_66717_136	SARG|gi|556259963|ref|WP_023287443.1|	100	402	403	402	6.05e-289	781
k141_66717_136	SARG|gi|556196078|ref|WP_023279555.1|	99.8	402	403	402	3.50e-288	779
k141_66717_136	SARG|gi|1031849806|ref|WP_064172465.1|	99.5	402	403	402	3.50e-288	779
k141_66717_136	SARG|gi|895877432|ref|WP_048983389.1|	99.5	402	403	402	4.97e-288	779
k141_66717_136	SARG|gi|694093966|ref|WP_032438582.1|	99.5	402	403	402	7.06e-288	778
k141_66717_136	SARG|gi|1032702279|ref|WP_064278936.1|	99.5	402	403	402	1.00e-287	778
k141_66717_136	SARG|gi|1041907918|ref|WP_065242246.1|	99.5	402	403	402	1.00e-287	778
k141_66717_136	SARG|gi|556280032|ref|WP_023289127.1|	99.5	402	403	402	1.00e-287	778
k141_66717_136	SARG|gi|749603476|ref|WP_040227333.1|	99.5	402	403	402	1.00e-287	778
k141_66717_136	SARG|gi|1031867709|ref|WP_064184126.1|	99.5	402	403	402	1.00e-287	778
k141_66717_174	SARG|AXF35727.1	25.6	203	234	497	8.55e-11	60.1
k141_66717_174	NCBI|AJP12342.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	37.0	81	234	550	2.52e-08	52.8
k141_66717_174	CARD|gb|BAB80490.1|ARO:3007644|Cper_cplR	35.4	79	234	568	1.49e-07	50.4
k141_66717_174	SARG|AAG08983	35.3	85	234	524	8.50e-07	48.1
k141_66717_174	NCBI|WP_063856937.1|1|1|vga(A)|vga(A)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(A)|AMR|lincosamide	37.8	82	234	522	3.68e-06	46.2
k141_66717_174	NCBI|WP_032492560.1|1|1|vga(A)|vga(A)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(A)|AMR|lincosamide	37.8	82	234	522	6.60e-06	45.4
k141_66717_174	SARG|DQ823382.1.gene1.p01	37.8	82	234	522	6.60e-06	45.4
k141_66717_174	megares|MEG_7687|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|VGA_1	37.8	82	234	522	6.60e-06	45.4
k141_66717_174	megares|MEG_7686|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|VGA_1	37.8	82	234	522	6.60e-06	45.4
k141_66717_174	SARG|KC539823.1.gene1.p01	37.8	82	234	522	6.60e-06	45.4
k141_49866_36	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	48.7	228	233	225	2.42e-66	203
k141_49866_36	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	39.0	236	233	252	2.94e-49	160
k141_49866_36	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	39.6	230	233	231	3.24e-49	160
k141_49866_36	CARD|gb|AAG05188.1|ARO:3005068|ParR	37.1	229	233	235	1.03e-48	159
k141_49866_36	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	37.6	229	233	230	5.01e-48	157
k141_49866_36	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	38.1	226	233	232	7.49e-48	156
k141_49866_36	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	37.5	224	233	231	1.03e-47	156
k141_49866_36	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	38.5	231	233	231	5.80e-47	154
k141_49866_36	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	38.8	227	233	231	1.16e-46	153
k141_49866_36	NCBI|WP_034872470.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	38.8	227	233	231	1.63e-46	153
k141_49866_37	CARD|gb|BAB38260.1|ARO:3000830|cpxA	93.7	457	458	457	1.06e-310	841
k141_49866_37	CARD|gb|ADM92606.1|ARO:3000549|adeS	28.7	275	458	361	6.35e-18	84.0
k141_49866_37	CARD|gb|CYF42523.1|ARO:3004047|kdpD	23.6	212	458	885	1.28e-11	65.9
k141_49866_47	NCBI|QHA94808.1|1|1|narA|narA||1|MADURAMICIN/NARASIN/SALINOMYCIN|IONOPHORE|ionophore_ABC_transporter_ATP-binding_subunit_NarA|AMR|ionophore	31.1	228	504	293	1.38e-23	99.8
k141_49866_47	SARG|gb|AAC75271.1|ARO:3003952|yojI	35.0	197	504	547	5.04e-18	85.9
k141_49866_47	SARG|gi|507023808|ref|WP_016095885.1|	27.8	230	504	309	9.52e-16	77.0
k141_49866_47	SARG|gi|447057509|ref|WP_001134765.1|	28.3	230	504	309	1.28e-15	76.6
k141_49866_47	SARG|gi|488068784|ref|WP_002140181.1|	27.8	230	504	309	1.72e-15	76.3
k141_49866_47	SARG|gi|488067981|ref|WP_002139378.1|	27.8	230	504	309	2.32e-15	75.9
k141_49866_47	SARG|gi|487936534|ref|WP_002010000.1|	27.8	230	504	309	2.32e-15	75.9
k141_49866_47	SARG|gi|445996719|ref|WP_000074574.1|	27.7	231	504	309	3.11e-15	75.5
k141_49866_47	SARG|gi|488120365|ref|WP_002191762.1|	27.4	230	504	309	3.11e-15	75.5
k141_49866_47	SARG|gi|488130770|ref|WP_002201978.1|	28.3	230	504	309	4.18e-15	75.1
k141_49866_74	NCBI|WP_011906899.1|1|1|estDL136|estDL136||2|CHLORAMPHENICOL/FLORFENICOL|PHENICOL|phenicol_hydrolase|AMR|phenicol	37.5	248	306	308	6.39e-48	161
k141_49866_74	megares|MEG_2865|Drugs|Phenicol|Chloramphenicol_hydrolase|ESTD_1	39.2	240	306	310	4.35e-45	154
k141_49866_79	SARG|FN594949.1.gene24.p01	46.2	130	608	640	4.42e-25	108
k141_49866_79	NCBI|WP_003454408.1|1|1|tet(44)|tet(44)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(44)|AMR|tetracycline	46.2	130	608	640	4.42e-25	108
k141_49866_79	SARG|ABV82118	44.6	130	608	639	5.70e-24	105
k141_49866_79	SARG|ZP_03989103	44.6	130	608	639	7.57e-24	105
k141_49866_79	SARG|ABV82120	44.6	130	608	639	7.57e-24	105
k141_49866_82	CARD|gb|AAK37618.1|ARO:3005008|TxR	41.5	248	470	318	2.80e-56	188
k141_49866_82	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.3	109	470	219	1.51e-09	57.0
k141_49866_82	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.3	109	470	219	1.51e-09	57.0
k141_49866_82	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.3	109	470	220	1.53e-09	57.0
k141_49866_82	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.3	109	470	220	2.07e-09	56.6
k141_49866_82	SARG|ZP_02848503	32.7	101	470	221	5.14e-09	55.5
k141_49866_82	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	31.3	99	470	220	5.52e-08	52.4
k141_29811_32	CARD|gb|AAL19308.1|ARO:3000504|golS	34.9	129	142	154	7.89e-18	73.9
k141_29811_37	SARG|B1LLK9	28.8	302	316	660	9.57e-35	132
k141_29811_37	SARG|gi|757799830|ref|WP_043017032.1|	28.8	302	316	660	2.43e-34	131
k141_29811_37	SARG|gi|507086291|ref|WP_016157032.1|	28.5	309	316	660	3.31e-34	130
k141_29811_37	SARG|gi|487375894|ref|WP_001649055.1|	27.8	302	316	660	8.40e-34	129
k141_29811_37	SARG|gi|851935911|ref|WP_048224705.1|	28.1	302	316	660	1.15e-33	129
k141_29811_37	SARG|gi|1002399350|ref|WP_061382108.1|	28.1	302	316	660	1.15e-33	129
k141_29811_37	SARG|gi|851917461|ref|WP_048217311.1|	28.1	302	316	660	2.13e-33	128
k141_29811_37	SARG|gi|446783041|ref|WP_000860297.1|	28.1	302	316	660	2.13e-33	128
k141_29811_37	SARG|gi|692997842|ref|WP_032184680.1|	28.1	302	316	660	2.90e-33	128
k141_29811_37	SARG|gi|754613472|ref|WP_042002901.1|	28.1	302	316	660	2.90e-33	128
k141_59380_24	CARD|gb|ALH22601.1|ARO:3000620|adeL	38.2	285	302	337	8.01e-66	208
k141_59380_26	SARG|gi|503803351|ref|WP_014037345.1|	38.4	73	287	290	1.22e-08	53.9
k141_59380_26	SARG|gi|896491778|ref|WP_049401445.1|	36.1	72	287	290	5.35e-08	52.0
k141_59380_26	SARG|gi|896523630|ref|WP_049427757.1|	36.1	72	287	290	5.35e-08	52.0
k141_59380_26	SARG|gi|83284971|gb|ABC02083.1|	36.1	72	287	290	5.35e-08	52.0
k141_59380_26	SARG|gi|923080094|ref|WP_053463073.1|	34.2	73	287	289	9.59e-08	51.2
k141_59380_26	NCBI|WP_304486996.1|1|1|blaL1|blaL1|hydrolase|2|||L1_family_subclass_B3_metallo-beta-lactamase|AMR|beta-lactam	37.0	73	287	290	9.63e-08	51.2
k141_59380_26	SARG|gi|727707622|ref|WP_033831205.1|	29.0	162	287	289	1.29e-07	50.8
k141_59380_26	SARG|ABO61000	37.0	73	287	289	1.73e-07	50.4
k141_59380_26	SARG|gi|896572065|ref|WP_049467111.1|	37.0	73	287	289	1.73e-07	50.4
k141_59380_26	SARG|gi|1032611298|ref|WP_064238644.1|	37.0	73	287	289	1.73e-07	50.4
k141_59380_32	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	33.3	237	342	574	1.50e-25	106
k141_59380_32	SARG|gi|507055561|ref|WP_016126482.1|	27.7	224	342	309	2.14e-23	97.4
k141_59380_32	SARG|gi|446026113|ref|WP_000103968.1|	29.6	206	342	306	3.87e-23	96.7
k141_59380_32	SARG|gi|895736250|emb|COF64653.1|	27.2	224	342	309	5.58e-23	96.3
k141_59380_32	SARG|gi|446110087|ref|WP_000187942.1|	27.2	224	342	309	5.58e-23	96.3
k141_59380_32	SARG|gi|445996714|ref|WP_000074569.1|	27.2	224	342	309	5.58e-23	96.3
k141_59380_32	SARG|gi|445996708|ref|WP_000074563.1|	27.7	224	342	309	7.68e-23	95.9
k141_59380_32	SARG|gi|445996722|ref|WP_000074577.1|	28.1	224	342	309	7.68e-23	95.9
k141_59380_32	SARG|gi|447195835|ref|WP_001273091.1|	28.1	224	342	306	1.01e-22	95.5
k141_59380_32	SARG|gi|500465078|gb|EOP76697.1|	26.9	227	342	306	1.01e-22	95.5
k141_59380_47	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	98.9	374	375	374	1.57e-279	755
k141_59380_47	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	53.5	368	375	357	4.09e-128	371
k141_59380_51	SARG|AAD41881	35.6	312	330	323	3.50e-59	192
k141_59380_51	SARG|gi|552942232|ref|WP_023043160.1|	34.9	312	330	323	6.95e-59	191
k141_59380_51	SARG|AAD51059	35.3	312	330	323	3.86e-58	189
k141_59380_51	SARG|AAR37059	35.4	314	330	323	3.86e-58	189
k141_59380_51	NCBI|WP_063856705.1|1|1|vanH-D|vanH-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-D|AMR|glycopeptide	34.6	312	330	323	3.86e-58	189
k141_59380_51	SARG|AY082011.1.gene6.p01	34.6	312	330	323	5.44e-58	189
k141_59380_51	SARG|AAD42183	35.3	312	330	322	8.22e-57	186
k141_59380_51	NCBI|WP_063856700.1|1|1|vanH-Ao2|vanH-Ao2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao2|AMR|glycopeptide	39.2	263	330	343	3.12e-55	182
k141_59380_51	NCBI|WP_063856699.1|1|1|vanH-Ao1|vanH-Ao1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao1|AMR|glycopeptide	39.2	263	330	348	1.96e-54	180
k141_59380_51	NCBI|WP_063856698.1|1|1|vanH-Ac1|vanH-Ac1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ac1|AMR|glycopeptide	33.3	321	330	351	8.28e-54	179
k141_59380_79	SARG|NC_008702.1.4608931.p01	33.0	457	460	473	2.46e-56	192
k141_59380_79	NCBI|AAY90615.1|1|1|emhC|emhC||1|EFFLUX|EFFLUX|efflux_RND_transporter_outer_membrane_subunit_EmhC|AMR|efflux	30.3	466	460	486	1.32e-51	180
k141_59380_79	NCBI|AAQ92182.1|1|1|emhC|emhC||1|EFFLUX|EFFLUX|efflux_RND_transporter_outer_membrane_subunit_EmhC|AMR|efflux	31.8	446	460	486	3.57e-51	179
k141_59380_79	SARG|gb|CAJ77855.1|ARO:3000779|adeH	28.8	431	460	483	3.27e-45	163
k141_59380_79	SARG|gb|AAG05913.1|ARO:3004072|OpmB	29.6	476	460	498	1.12e-44	162
k141_59380_79	CARD|gb|AAX14803.1|ARO:3000782|adeK	29.6	453	460	484	6.23e-44	159
k141_59380_79	SARG|gb|BAM10414.1|ARO:3003039|oprA	28.3	460	460	467	8.42e-42	153
k141_59380_79	NCBI|AAD15665.1|1|1|tbtM|tbtM||1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_outer_membrane_channel_subunit_TbtM|AMR|efflux	29.4	469	460	476	9.76e-42	153
k141_59380_79	SARG|YP_001949526	28.0	468	460	511	1.21e-41	154
k141_59380_79	SARG|ZP_03583211	28.0	468	460	516	1.30e-41	154
k141_59380_80	SARG|gi|896186420|ref|WP_049196554.1|	30.1	352	362	391	6.97e-39	141
k141_59380_80	SARG|gi|490366423|ref|WP_004246087.1|	30.1	352	362	391	6.97e-39	141
k141_59380_80	SARG|gi|1012702223|ref|WP_062814406.1|	30.1	352	362	391	9.71e-39	141
k141_59380_80	SARG|gi|896217236|ref|WP_049220241.1|	30.1	352	362	391	9.71e-39	141
k141_59380_80	SARG|CP004022.1.gene547.p01	30.1	352	362	391	9.71e-39	141
k141_59380_80	SARG|gi|896193189|ref|WP_049201850.1|	31.6	313	362	391	1.88e-38	140
k141_59380_80	SARG|gi|896195525|ref|WP_049203604.1|	31.6	313	362	391	1.88e-38	140
k141_59380_80	SARG|gi|1036665295|ref|WP_064719275.1|	30.9	311	362	391	1.36e-37	138
k141_59380_80	SARG|gi|739067214|ref|WP_036938621.1|	29.8	346	362	392	1.92e-37	137
k141_59380_80	SARG|gi|857775939|emb|CRL64640.1|	30.5	311	362	392	2.67e-36	134
k141_59380_83	CARD|gb|ALH22601.1|ARO:3000620|adeL	26.7	281	316	337	4.57e-26	104
k141_59380_92	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	38.5	421	442	429	8.29e-96	293
k141_59380_170	SARG|gb|AAG05187.1|ARO:3005067|ParS	32.9	432	434	428	3.43e-67	219
k141_59380_170	CARD|gb|BAB38260.1|ARO:3000830|cpxA	31.7	300	434	457	5.34e-39	145
k141_59380_170	NCBI|WP_063856734.1|1|1|vanS-E|vanS-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-E|AMR|glycopeptide	28.5	214	434	357	1.53e-14	73.6
k141_59380_170	megares|MEG_7511|Drugs|Glycopeptide|VanE-type_regulator|VANSE_1	28.5	214	434	357	1.53e-14	73.6
k141_59380_173	CARD|gb|AAG05188.1|ARO:3005068|ParR	46.6	238	240	235	5.69e-69	211
k141_59380_173	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	38.0	237	240	252	2.90e-45	150
k141_59380_173	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	34.3	233	240	228	4.91e-37	129
k141_59380_173	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	34.1	232	240	232	4.24e-36	126
k141_59380_173	CARD|gb|AAD51348.1|ARO:3003066|smeR	33.5	233	240	229	3.35e-34	121
k141_59380_173	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	30.4	230	240	231	2.28e-31	114
k141_59380_173	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	29.5	234	240	225	3.89e-31	113
k141_59380_173	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	29.1	230	240	231	2.46e-30	111
k141_59380_173	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	29.1	230	240	231	2.46e-30	111
k141_59380_173	NCBI|XSG12259.1|1|1|drcR|drcR||1|||daptomycin_efflux_response_regulator_transcription_factor_DrcR|AMR|peptide	30.1	229	240	223	1.51e-24	96.3
k141_59380_217	NCBI|AKA30736.1|1|1|cxpE|cxpE||1|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_transporter_CxpE|AMR|phenicol	22.0	337	345	397	1.50e-08	54.7
k141_59380_218	CARD|gb|BAH63251.1|ARO:3004580|Kpne_KpnE	99.2	120	121	120	2.49e-73	213
k141_59380_218	SARG|gb|CAD55144.1|ARO:3007014|qacJ	35.8	95	121	107	1.44e-11	55.8
k141_59380_218	SARG|gb|AEH26330.1|ARO:3005009|qacE	29.6	98	121	110	4.71e-10	52.0
k141_59380_218	SARG|gb|WP_015740450.1|ARO:3007015|qacG	32.4	102	121	107	6.22e-10	51.6
k141_59380_218	SARG|gb|AAZ42322.1|ARO:3003836|qacH	30.7	101	121	110	1.31e-09	50.8
k141_59380_218	SARG|gb|CAA76544.1|ARO:3003836|qacH	27.8	97	121	107	3.42e-09	49.7
k141_59380_218	SARG|gb|AAG08375.1|ARO:3004038|Pseudomonas	27.1	96	121	110	3.63e-09	49.7
k141_59380_218	SARG|NC_010410.6003348.p01	31.6	95	121	109	5.00e-09	49.3
k141_59380_218	SARG|gb|AAC44316.1|ARO:3005010|qacEdelta1	26.9	104	121	115	5.63e-09	49.3
k141_59380_218	SARG|gi|643599925|ref|WP_025237077.1|	36.8	95	121	110	1.08e-07	45.8
k141_59380_219	CARD|gb|BAH63252.1|ARO:3004583|Kpne_KpnF	100	109	110	109	1.11e-73	213
k141_59380_224	NCBI|WP_115421099.1|1|1|cml_Ensi|cml_Ensi|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	30.9	165	417	400	3.13e-10	60.5
k141_59380_224	megares|MEG_8021|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML_1	30.9	165	417	400	3.13e-10	60.5
k141_59380_224	SARG|AF034958.gene.p01	24.2	277	417	409	4.27e-10	60.1
k141_59380_224	megares|MEG_1774|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLB_1	24.2	277	417	409	4.27e-10	60.1
k141_59380_224	SARG|gi|851982891|ref|WP_048241697.1|	29.5	220	417	413	7.63e-10	59.3
k141_59380_224	SARG|CAI29522	28.3	300	417	418	7.72e-10	59.3
k141_59380_224	megares|MEG_1758|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	28.3	300	417	418	7.72e-10	59.3
k141_59380_224	SARG|gi|754956476|ref|WP_042312591.1|	29.1	220	417	413	1.35e-09	58.5
k141_59380_224	SARG|gi|491276012|ref|WP_005134118.1|	29.1	220	417	413	1.35e-09	58.5
k141_59380_224	megares|MEG_1770|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	27.5	305	417	390	1.68e-09	58.2
k141_114211_1	NCBI|WP_050824634.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	34.2	79	90	639	7.84e-08	47.0
k141_70034_6	SARG|gb|ALV80601.1|ARO:3003801|bcr-1	38.3	107	457	402	7.05e-13	68.9
k141_70034_6	SARG|YP_808159	32.3	127	457	387	2.03e-10	61.2
k141_70034_6	SARG|ZP_04648601	31.5	127	457	384	6.28e-10	59.7
k141_70034_6	SARG|ZP_03982909	31.5	127	457	394	6.49e-10	59.7
k141_70034_6	SARG|ZP_03948381	31.5	127	457	394	6.49e-10	59.7
k141_70034_6	SARG|AAY21388	31.5	127	457	384	1.11e-09	58.9
k141_70034_6	NCBI|WP_061345584.1|1|1|cml_Ochro|cml_Ochro|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	26.0	181	457	397	6.35e-09	56.6
k141_70034_6	NCBI|WP_430673474.1|1|1|nms|nms||2|AMIKACIN/CLINDAMYCIN/DOXYCYCLINE/ERYTHROMYCIN/GENTAMICIN/MINOCYCLINE/PLEUROMUTILIN/TETRACYCLINE|aminoglycoside/LINCOSAMIDE/MACROLIDE/PLEUROMUTILIN/TETRACYCLINE|multidrug_efflux_MFS_transporter_Nms|AMR|multidrug	30.1	136	457	374	2.45e-08	54.7
k141_70034_6	NCBI|WP_115421099.1|1|1|cml_Ensi|cml_Ensi|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	33.3	144	457	400	2.64e-08	54.7
k141_70034_6	megares|MEG_8021|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML_1	33.3	144	457	400	2.64e-08	54.7
k141_70034_17	SARG|gi|331067648|gb|EGI39050.1|	32.5	295	388	391	4.35e-34	129
k141_70034_17	SARG|B7NR12	32.8	287	388	391	8.33e-34	128
k141_70034_17	SARG|gi|446008139|ref|WP_000085994.1|	32.8	287	388	391	8.33e-34	128
k141_70034_17	SARG|gi|545297915|ref|WP_021578120.1|	32.8	287	388	391	8.33e-34	128
k141_70034_17	SARG|B1LL36	32.8	287	388	391	1.15e-33	128
k141_70034_17	SARG|gi|446008144|ref|WP_000085999.1|	32.8	287	388	391	1.15e-33	128
k141_70034_17	SARG|A7ZTR5	32.8	287	388	391	1.15e-33	128
k141_70034_17	SARG|YP_405598	32.8	287	388	391	1.15e-33	128
k141_70034_17	SARG|gi|754720184|ref|WP_042093261.1|	32.8	287	388	391	1.59e-33	127
k141_70034_17	SARG|B7NF27	32.4	287	388	391	1.59e-33	127
k141_70034_18	SARG|gi|475005571|emb|CCP13702.1|	45.0	449	455	471	3.57e-106	322
k141_70034_18	CARD|gb|AAD51346.1|ARO:3003053|smeC	44.1	449	455	471	4.49e-104	317
k141_70034_18	SARG|NC_008702.1.4606278.p01	42.7	468	455	467	9.84e-99	303
k141_70034_18	NCBI|AAQ92182.1|1|1|emhC|emhC||1|EFFLUX|EFFLUX|efflux_RND_transporter_outer_membrane_subunit_EmhC|AMR|efflux	40.6	463	455	486	6.35e-92	286
k141_70034_18	NCBI|AAY90615.1|1|1|emhC|emhC||1|EFFLUX|EFFLUX|efflux_RND_transporter_outer_membrane_subunit_EmhC|AMR|efflux	40.2	465	455	486	3.54e-91	284
k141_70034_18	ResF|TOprJ4_1_CP091084_1	41.1	462	455	476	2.32e-89	279
k141_70034_18	NCBI|AAD15665.1|1|1|tbtM|tbtM||1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_outer_membrane_channel_subunit_TbtM|AMR|efflux	41.1	467	455	476	3.26e-89	278
k141_70034_18	NCBI|WP_088903432.1|1|1|toprJ2|toprJ||2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_transporter_outer_membrane_subunit_TOprJ2|AMR|tetracycline	41.9	449	455	477	1.32e-88	277
k141_70034_18	NCBI|WP_003152694.1|1|1|toprJ1|toprJ||2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_transporter_outer_membrane_subunit_TOprJ1|AMR|tetracycline	41.6	449	455	477	7.35e-88	275
k141_70034_18	SARG|CAC14596	40.8	448	455	466	6.58e-86	270
k141_70034_19	NCBI|AAN38824.2|1|1|adeE|adeE|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_AdeE|AMR|efflux	57.8	1031	1036	1036	0.0	1093
k141_70034_19	SARG|CP000647.1.gene3710.p01	58.0	1032	1036	1036	0.0	1092
k141_70034_19	SARG|gi|694076105|ref|WP_032421853.1|	58.0	1032	1036	1036	0.0	1092
k141_70034_19	SARG|gi|496667122|ref|WP_009309612.1|	57.9	1032	1036	1036	0.0	1091
k141_70034_19	CARD|gb|AAC73564.1|ARO:3000216|acrB	57.2	1040	1036	1049	0.0	1090
k141_70034_19	SARG|gi|556290479|ref|WP_023291164.1|	57.9	1032	1036	1036	0.0	1090
k141_70034_19	SARG|gi|447196024|ref|WP_001273280.1|	57.2	1033	1036	1037	0.0	1085
k141_70034_19	SARG|gi|487663012|ref|WP_001752778.1|	57.1	1033	1036	1037	0.0	1085
k141_70034_19	SARG|gi|817600095|ref|WP_046594084.1|	57.1	1033	1036	1037	0.0	1083
k141_70034_19	SARG|gi|817604860|ref|WP_046598079.1|	57.1	1033	1036	1037	0.0	1082
k141_70034_20	SARG|gi|960884274|ref|WP_058355529.1|	52.8	375	375	383	2.99e-111	329
k141_70034_20	SARG|gi|959849088|ref|WP_058134093.1|	52.5	375	375	383	8.49e-111	328
k141_70034_20	SARG|gi|759812131|ref|WP_043509561.1|	52.5	375	375	383	1.20e-110	327
k141_70034_20	SARG|gi|730361989|ref|WP_033999032.1|	52.8	375	375	383	1.20e-110	327
k141_70034_20	SARG|gi|384397570|gb|EIE43981.1|	52.5	375	375	377	1.40e-110	327
k141_70034_20	SARG|gi|950484392|ref|WP_057379444.1|	52.5	375	375	383	1.70e-110	327
k141_70034_20	SARG|gi|553772752|ref|WP_023104683.1|	52.5	375	375	383	1.70e-110	327
k141_70034_20	SARG|gi|553784544|ref|WP_023116004.1|	52.5	375	375	383	1.70e-110	327
k141_70034_20	SARG|gi|757606897|ref|WP_042853548.1|	52.5	375	375	383	1.70e-110	327
k141_70034_20	SARG|gi|685985750|ref|WP_031692208.1|	52.5	375	375	383	1.70e-110	327
k141_70034_34	SARG|Q83LR7	35.3	221	620	648	4.26e-17	84.0
k141_70034_34	SARG|gi|647325472|ref|WP_025760953.1|	35.3	221	620	648	4.26e-17	84.0
k141_70034_34	SARG|gi|647323678|ref|WP_025760497.1|	35.3	221	620	648	4.26e-17	84.0
k141_70034_34	SARG|gi|1035686596|ref|WP_064530178.1|	35.3	221	620	648	4.26e-17	84.0
k141_70034_34	SARG|gi|446110305|ref|WP_000188160.1|	35.3	221	620	648	9.84e-17	82.8
k141_70034_34	SARG|gi|974672242|ref|WP_059256507.1|	33.8	228	620	648	3.00e-16	81.3
k141_70034_34	SARG|gi|974641719|ref|WP_059227752.1|	33.8	228	620	648	3.00e-16	81.3
k141_70034_34	SARG|gi|693054987|ref|WP_032223114.1|	34.4	221	620	648	3.00e-16	81.3
k141_70034_34	SARG|gi|446110299|ref|WP_000188154.1|	33.8	228	620	648	3.00e-16	81.3
k141_70034_34	SARG|ZP_02903696	33.8	228	620	648	3.00e-16	81.3
k141_70034_46	CARD|gb|AAA99503.1|ARO:3003250|bcrC	26.6	184	198	203	3.66e-15	69.7
k141_70034_47	SARG|YP_001334540	99.8	410	411	410	1.75e-292	791
k141_70034_47	SARG|gi|1044124951|emb|SBX86682.1|	99.8	410	411	410	5.01e-292	790
k141_70034_47	SARG|gi|1044002084|emb|SBX40186.1|	99.5	410	411	410	7.12e-292	789
k141_70034_47	SARG|gi|1044109257|emb|SBZ85298.1|	99.5	410	411	410	1.01e-291	789
k141_70034_47	SARG|YP_002239509	99.5	409	411	410	3.38e-290	785
k141_70034_47	SARG|gi|410113988|emb|CCM84499.1|	99.7	394	411	394	1.49e-280	760
k141_70034_47	SARG|YP_002848751	89.0	410	411	410	2.12e-261	712
k141_70034_47	SARG|ZP_02775049	87.8	410	411	410	3.51e-260	709
k141_70034_47	SARG|NP_752857	87.8	410	411	420	5.10e-260	709
k141_70034_47	SARG|YP_668774	87.8	410	411	410	7.08e-260	708
k141_70034_59	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	35.5	200	389	255	2.70e-34	126
k141_70034_59	SARG|gi|895865878|ref|WP_048974758.1|	34.7	225	389	646	2.74e-29	118
k141_70034_59	SARG|gi|639209604|ref|WP_024547784.1|	34.4	227	389	648	2.19e-25	107
k141_70034_64	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	44.6	231	239	228	7.96e-62	192
k141_70034_64	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	41.2	226	239	231	5.66e-60	187
k141_70034_64	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	41.9	227	239	232	4.28e-57	180
k141_70034_64	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	38.3	230	239	233	2.91e-52	168
k141_70034_64	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	37.9	232	239	239	3.47e-52	168
k141_70034_64	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	38.9	234	239	235	2.46e-51	166
k141_70034_64	CARD|gb|ATC67679.1|ARO:3000838|arlR	41.1	224	239	219	1.74e-50	163
k141_70034_64	CARD|gb|AAG05188.1|ARO:3005068|ParR	39.4	231	239	235	3.93e-50	162
k141_70034_64	NCBI|WP_063856727.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	38.3	230	239	232	2.03e-49	160
k141_70034_64	NCBI|WP_016295750.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	38.3	230	239	232	2.87e-49	160
k141_70034_65	NCBI|WP_063856748.1|1|1|vanS-M|vanS-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-M|AMR|glycopeptide	30.7	257	491	370	4.70e-28	114
k141_70034_65	NCBI|WP_006285582.1|1|1|vanS-F|vanS-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-F|AMR|glycopeptide	28.8	264	491	365	6.15e-26	107
k141_70034_65	NCBI|AXB64455.1|1|1|vanS-Cd|vanS-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|VanG-Cd-type_glycopeptide_resistance_histidine_kinase_VanS|AMR|glycopeptide	26.4	227	491	380	5.41e-24	102
k141_70034_65	megares|MEG_7498|Drugs|Glycopeptide|VanC-type_regulator|VANSC_1	26.4	227	491	380	5.41e-24	102
k141_70034_65	NCBI|WP_063856732.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	25.4	236	491	367	4.76e-21	93.6
k141_70034_65	NCBI|WP_021418927.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	25.4	236	491	368	4.82e-21	93.6
k141_70034_65	CARD|gb|AEX49906.1|ARO:3003583|basS	27.7	364	491	477	2.04e-20	92.8
k141_70034_65	SARG|gb|AAG05187.1|ARO:3005067|ParS	29.8	309	491	428	2.71e-20	92.0
k141_70034_65	NCBI|WP_063856744.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	24.6	252	491	381	8.03e-20	90.1
k141_70034_65	megares|MEG_7504|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	24.6	252	491	381	8.03e-20	90.1
k141_70034_70	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	33.0	221	243	325	1.72e-31	117
k141_70034_70	SARG|gb|AAA26793|ARO:3003748|oleC	33.0	221	243	325	3.36e-31	116
k141_70034_70	SARG|gb|AAR96051.1|ARO:3002894|otrC	26.8	228	243	351	1.17e-14	71.2
k141_70034_70	megares|MEG_4383|Drugs|Tetracycline|Tetracycline_resistance_ABC_efflux_pumps|OTRC_1	26.8	228	243	351	2.17e-14	70.5
k141_70034_85	SARG|CP000647.1.gene911.p01	100	371	372	371	1.38e-251	684
k141_70034_85	SARG|gi|1031832983|ref|WP_064159164.1|	99.7	371	372	371	5.61e-251	682
k141_70034_85	SARG|gi|942456329|ref|WP_055316401.1|	99.7	371	372	371	5.61e-251	682
k141_70034_85	SARG|gi|694073946|ref|WP_032419781.1|	99.7	371	372	371	5.61e-251	682
k141_70034_85	SARG|gi|746036851|ref|WP_039108682.1|	99.7	371	372	371	7.96e-251	682
k141_70034_85	SARG|gi|490295688|ref|WP_004191152.1|	99.7	371	372	371	7.96e-251	682
k141_70034_85	SARG|gi|742286387|ref|WP_038808052.1|	99.7	371	372	371	1.13e-250	682
k141_70034_85	SARG|gi|694079011|ref|WP_032424286.1|	99.5	371	372	371	1.13e-250	682
k141_70034_85	SARG|gi|749533846|ref|WP_040169856.1|	99.5	371	372	371	1.13e-250	682
k141_70034_85	SARG|gi|1031818725|ref|WP_064146978.1|	99.5	371	372	371	1.13e-250	682
k141_70034_86	SARG|gi|501015807|ref|WP_012068502.1|	100	646	647	646	0.0	1223
k141_70034_86	SARG|gi|490320210|ref|WP_004209695.1|	99.8	646	647	646	0.0	1222
k141_70034_86	SARG|BAH62608	99.7	646	647	646	0.0	1221
k141_70034_86	SARG|gi|1031835425|ref|WP_064161077.1|	99.5	646	647	646	0.0	1219
k141_70034_86	SARG|gi|490295685|ref|WP_004191149.1|	99.5	646	647	646	0.0	1219
k141_70034_86	SARG|gi|1031836330|ref|WP_064161764.1|	99.5	646	647	646	0.0	1219
k141_70034_86	SARG|gi|544902100|ref|WP_021313340.1|	99.5	646	647	646	0.0	1219
k141_70034_86	SARG|gi|1031833294|ref|WP_064159420.1|	99.5	646	647	646	0.0	1219
k141_70034_86	SARG|gi|1043941253|emb|SBY03087.1|	99.5	646	647	646	0.0	1219
k141_70034_86	SARG|gi|749538518|ref|WP_040174114.1|	99.5	646	647	646	0.0	1219
k141_70034_92	SARG|gb|AAC74000.1|ARO:3003950|msbA	28.2	521	574	582	9.70e-50	180
k141_70034_92	SARG|gi|928900436|ref|WP_053931243.1|	26.4	565	574	600	1.87e-46	171
k141_70034_92	SARG|gi|664244930|ref|WP_030776974.1|	27.1	524	574	601	1.90e-46	171
k141_70034_92	SARG|gi|664579989|ref|WP_031094015.1|	26.4	565	574	601	1.90e-46	171
k141_70034_92	SARG|gi|948137056|ref|WP_056795395.1|	26.0	561	574	602	4.95e-46	170
k141_70034_92	SARG|gi|764446018|ref|WP_044369325.1|	25.8	565	574	605	1.81e-45	168
k141_70034_92	SARG|gi|664180077|ref|WP_030714054.1|	25.8	565	574	605	1.81e-45	168
k141_70034_92	SARG|gi|664458452|ref|WP_030980047.1|	27.2	566	574	601	2.36e-45	168
k141_70034_92	SARG|gi|695887424|ref|WP_032788534.1|	25.4	566	574	605	2.48e-45	168
k141_70034_92	SARG|gi|664395661|ref|WP_030922045.1|	26.5	565	574	601	3.23e-45	167
k141_70034_93	SARG|gi|1043542993|ref|WP_065386235.1|	24.3	251	589	492	1.76e-06	49.7
k141_70034_93	SARG|gi|922777287|ref|WP_053374995.1|	24.3	251	589	492	1.76e-06	49.7
k141_70034_93	SARG|ZP_04433622	25.2	230	589	498	7.10e-06	47.8
k141_70034_93	SARG|gi|488327681|ref|WP_002397066.1|	25.2	230	589	498	7.10e-06	47.8
k141_70034_93	SARG|gi|488319039|ref|WP_002388424.1|	25.0	248	589	498	7.10e-06	47.8
k141_70034_93	SARG|gi|488322547|ref|WP_002391932.1|	25.0	248	589	498	7.10e-06	47.8
k141_106705_12	megares|MEG_497|Drugs|beta-lactam|Class_C_betalactamases|ACT_1	58.4	77	178	77	1.72e-29	102
k141_106705_14	SARG|gi|499256187|ref|WP_010953727.1|	26.2	1044	1050	1042	3.52e-69	250
k141_106705_14	SARG|YP_608682	25.2	1050	1050	1042	1.00e-66	243
k141_106705_14	SARG|gi|496339859|ref|WP_009049037.1|	24.8	1050	1050	1043	4.43e-66	241
k141_106705_14	SARG|gi|1011729993|ref|WP_062573631.1|	25.3	1057	1050	1042	1.07e-65	239
k141_106705_14	SARG|YP_001668663	24.7	1056	1050	1043	1.94e-65	239
k141_106705_14	SARG|gi|757680562|ref|WP_042911120.1|	24.9	1054	1050	1043	8.86e-64	234
k141_106705_14	SARG|gi|759350549|ref|WP_043081214.1|	24.9	1054	1050	1043	8.86e-64	234
k141_106705_14	SARG|gi|553756961|ref|WP_023089641.1|	24.8	1054	1050	1043	1.19e-63	233
k141_106705_14	SARG|gi|489226605|ref|WP_003134989.1|	24.8	1054	1050	1043	1.59e-63	233
k141_106705_14	SARG|gi|553771491|ref|WP_023103521.1|	24.8	1054	1050	1043	1.59e-63	233
k141_106705_15	CARD|gb|AAL14439.1|ARO:3000774|adeA	21.5	372	421	396	5.44e-09	56.6
k141_106705_17	NCBI|AAD15665.1|1|1|tbtM|tbtM||1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_outer_membrane_channel_subunit_TbtM|AMR|efflux	41.5	467	498	476	5.60e-100	308
k141_106705_17	SARG|gi|496339860|ref|WP_009049038.1|	42.0	469	498	474	7.45e-100	307
k141_106705_17	NCBI|WP_003152694.1|1|1|toprJ1|toprJ||2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_transporter_outer_membrane_subunit_TOprJ1|AMR|tetracycline	41.8	466	498	477	8.14e-100	307
k141_106705_17	NCBI|WP_088903432.1|1|1|toprJ2|toprJ||2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_transporter_outer_membrane_subunit_TOprJ2|AMR|tetracycline	41.8	466	498	477	8.14e-100	307
k141_106705_17	SARG|CAG34266	41.4	461	498	474	5.87e-99	305
k141_106705_17	ResF|TOprJ4_1_CP091084_1	42.1	466	498	476	4.89e-98	303
k141_106705_17	SARG|YP_001973746	40.7	469	498	466	7.27e-98	302
k141_106705_17	SARG|gi|544780240|ref|WP_021203903.1|	41.0	468	498	461	8.85e-98	301
k141_106705_17	SARG|gi|491553496|ref|WP_005411087.1|	40.7	469	498	461	8.85e-98	301
k141_106705_17	SARG|CAG34251	40.9	469	498	466	1.45e-97	301
k141_106705_18	CARD|gb|ATC67679.1|ARO:3000838|arlR	39.3	219	228	219	8.75e-48	155
k141_106705_18	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	41.5	224	228	228	6.39e-47	154
k141_106705_18	CARD|gb|AAG06465.1|ARO:3005063|cprR	37.7	220	228	223	1.76e-45	150
k141_106705_18	NCBI|WP_063856729.1|1|1|vanR-O|vanR-O|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-O|AMR|glycopeptide	37.7	228	228	233	5.21e-44	146
k141_106705_18	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.9	222	228	219	3.13e-42	141
k141_106705_18	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.5	222	228	219	1.25e-41	140
k141_106705_18	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.5	222	228	220	1.28e-41	140
k141_106705_18	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.5	222	228	220	1.28e-41	140
k141_106705_18	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.5	222	228	220	1.81e-41	139
k141_106705_18	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	34.8	227	228	229	2.58e-40	137
k141_106705_19	CARD|gb|AEX49906.1|ARO:3003583|basS	29.3	369	478	477	6.09e-35	135
k141_106705_19	CARD|gb|AAD51347.1|ARO:3003067|smeS	31.8	245	478	467	3.99e-28	115
k141_106705_19	CARD|gb|AAC75429.1|ARO:3000833|evgS	26.0	227	478	1197	1.17e-15	79.0
k141_33294_8	SARG|gi|445996710|ref|WP_000074565.1|	29.4	231	507	309	7.64e-15	74.3
k141_33294_8	SARG|gi|446110087|ref|WP_000187942.1|	29.1	227	507	309	2.49e-14	72.8
k141_33294_8	SARG|gi|542061059|gb|ERI11611.1|	27.4	223	507	316	3.58e-14	72.4
k141_33294_8	SARG|gi|445996719|ref|WP_000074574.1|	28.2	227	507	309	4.48e-14	72.0
k141_33294_8	SARG|gi|445996722|ref|WP_000074577.1|	28.2	227	507	309	6.02e-14	71.6
k141_33294_8	SARG|gi|895736250|emb|COF64653.1|	28.6	227	507	309	8.07e-14	71.2
k141_33294_8	SARG|gi|445996714|ref|WP_000074569.1|	28.6	227	507	309	8.07e-14	71.2
k141_33294_8	SARG|gi|445996723|ref|WP_000074578.1|	28.2	227	507	309	8.07e-14	71.2
k141_33294_8	SARG|gi|814314593|emb|CKF49145.1|	29.0	231	507	309	8.07e-14	71.2
k141_33294_8	SARG|gi|884875933|emb|CKG93789.1|	28.2	227	507	309	1.08e-13	70.9
k141_33294_19	CARD|gb|WMY66391.1|ARO:3007682|MdtQ	99.8	479	480	479	0.0	915
k141_33294_19	SARG|gi|554036077|gb|ESE82040.1|	37.3	461	480	485	1.33e-91	286
k141_33294_19	SARG|gi|554022400|gb|ESE68782.1|	37.7	462	480	484	1.82e-91	285
k141_33294_19	SARG|gi|554039504|gb|ESE85345.1|	38.1	464	480	484	1.42e-90	283
k141_33294_19	SARG|YP_001572363	38.1	464	480	479	3.46e-90	282
k141_33294_19	SARG|gi|693058885|ref|WP_032226462.1|	37.3	464	480	488	1.93e-88	278
k141_33294_19	SARG|YP_002385300	36.1	465	480	485	4.95e-88	276
k141_33294_19	SARG|ZP_03030551	36.4	461	480	488	7.57e-88	276
k141_33294_19	SARG|gi|487562202|ref|WP_001717107.1|	36.4	461	480	488	1.50e-87	275
k141_33294_19	SARG|gi|693049450|ref|WP_032218920.1|	36.4	459	480	488	1.50e-87	275
k141_33294_28	SARG|gi|495067432|ref|WP_007792257.1|	38.5	208	316	647	2.03e-33	128
k141_33294_28	SARG|gi|1039430674|ref|WP_064794447.1|	43.5	207	316	646	4.46e-32	124
k141_33294_28	SARG|gi|696411918|ref|WP_032982657.1|	38.5	208	316	647	8.30e-32	124
k141_33294_28	SARG|gi|896073592|ref|WP_049116987.1|	40.9	232	316	646	2.09e-31	122
k141_33294_28	SARG|gi|695840638|ref|WP_032753940.1|	40.1	232	316	646	2.09e-31	122
k141_33294_28	SARG|gi|696402390|ref|WP_032974230.1|	38.5	208	316	647	2.09e-31	122
k141_33294_28	SARG|gi|696423952|ref|WP_032993748.1|	38.5	208	316	647	2.09e-31	122
k141_33294_28	SARG|gi|556476567|ref|WP_023328168.1|	42.9	203	316	641	2.80e-31	122
k141_33294_28	SARG|gi|1031822889|ref|WP_064150402.1|	43.0	207	316	646	2.84e-31	122
k141_33294_28	SARG|gi|490306253|ref|WP_004201358.1|	43.0	207	316	646	2.84e-31	122
k141_33294_36	megares|MEG_258|Drugs|Aminoglycosides|Aminoglycoside_N-acetyltransferases|AAC6-PRIME_1	33.3	105	154	153	1.64e-06	44.3
k141_33294_36	NCBI|WP_049440615.1|1|1|aac(6')-Iz|aac(6')-Iz|acetyltransferase|2|TOBRAMYCIN|aminoglycoside|aminoglycoside_N-acetyltransferase_AAC(6')-Iz|AMR|aminoglycoside	33.3	105	154	153	1.64e-06	44.3
k141_33294_36	megares|MEG_261|Drugs|Aminoglycosides|Aminoglycoside_N-acetyltransferases|AAC6-PRIME_1	32.4	105	154	153	4.32e-06	43.1
k141_33294_36	NCBI|WP_005414154.1|1|1|aac(6')-Iz|aac(6')-Iz|acetyltransferase|2|aminoglycoside|aminoglycoside|aminoglycoside_N-acetyltransferase_AAC(6')-Iz|AMR|aminoglycoside	32.4	105	154	153	4.32e-06	43.1
k141_33294_60	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	29.7	229	258	343	2.41e-18	82.0
k141_33294_60	SARG|gb|AEA37904.1|ARO:3003112|lsaC	26.3	209	258	492	6.40e-12	63.9
k141_33294_63	CARD|gb|AAD51348.1|ARO:3003066|smeR	57.2	222	241	229	4.20e-85	251
k141_33294_63	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	39.0	228	241	228	3.42e-50	162
k141_33294_63	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	38.2	228	241	232	3.87e-47	155
k141_33294_63	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	38.2	228	241	232	3.87e-47	155
k141_33294_63	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	37.0	227	241	231	1.06e-46	154
k141_33294_63	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	37.0	227	241	231	1.06e-46	154
k141_33294_63	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	37.0	227	241	231	2.12e-46	153
k141_33294_63	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	35.9	237	241	239	2.65e-46	153
k141_33294_63	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	36.6	227	241	231	4.22e-46	152
k141_33294_63	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	36.6	227	241	231	1.19e-45	151
k141_33294_64	CARD|gb|AAD51347.1|ARO:3003067|smeS	38.7	481	493	467	1.46e-99	306
k141_33294_65	SARG|CP001918.1.gene3442.p01	85.6	457	472	457	3.82e-273	746
k141_33294_65	SARG|NC_010410.6003262.p01	28.7	414	472	507	2.04e-37	142
k141_33294_65	SARG|gi|692126801|ref|WP_032082759.1|	29.3	400	472	512	2.17e-37	142
k141_33294_65	SARG|gi|693264691|ref|WP_032363351.1|	29.3	400	472	512	4.08e-37	141
k141_33294_65	SARG|gi|486386396|ref|WP_001600385.1|	29.3	400	472	512	5.59e-37	141
k141_33294_65	SARG|gi|754931714|ref|WP_042288532.1|	29.5	404	472	512	5.59e-37	141
k141_33294_65	SARG|gi|817112355|ref|WP_046485582.1|	29.7	404	472	512	5.59e-37	141
k141_33294_65	SARG|gi|924501662|ref|WP_053509023.1|	29.8	400	472	512	5.59e-37	141
k141_33294_65	SARG|gi|544880697|ref|WP_021293434.1|	29.3	400	472	512	5.59e-37	141
k141_33294_65	SARG|gi|545246045|ref|WP_021544659.1|	29.3	400	472	512	5.59e-37	141
k141_33294_66	CARD|gb|AAC75137.1|ARO:3000794|mdtC	91.6	1025	1026	1025	0.0	1779
k141_33294_66	SARG|gb|AAG05914|ARO:3004075|MuxC	62.8	1012	1026	1036	0.0	1168
k141_33294_66	SARG|gb|AAG05915.1|ARO:3004074|MuxB	51.2	1020	1026	1043	0.0	949
k141_33294_66	CARD|gb|AAC75136.1|ARO:3000793|mdtB	50.0	1025	1026	1040	0.0	915
k141_33294_66	SARG|gb|BAE06006.1|ARO:3003705|mexN	48.6	1008	1026	1036	3.94e-296	850
k141_33294_66	SARG|gb|CAH14033.1|ARO:3004100|LpeB	30.7	1012	1026	1014	7.48e-137	436
k141_33294_66	SARG|CAY51926	29.8	1014	1026	1008	2.15e-129	416
k141_33294_66	SARG|YP_350221	29.5	1004	1026	1009	2.20e-129	416
k141_33294_66	NCBI|AAN29241.1|1|1|bepE|bepE|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepE|AMR|efflux	30.6	1028	1026	1051	2.84e-129	417
k141_33294_66	SARG|gi|803453816|ref|WP_046068030.1|	30.0	1051	1026	1059	3.42e-128	414
k141_33294_67	CARD|gb|AAC75136.1|ARO:3000793|mdtB	90.1	1040	1041	1040	0.0	1751
k141_33294_67	SARG|gb|AAG05915.1|ARO:3004074|MuxB	67.4	1015	1041	1043	0.0	1284
k141_33294_67	SARG|gb|AAG05914|ARO:3004075|MuxC	50.0	1012	1041	1036	5.86e-316	901
k141_33294_67	CARD|gb|AAC75137.1|ARO:3000794|mdtC	49.7	1022	1041	1025	2.62e-314	896
k141_33294_67	SARG|gb|BAE06006.1|ARO:3003705|mexN	49.1	1014	1041	1036	1.86e-306	877
k141_33294_67	SARG|YP_350221	30.5	1007	1041	1009	1.73e-138	441
k141_33294_67	SARG|ZP_02357857	31.1	1042	1041	1061	1.14e-136	437
k141_33294_67	CARD|gb|AAG07594.1|ARO:3000808|MexI	30.9	1013	1041	1029	1.55e-135	434
k141_33294_67	SARG|ZP_02371789	30.7	1042	1041	1061	1.67e-134	432
k141_33294_67	SARG|ABC36050	30.7	1042	1041	1061	1.67e-134	432
k141_33294_68	CARD|gb|AAC75135.2|ARO:3000792|mdtA	78.1	415	413	415	1.06e-214	594
k141_33294_68	SARG|gb|AAG05916.1|ARO:3004073|MuxA	47.3	349	413	426	1.05e-93	287
k141_33294_68	SARG|gb|BAE06005.1|ARO:3003704|mexM	40.2	333	413	385	4.32e-68	219
k141_33294_68	SARG|ZP_02904981	32.7	349	413	405	1.98e-53	182
k141_33294_68	SARG|gi|654292006|ref|WP_027806808.1|	32.7	333	413	405	1.98e-53	182
k141_33294_68	SARG|YP_001778538	32.7	333	413	405	2.76e-53	181
k141_33294_68	SARG|gi|736062670|ref|WP_034206052.1|	32.1	333	413	405	7.58e-53	180
k141_33294_68	SARG|gi|654275318|ref|WP_027790469.1|	32.7	333	413	405	2.91e-52	179
k141_33294_68	SARG|YP_001583349	32.4	333	413	405	2.91e-52	179
k141_33294_68	SARG|ZP_02889084	32.7	333	413	405	2.91e-52	179
k141_33294_72	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	27.9	233	234	252	2.36e-16	74.7
k141_33294_72	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	32.5	114	234	229	1.18e-15	72.4
k141_33294_72	CARD|gb|ADM92605.1|ARO:3000553|adeR	25.2	234	234	247	2.54e-13	66.2
k141_33294_72	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	29.5	105	234	231	3.95e-13	65.5
k141_33294_72	NCBI|WP_034872470.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	29.5	105	234	231	5.43e-13	65.1
k141_33294_72	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	29.5	105	234	231	5.43e-13	65.1
k141_33294_72	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	27.6	105	234	231	1.41e-12	63.9
k141_33294_72	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	27.0	122	234	230	9.30e-12	61.6
k141_33294_73	megares|MEG_7501|Drugs|Glycopeptide|VanC-type_regulator|VANSC_1	27.3	260	619	354	9.33e-13	68.9
k141_33294_73	megares|MEG_7503|Drugs|Glycopeptide|VanC-type_regulator|VANSC_1	27.7	260	619	354	1.66e-12	68.2
k141_33294_73	megares|MEG_7500|Drugs|Glycopeptide|VanC-type_regulator|VANSC_1	26.5	257	619	352	5.19e-12	66.6
k141_33294_73	megares|MEG_7497|Drugs|Glycopeptide|VanC-type_regulator|VANSC_1	26.5	257	619	376	5.98e-12	66.6
k141_33294_73	NCBI|WP_034869172.1|1|1|vanS-C|vanS-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-C|AMR|glycopeptide	26.5	257	619	376	5.98e-12	66.6
k141_33294_73	NCBI|WP_063856748.1|1|1|vanS-M|vanS-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-M|AMR|glycopeptide	25.3	221	619	370	9.80e-10	59.7
k141_33294_73	megares|MEG_7507|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	36.5	115	619	381	2.40e-09	58.5
k141_33294_73	NCBI|WP_063856738.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	36.5	115	619	381	2.40e-09	58.5
k141_33294_73	megares|MEG_7505|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	37.3	118	619	381	3.18e-09	58.2
k141_33294_73	NCBI|WP_063856730.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	37.3	118	619	381	3.18e-09	58.2
k141_33294_78	megares|MEG_1179|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|ASMA_1	100	607	616	607	0.0	1174
k141_33294_78	megares|MEG_1180|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|ASMA_1	62.2	617	616	617	1.33e-272	758
k141_33294_96	SARG|gb|AAC75089.1|ARO:3003577|ugd	83.0	388	389	388	1.02e-234	643
k141_33294_101	SARG|gb|AAK76137.1|ARO:3000024|patA	27.4	223	432	564	7.40e-16	78.6
k141_33294_101	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	29.1	189	432	655	2.66e-09	58.2
k141_33294_101	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	29.1	189	432	655	2.66e-09	58.2
k141_33294_101	SARG|gb|AAR96051.1|ARO:3002894|otrC	23.7	139	432	351	1.16e-08	55.5
k141_33294_101	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.6	189	432	655	1.88e-08	55.5
k141_33294_101	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.6	189	432	655	2.49e-08	55.1
k141_33294_101	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.6	189	432	655	2.49e-08	55.1
k141_33294_101	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.6	189	432	655	2.49e-08	55.1
k141_33294_101	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.6	189	432	655	2.49e-08	55.1
k141_33294_101	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.6	189	432	655	2.49e-08	55.1
k141_33294_118	SARG|L42544.gene.p01	26.9	674	701	651	6.03e-76	256
k141_33294_118	SARG|AAV80410	26.9	674	701	651	8.38e-76	255
k141_33294_118	SARG|NP_348076	26.7	685	701	652	3.15e-72	246
k141_33294_118	megares|MEG_7163|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	27.7	678	701	629	1.01e-71	244
k141_33294_118	ResF|tet(O/W)_5_AM889122_1	27.7	678	701	639	1.24e-71	244
k141_33294_118	megares|MEG_7175|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	27.7	678	701	639	1.23e-70	241
k141_33294_118	megares|MEG_7169|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	28.3	679	701	629	1.39e-70	241
k141_33294_118	ResF|tet(O/W)_3_AM889120_1	28.3	679	701	639	1.71e-70	241
k141_33294_118	megares|MEG_7173|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	27.6	678	701	629	1.93e-70	240
k141_33294_118	megares|MEG_7174|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	27.6	678	701	629	1.93e-70	240
k141_33294_131	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	37.9	419	440	429	1.35e-90	280
k141_33294_136	CARD|gb|ALH22601.1|ARO:3000620|adeL	25.2	250	305	337	2.28e-13	68.6
k141_33294_149	SARG|gb|AML99881.1|ARO:3001327|mdtK	83.3	472	479	474	6.88e-289	787
k141_35874_52	SARG|gi|851928815|ref|WP_048221086.1|	38.0	221	344	648	1.57e-42	155
k141_35874_52	SARG|gi|780033092|ref|WP_045444768.1|	38.0	221	344	648	1.57e-42	155
k141_35874_52	SARG|gi|740856590|ref|WP_038641842.1|	37.6	221	344	648	5.61e-42	153
k141_35874_52	SARG|gi|542061059|gb|ERI11611.1|	31.6	228	344	316	6.11e-31	118
k141_35874_52	SARG|YP_001373621	31.6	225	344	318	1.20e-28	112
k141_35874_52	SARG|gi|500194536|ref|WP_011867743.1|	30.6	222	344	306	1.33e-28	111
k141_94380_36	CARD|gb|ALH22601.1|ARO:3000620|adeL	45.5	288	295	337	2.30e-83	253
k141_94380_38	CARD|gb|BAA15221.2|ARO:3000263|marA	48.1	104	122	127	1.15e-31	107
k141_94380_38	CARD|gb|AFK13828.1|ARO:3000823|ramA	43.4	106	122	124	9.82e-30	102
k141_94380_39	SARG|gb|AAP43109.1|ARO:3003922|oqxA	100	391	392	391	3.67e-273	740
k141_94380_39	NCBI|WP_063865358.1|1|1|oqxA2|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA2|AMR|multidrug	99.7	391	392	391	5.21e-273	740
k141_94380_39	NCBI|WP_047693838.1|1|1|oqxA6|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA6|AMR|multidrug	99.7	391	392	391	1.05e-272	739
k141_94380_39	NCBI|WP_004212918.1|1|1|oqxA11|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA11|AMR|multidrug	99.7	391	392	391	1.49e-272	739
k141_94380_39	NCBI|WP_063865373.1|1|1|oqxA5|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA5|AMR|multidrug	99.7	391	392	391	1.49e-272	739
k141_94380_39	NCBI|WP_063865385.1|1|1|oqxA7|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA7|AMR|multidrug	99.7	391	392	391	2.12e-272	738
k141_94380_39	NCBI|WP_004890321.1|1|1|oqxA3|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA3|AMR|multidrug	99.7	391	392	391	2.12e-272	738
k141_94380_39	NCBI|WP_004149398.1|1|1|oqxA10|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA10|AMR|multidrug	99.7	391	392	391	3.01e-272	738
k141_94380_39	NCBI|WP_063865399.1|1|1|oqxA9|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA9|AMR|multidrug	99.7	391	392	391	6.08e-272	737
k141_94380_39	NCBI|WP_063865368.1|1|1|oqxA4|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA4|AMR|multidrug	99.5	391	392	391	1.23e-271	736
k141_94380_40	NCBI|WP_004149399.1|1|1|oqxB19|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB19|AMR|multidrug	100	1050	1051	1050	0.0	1988
k141_94380_40	NCBI|WP_063865478.1|1|1|oqxB22|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB22|AMR|multidrug	99.9	1050	1051	1050	0.0	1987
k141_94380_40	NCBI|WP_019704817.1|1|1|oqxB14|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB14|AMR|multidrug	99.9	1050	1051	1050	0.0	1986
k141_94380_40	NCBI|WP_021312368.1|1|1|oqxB20|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB20|AMR|multidrug	99.9	1050	1051	1050	0.0	1986
k141_94380_40	NCBI|WP_016947602.1|1|1|oqxB25|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB25|AMR|multidrug	99.9	1050	1051	1050	0.0	1986
k141_94380_40	NCBI|WP_004174783.1|1|1|oqxB5|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB5|AMR|multidrug	99.8	1050	1051	1050	0.0	1985
k141_94380_40	NCBI|WP_063865413.1|1|1|oqxB12|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB12|AMR|multidrug	99.9	1050	1051	1050	0.0	1985
k141_94380_40	NCBI|WP_063865509.1|1|1|oqxB26|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB26|AMR|multidrug	99.8	1050	1051	1050	0.0	1985
k141_94380_40	NCBI|WP_063865552.1|1|1|oqxB4|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB4|AMR|multidrug	99.8	1050	1051	1050	0.0	1985
k141_94380_40	NCBI|WP_038435619.1|1|1|oqxB21|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB21|AMR|multidrug	99.9	1050	1051	1050	0.0	1985
k141_94380_47	SARG|gi|1028112073|ref|WP_063866263.1|	38.2	241	507	646	5.06e-35	137
k141_94380_47	SARG|gi|1022698495|ref|WP_063449190.1|	38.2	241	507	646	6.84e-35	137
k141_94380_47	SARG|gi|895905590|ref|WP_049005458.1|	38.3	235	507	646	9.25e-35	137
k141_94380_47	SARG|gi|654551607|ref|WP_028019265.1|	38.2	241	507	646	1.25e-34	136
k141_94380_47	SARG|gi|895898290|ref|WP_048999361.1|	37.8	241	507	646	1.25e-34	136
k141_94380_47	SARG|gi|998245120|ref|WP_061098715.1|	37.4	235	507	646	1.25e-34	136
k141_94380_47	SARG|gi|983405167|ref|WP_060572706.1|	37.8	241	507	646	1.25e-34	136
k141_94380_47	SARG|gi|779850732|ref|WP_045348329.1|	37.8	241	507	646	1.25e-34	136
k141_94380_47	SARG|gi|754493745|ref|WP_041910640.1|	37.8	241	507	646	1.69e-34	136
k141_94380_47	SARG|gi|782756348|ref|WP_045630015.1|	37.8	241	507	646	1.69e-34	136
k141_94380_49	SARG|gb|MBY8651254.1|ARO:3007188|vanH_in_vanP_cl	32.8	125	311	314	8.80e-10	57.8
k141_94380_61	CARD|gb|AAA99503.1|ARO:3003250|bcrC	37.8	127	199	203	3.71e-16	72.4
k141_94380_68	CARD|gb|BAB35162.1|ARO:3000676|H-NS	53.3	135	134	137	3.60e-33	112
k141_94380_78	SARG|gi|542061059|gb|ERI11611.1|	29.4	235	401	316	8.00e-28	110
k141_94380_78	SARG|gi|500194536|ref|WP_011867743.1|	31.4	207	401	306	1.54e-25	104
k141_94380_78	SARG|gi|447057509|ref|WP_001134765.1|	30.4	207	401	309	1.09e-24	102
k141_94380_78	SARG|YP_001373621	30.1	236	401	318	1.26e-24	102
k141_94380_78	SARG|gi|488042066|ref|WP_002113463.1|	30.0	207	401	309	2.05e-24	101
k141_94380_78	SARG|gi|488068784|ref|WP_002140181.1|	30.4	207	401	309	2.81e-24	100
k141_94380_78	SARG|gi|500465078|gb|EOP76697.1|	29.4	221	401	306	3.67e-24	100
k141_94380_78	SARG|gi|507035724|ref|WP_016107411.1|	29.0	207	401	309	3.86e-24	100
k141_94380_78	SARG|gi|488120365|ref|WP_002191762.1|	30.7	202	401	309	3.86e-24	100
k141_94380_78	SARG|gi|507055561|ref|WP_016126482.1|	30.0	207	401	309	3.86e-24	100
k141_94380_83	CARD|gb|AAC75731.1|ARO:3000516|emrR	92.6	175	177	176	2.41e-116	326
k141_94380_84	SARG|CP000647.1.gene3014.p01	100	390	391	390	1.13e-271	736
k141_94380_84	SARG|gi|749652887|ref|WP_040253321.1|	99.7	390	391	390	2.29e-271	736
k141_94380_84	SARG|gi|895858069|ref|WP_048969082.1|	99.7	390	391	390	2.29e-271	736
k141_94380_84	SARG|gi|694071897|ref|WP_032417839.1|	99.7	390	391	390	3.25e-271	735
k141_94380_84	SARG|gi|496665986|ref|WP_009308476.1|	99.7	390	391	390	3.25e-271	735
k141_94380_84	SARG|gi|659675967|ref|WP_029884665.1|	99.7	390	391	390	3.25e-271	735
k141_94380_84	SARG|gi|896074650|ref|WP_049117729.1|	99.7	390	391	390	4.62e-271	735
k141_94380_84	SARG|gi|852300605|ref|WP_048334316.1|	99.7	390	391	390	6.56e-271	734
k141_94380_84	SARG|gi|895872851|ref|WP_048980086.1|	99.7	390	391	390	6.56e-271	734
k141_94380_84	SARG|gi|647584791|ref|WP_025862145.1|	99.7	390	391	390	9.31e-271	734
k141_94380_85	SARG|gi|896057666|ref|WP_049106280.1|	99.4	512	513	512	0.0	991
k141_94380_85	SARG|CP000647.1.gene3015.p01	100	512	513	512	0.0	991
k141_94380_85	SARG|gi|694069085|ref|WP_032415421.1|	99.8	512	513	512	0.0	991
k141_94380_85	SARG|gi|835846408|ref|WP_047681013.1|	99.8	512	513	512	0.0	989
k141_94380_85	SARG|gi|491038386|ref|WP_004900055.1|	99.8	512	513	512	0.0	989
k141_94380_85	SARG|gi|692190551|ref|WP_032104399.1|	99.8	512	513	512	0.0	989
k141_94380_85	SARG|gi|852126944|ref|WP_048291088.1|	99.8	512	513	512	0.0	989
k141_94380_85	SARG|gi|895919844|ref|WP_049017006.1|	99.4	512	513	512	0.0	988
k141_94380_85	SARG|gi|556196973|ref|WP_023280446.1|	99.8	512	513	512	0.0	988
k141_94380_85	SARG|gi|763385179|ref|WP_044242332.1|	99.6	512	513	512	0.0	987
k141_94380_93	CARD|gb|AAC16242.1|ARO:3005069|rsmA	85.2	61	62	61	4.58e-31	101
k141_94380_100	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	24.6	211	226	579	1.90e-06	47.0
k141_94380_100	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	24.8	210	226	579	4.59e-06	45.8
k141_94380_110	CARD|gb|AAK37618.1|ARO:3005008|TxR	39.1	320	517	318	2.46e-59	197
k141_94380_113	CARD|gb|NP_217372.1|ARO:3007659|Rv2856	44.8	286	338	372	1.63e-78	243
k141_94380_121	SARG|gb|AAG57600.1|ARO:3000318|mphB	47.7	130	137	158	4.48e-34	115
k141_94380_134	CARD|gb|AAK37618.1|ARO:3005008|TxR	38.8	304	691	318	5.21e-67	222
k141_94380_146	SARG|gi|1032819400|ref|WP_064325534.1|	31.7	186	274	646	2.31e-18	83.6
k141_94380_146	SARG|gb|AAC75271.1|ARO:3003952|yojI	29.2	202	274	547	1.15e-11	63.5
k141_94380_146	SARG|gi|736993687|ref|WP_034989673.1|	37.2	78	274	513	1.23e-09	57.4
k141_94380_146	SARG|AF024666.2.gene6.p01	37.2	78	274	513	1.23e-09	57.4
k141_94380_146	SARG|gi|491465657|ref|WP_005323423.1|	37.2	78	274	513	1.23e-09	57.4
k141_94380_146	SARG|gi|558693259|ref|WP_023522676.1|	23.7	177	274	492	9.32e-09	54.7
k141_94380_146	SARG|gi|171851258|emb|CAQ04234.1|	35.9	78	274	483	1.24e-08	54.3
k141_94380_146	SARG|gi|445983947|ref|WP_000061802.1|	23.7	177	274	492	1.25e-08	54.3
k141_94380_146	SARG|gi|1024915484|ref|WP_063548266.1|	23.7	177	274	492	1.67e-08	53.9
k141_94380_146	SARG|gi|445983948|ref|WP_000061803.1|	23.2	177	274	492	1.67e-08	53.9
k141_94380_158	SARG|gi|446048013|ref|WP_000125868.1|	30.9	233	260	648	1.74e-18	83.6
k141_94380_158	SARG|gi|944152509|ref|WP_055644808.1|	29.6	223	260	616	1.65e-12	65.9
k141_94380_158	SARG|gi|739906046|ref|WP_037756452.1|	30.8	237	260	620	1.65e-12	65.9
k141_94380_158	SARG|gi|516574297|ref|WP_017949361.1|	30.8	237	260	620	1.65e-12	65.9
k141_94380_158	SARG|gi|655401130|ref|WP_028800283.1|	29.4	221	260	599	2.20e-12	65.5
k141_94380_158	SARG|gi|493394434|ref|WP_006350564.1|	28.7	247	260	602	5.37e-12	64.3
k141_94380_158	SARG|gi|817122037|ref|WP_046494699.1|	29.5	227	260	613	9.78e-12	63.5
k141_94380_158	SARG|gi|497748188|ref|WP_010062372.1|	28.5	239	260	605	1.31e-11	63.2
k141_94380_158	SARG|gi|947982677|ref|WP_056642336.1|	29.0	224	260	626	1.33e-11	63.2
k141_94380_158	SARG|gi|639892676|ref|WP_024755698.1|	29.0	224	260	631	1.33e-11	63.2
k141_94380_166	SARG|NC_002951.3237419.p01	23.8	407	401	480	1.01e-27	113
k141_94380_166	SARG|gi|828164785|ref|WP_047255785.1|	34.4	186	401	513	1.30e-27	113
k141_94380_166	SARG|gi|928870254|ref|WP_053909077.1|	34.4	186	401	513	1.30e-27	113
k141_94380_166	SARG|gi|916815475|ref|WP_051422531.1|	34.9	186	401	499	2.17e-27	112
k141_94380_166	SARG|gi|916813154|ref|WP_051420210.1|	34.9	186	401	500	2.97e-27	112
k141_94380_166	SARG|gi|493711289|ref|WP_006660923.1|	34.9	186	401	500	2.97e-27	112
k141_94380_166	SARG|gi|916852589|ref|WP_051459645.1|	34.9	186	401	500	2.97e-27	112
k141_94380_166	SARG|gi|496192662|ref|WP_008914998.1|	34.9	186	401	513	8.11e-27	110
k141_94380_166	SARG|gi|493866184|ref|WP_006812840.1|	34.4	186	401	499	2.51e-26	109
k141_94380_166	SARG|gi|915327072|ref|WP_050763760.1|	35.3	167	401	499	3.41e-26	108
k141_94380_193	CARD|gb|AAD51347.1|ARO:3003067|smeS	24.5	376	917	467	1.18e-17	85.9
k141_94380_193	CARD|gb|AAC75429.1|ARO:3000833|evgS	27.4	263	917	1197	8.17e-13	71.6
k141_94380_193	CARD|gb|AAD51348.1|ARO:3003066|smeR	31.9	141	917	229	5.45e-09	56.6
k141_94380_193	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	32.1	112	917	225	5.58e-08	53.5
k141_94380_193	CARD|gb|AAC73788.1|ARO:3003841|kdpE	32.1	112	917	225	5.58e-08	53.5
k141_94380_193	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	27.9	104	917	231	1.45e-07	52.4
k141_94380_193	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	28.9	114	917	232	2.65e-07	51.6
k141_94380_193	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	29.1	110	917	232	4.78e-07	50.8
k141_94380_193	NCBI|WP_063856715.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	29.1	127	917	232	2.08e-06	48.9
k141_94380_193	NCBI|WP_023043165.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	29.4	102	917	232	5.01e-06	47.8
k141_94380_215	CARD|gb|AAK37618.1|ARO:3005008|TxR	39.6	298	648	318	2.24e-57	195
k141_94380_226	CARD|gb|CAA79966.1|ARO:3003665|NmcR	30.0	260	275	295	1.40e-34	125
k141_94380_235	SARG|gb|APB03219.1|ARO:3003986|TaeA	24.9	233	275	648	3.17e-10	59.3
k141_94380_308	SARG|gi|748767925|ref|WP_040019608.1|	29.8	242	376	623	1.93e-18	85.9
k141_94380_308	SARG|gi|817122037|ref|WP_046494699.1|	28.4	243	376	613	2.56e-18	85.5
k141_94380_308	SARG|AF170880.4.gene1.p01	29.0	221	376	615	3.54e-17	82.0
k141_94380_308	SARG|gi|944152509|ref|WP_055644808.1|	29.0	241	376	616	4.73e-17	81.6
k141_94380_308	SARG|gi|754608317|ref|WP_041998010.1|	28.6	262	376	612	1.13e-16	80.5
k141_94380_308	SARG|gi|944009777|ref|WP_055601444.1|	28.6	241	376	628	1.15e-16	80.5
k141_94380_308	SARG|gi|558888514|ref|WP_023543283.1|	28.5	221	376	615	1.51e-16	80.1
k141_94380_308	SARG|gi|926400371|ref|WP_053728483.1|	30.2	222	376	603	4.76e-16	78.6
k141_94380_308	SARG|gi|663350985|ref|WP_030349761.1|	28.5	242	376	613	4.81e-16	78.6
k141_94380_308	SARG|gi|926351744|ref|WP_053683383.1|	30.3	218	376	648	6.67e-16	78.2
k141_94380_348	SARG|gi|545300138|ref|WP_021579975.1|	62.2	333	342	343	6.89e-137	391
k141_94380_348	SARG|NP_709857	61.9	333	342	343	9.77e-137	391
k141_94380_348	SARG|gi|545298014|ref|WP_021578218.1|	62.2	333	342	343	9.77e-137	391
k141_94380_348	SARG|gi|766974849|ref|WP_044866795.1|	61.9	333	342	343	9.77e-137	391
k141_94380_348	SARG|NP_290715	61.9	333	342	343	2.79e-136	390
k141_94380_348	SARG|gi|984670524|ref|WP_060773951.1|	61.9	333	342	343	2.79e-136	390
k141_94380_348	SARG|gi|979588572|ref|WP_059340812.1|	61.9	333	342	343	3.95e-136	389
k141_94380_348	SARG|gi|723112106|ref|WP_033557598.1|	61.9	333	342	343	3.95e-136	389
k141_94380_348	SARG|gi|545285852|ref|WP_021568926.1|	61.9	333	342	343	3.95e-136	389
k141_94380_348	SARG|YP_001726873	61.9	333	342	343	3.95e-136	389
k141_94380_349	SARG|gi|545269220|ref|WP_021559623.1|	37.5	528	646	683	2.90e-85	280
k141_94380_349	SARG|gi|545262088|ref|WP_021555845.1|	37.1	525	646	683	2.90e-85	280
k141_94380_349	SARG|gi|693076173|ref|WP_032239078.1|	37.5	528	646	683	4.04e-85	280
k141_94380_349	SARG|gi|545290357|ref|WP_021573013.1|	37.5	528	646	683	4.04e-85	280
k141_94380_349	SARG|gi|545299543|ref|WP_021579426.1|	37.5	528	646	683	4.04e-85	280
k141_94380_349	SARG|gi|545298013|ref|WP_021578217.1|	37.5	528	646	683	4.04e-85	280
k141_94380_349	SARG|ZP_03069403	37.5	528	646	683	4.04e-85	280
k141_94380_349	SARG|ZP_03002663	37.3	528	646	683	4.04e-85	280
k141_94380_349	SARG|gi|545288529|ref|WP_021571502.1|	37.5	528	646	683	4.04e-85	280
k141_94380_349	SARG|YP_672169	37.1	525	646	683	4.04e-85	280
k141_94380_350	SARG|gi|693033640|ref|WP_032208687.1|	50.0	462	483	488	2.16e-147	429
k141_94380_350	SARG|gi|727370340|ref|WP_033802462.1|	49.8	462	483	488	1.74e-146	427
k141_94380_350	SARG|gi|486214727|ref|WP_001556350.1|	49.8	462	483	488	1.74e-146	427
k141_94380_350	SARG|gi|693165834|ref|WP_032299413.1|	49.8	462	483	488	1.74e-146	427
k141_94380_350	SARG|P32714	49.8	462	483	488	1.74e-146	427
k141_94380_350	SARG|gi|693163832|ref|WP_032298198.1|	49.8	462	483	488	1.74e-146	427
k141_94380_350	SARG|gi|519088794|ref|WP_020244669.1|	49.8	462	483	488	1.74e-146	427
k141_94380_350	SARG|gi|486137290|ref|WP_001514840.1|	49.8	462	483	488	2.47e-146	426
k141_94380_350	SARG|gi|693076172|ref|WP_032239077.1|	49.8	462	483	488	4.95e-146	426
k141_94380_350	SARG|gi|446533224|ref|WP_000610570.1|	49.6	462	483	488	7.00e-146	425
k141_94380_365	SARG|YP_002193132	35.6	222	267	537	8.51e-28	110
k141_94380_365	SARG|YP_002188856	33.8	222	267	537	2.17e-27	109
k141_94380_365	SARG|YP_001419960	30.7	218	267	510	7.38e-21	90.5
k141_94380_365	SARG|P42670	32.4	204	267	503	1.81e-20	89.4
k141_94380_365	SARG|CAB12101	30.7	218	267	512	1.85e-20	89.4
k141_94380_373	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	32.1	212	299	346	1.47e-18	83.6
k141_94380_396	SARG|gi|746609237|ref|WP_039635344.1|	31.1	257	411	322	5.07e-27	108
k141_94380_396	NCBI|WP_063856705.1|1|1|vanH-D|vanH-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-D|AMR|glycopeptide	31.9	254	411	323	2.53e-26	107
k141_94380_396	SARG|DQ018711.1.gene4.p01	31.1	257	411	322	3.42e-26	106
k141_94380_396	SARG|gi|738848198|ref|WP_036737307.1|	31.1	257	411	323	9.00e-26	105
k141_94380_396	SARG|gi|740152780|ref|WP_037997109.1|	31.9	226	411	322	2.29e-25	104
k141_94380_396	SARG|gi|737310392|ref|WP_035293250.1|	30.7	257	411	323	5.99e-25	103
k141_94380_396	SARG|AF155139.2.gene6.p01	30.2	255	411	322	2.85e-24	101
k141_94380_396	SARG|FJ349556.1.gene5.p01	30.8	247	411	326	1.99e-23	99.0
k141_94380_396	SARG|gi|749574782|ref|WP_040203616.1|	31.1	228	411	323	4.85e-23	97.8
k141_94380_396	NCBI|WP_063856698.1|1|1|vanH-Ac1|vanH-Ac1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ac1|AMR|glycopeptide	32.6	227	411	351	5.23e-23	98.2
k141_94380_398	CARD|gb|CAA79966.1|ARO:3003665|NmcR	23.4	256	298	295	1.07e-07	51.2
k141_21219_1	SARG|gi|655401130|ref|WP_028800283.1|	30.1	206	266	599	7.39e-13	67.0
k141_21219_1	SARG|gi|817122037|ref|WP_046494699.1|	29.6	206	266	613	7.46e-13	67.0
k141_21219_1	SARG|gi|639892676|ref|WP_024755698.1|	28.2	238	266	631	1.01e-12	66.6
k141_21219_1	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	27.0	211	266	307	2.41e-12	64.7
k141_21219_1	SARG|gi|930482089|ref|WP_054228897.1|	27.3	238	266	599	2.42e-12	65.5
k141_21219_1	SARG|gi|985844137|ref|WP_060895163.1|	27.3	238	266	599	2.42e-12	65.5
k141_21219_1	SARG|gi|748767925|ref|WP_040019608.1|	31.2	205	266	623	2.46e-12	65.5
k141_21219_1	SARG|gi|943909899|ref|WP_055545300.1|	28.1	231	266	601	4.38e-12	64.7
k141_21219_1	SARG|gi|516795764|ref|WP_018105258.1|	29.6	206	266	601	5.90e-12	64.3
k141_21219_1	SARG|gi|947982677|ref|WP_056642336.1|	29.6	206	266	626	8.05e-12	63.9
k141_21219_32	SARG|JQ768046.1.gene8.p1	33.2	428	476	559	3.36e-63	213
k141_21219_32	SARG|gb|WP_002289367.1|ARO:3007011|mdeA	30.0	273	476	453	4.71e-22	97.4
k141_21219_32	SARG|NC_002951.3238155.p01	20.6	407	476	465	2.84e-11	64.3
k141_21219_32	SARG|NC_009641.5331418.p01	20.7	382	476	452	3.50e-10	60.8
k141_21219_35	CARD|gb|AAK37618.1|ARO:3005008|TxR	29.8	282	910	318	3.55e-19	88.6
k141_21219_42	megares|MEG_8662|Drugs|Metronidazole|rdxA_nitroimidazole_reductase|RDXA_1	28.8	160	218	210	8.14e-13	63.9
k141_21219_45	megares|MEG_1246|Drugs|beta-lactam|Class_A_betalactamases|BLAA_1	36.8	321	367	339	1.56e-72	228
k141_21219_46	CARD|gb|AFK13828.1|ARO:3000823|ramA	92.0	113	114	124	3.28e-77	222
k141_21219_50	SARG|gi|691139985|ref|WP_032053373.1|	32.7	342	360	406	2.04e-45	159
k141_21219_50	SARG|gi|691070849|ref|WP_032012412.1|	33.1	311	360	406	5.75e-44	155
k141_21219_50	SARG|gi|491209910|ref|WP_005068241.1|	33.1	311	360	406	1.12e-43	154
k141_21219_50	SARG|gi|748187801|ref|WP_039758925.1|	33.1	311	360	406	1.12e-43	154
k141_21219_50	SARG|gi|518286938|ref|WP_019457146.1|	32.5	311	360	406	8.25e-43	152
k141_21219_50	SARG|gi|690992826|ref|WP_031962668.1|	31.9	342	360	406	1.15e-42	152
k141_21219_50	SARG|gi|727726402|ref|WP_033847639.1|	32.8	311	360	406	1.15e-42	152
k141_21219_50	CARD|gb|AAC75135.2|ARO:3000792|mdtA	31.5	343	360	415	1.37e-42	152
k141_21219_50	SARG|gi|515955949|ref|WP_017386532.1|	32.8	311	360	406	2.24e-42	151
k141_21219_50	SARG|gi|545156412|ref|WP_021511564.1|	31.6	342	360	406	2.24e-42	151
k141_21219_51	NCBI|AAN33534.1|1|1|bepG|bepG|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepG|AMR|efflux	46.8	1034	1031	1074	9.17e-295	848
k141_21219_51	NCBI|AAN29241.1|1|1|bepE|bepE|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepE|AMR|efflux	43.8	1030	1031	1051	3.63e-268	779
k141_21219_51	SARG|gb|AAL19305.1|ARO:3000790|mdsB	41.8	1036	1031	1055	2.95e-253	741
k141_21219_51	SARG|gi|780147796|ref|WP_045491627.1|	41.5	1043	1031	1063	4.24e-252	738
k141_21219_51	SARG|gi|685895165|ref|WP_031636098.1|	41.8	1039	1031	1062	5.80e-252	738
k141_21219_51	SARG|gi|730317804|ref|WP_033983157.1|	41.9	1039	1031	1062	5.80e-252	738
k141_21219_51	SARG|gi|491017944|ref|WP_004879650.1|	41.5	1042	1031	1063	8.45e-252	737
k141_21219_51	SARG|gb|BAE06008.1|ARO:3003699|mexQ	42.3	1038	1031	1053	8.75e-252	737
k141_21219_51	SARG|gi|844727272|ref|WP_047925316.1|	41.8	1039	1031	1062	1.16e-251	737
k141_21219_51	SARG|YP_001348104	41.8	1039	1031	1062	1.63e-251	736
k141_21219_57	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	27.6	239	346	574	1.81e-16	79.3
k141_21219_58	SARG|gi|974672242|ref|WP_059256507.1|	32.1	237	337	648	2.92e-25	105
k141_21219_58	SARG|gi|974641719|ref|WP_059227752.1|	32.1	237	337	648	2.92e-25	105
k141_21219_58	SARG|gi|643601187|ref|WP_025237288.1|	32.1	237	337	648	2.92e-25	105
k141_21219_58	SARG|gi|974628291|ref|WP_059215695.1|	32.1	237	337	648	2.92e-25	105
k141_21219_58	SARG|gi|446110298|ref|WP_000188153.1|	32.1	237	337	648	2.92e-25	105
k141_21219_58	SARG|gi|446110299|ref|WP_000188154.1|	32.1	237	337	648	2.92e-25	105
k141_21219_58	SARG|ZP_02903696	32.1	237	337	648	2.92e-25	105
k141_21219_58	SARG|gi|974633183|ref|WP_059219858.1|	32.1	237	337	648	2.92e-25	105
k141_21219_58	SARG|gi|974684692|ref|WP_059267998.1|	32.1	237	337	648	2.92e-25	105
k141_21219_58	SARG|gi|974688082|ref|WP_059271287.1|	32.1	237	337	648	2.92e-25	105
k141_21219_66	SARG|gi|851913025|ref|WP_048215946.1|	37.6	218	254	648	1.27e-39	144
k141_21219_66	SARG|gi|489930965|ref|WP_003834285.1|	37.6	218	254	648	1.27e-39	144
k141_21219_66	SARG|gi|740856590|ref|WP_038641842.1|	35.5	234	254	648	1.74e-39	143
k141_21219_66	SARG|YP_002850060	37.6	218	254	648	1.74e-39	143
k141_21219_66	SARG|gi|489936909|ref|WP_003840216.1|	37.6	218	254	648	1.74e-39	143
k141_21219_66	SARG|gi|507079862|ref|WP_016150620.1|	37.6	218	254	648	1.74e-39	143
k141_21219_66	SARG|gi|949791377|ref|WP_057104572.1|	37.6	218	254	648	1.74e-39	143
k141_21219_66	SARG|gi|493734654|ref|WP_006683876.1|	35.4	240	254	648	1.74e-39	143
k141_21219_66	SARG|gi|803568669|ref|WP_046077412.1|	37.2	231	254	648	2.40e-39	143
k141_21219_66	SARG|gi|446110352|ref|WP_000188207.1|	37.2	231	254	648	2.40e-39	143
k141_21219_69	SARG|gb|APB03219.1|ARO:3003986|TaeA	27.2	254	235	648	7.19e-14	69.3
k141_21219_69	ResF|poxtA-Ef_1_WP094899500.1_1	24.0	204	235	538	3.60e-07	49.3
k141_21219_69	megares|MEG_8639|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT_1	24.0	204	235	543	3.61e-07	49.3
k141_21219_69	NCBI|WP_094899500.1|1|1|poxtA-Ef|poxtA-Ef|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA-Ef|AMR|multidrug	24.0	204	235	543	3.61e-07	49.3
k141_21219_90	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	28.8	208	509	255	1.40e-16	78.6
k141_21219_90	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	27.5	244	509	343	3.50e-13	69.7
k141_21219_90	SARG|gb|AAK76137.1|ARO:3000024|patA	24.2	269	509	564	3.61e-10	61.2
k141_21219_90	megares|MEG_2670|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|DRRA_1	26.3	213	509	293	4.61e-10	59.7
k141_21219_90	SARG|gb|AAA26793|ARO:3003748|oleC	22.5	209	509	325	7.59e-08	53.1
k141_21219_90	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	22.5	209	509	325	7.59e-08	53.1
k141_21219_90	SARG|gb|AAC75271.1|ARO:3003952|yojI	32.7	147	509	547	9.31e-08	53.5
k141_21219_90	SARG|gb|AAR96051.1|ARO:3002894|otrC	22.6	212	509	351	4.62e-07	50.8
k141_21219_90	megares|MEG_4383|Drugs|Tetracycline|Tetracycline_resistance_ABC_efflux_pumps|OTRC_1	22.6	212	509	351	4.62e-07	50.8
k141_21219_90	SARG|gb|CDO61516.1|ARO:3003949|efrB	24.3	181	509	362	1.12e-06	49.7
k141_21219_98	CARD|gb|BAB80490.1|ARO:3007644|Cper_cplR	24.2	219	265	568	1.09e-10	60.5
k141_21219_98	SARG|gb|AHB37625.1|ARO:3004715|vga(E)	26.6	222	265	524	1.41e-10	60.1
k141_21219_98	SARG|FR772051.1.gene9.p01	26.6	222	265	524	1.99e-09	56.6
k141_21219_98	SARG|ABA02367	25.0	188	265	488	1.50e-08	53.9
k141_21219_98	SARG|gi|127359|sp|P23212.1|MSRA_STAEP	25.0	188	265	488	1.50e-08	53.9
k141_21219_98	SARG|gi|486352750|ref|WP_001590778.1|	25.0	188	265	488	1.50e-08	53.9
k141_21219_98	SARG|gi|686444151|ref|WP_031925491.1|	25.5	188	265	488	1.50e-08	53.9
k141_21219_98	SARG|gb|CAA36304.1|ARO:3000251|msrA	25.0	188	265	488	1.50e-08	53.9
k141_21219_98	SARG|BAD86537	25.0	188	265	488	1.50e-08	53.9
k141_21219_98	SARG|gi|581672381|gb|EVQ77821.1|	25.0	188	265	394	1.79e-08	53.5
k141_21219_114	SARG|gb|AAK76137.1|ARO:3000024|patA	25.0	232	501	564	7.53e-09	57.0
k141_21219_129	SARG|AAD41881	31.8	267	343	323	4.25e-21	91.3
k141_21219_129	SARG|AAR37059	32.8	247	343	323	5.82e-21	90.9
k141_21219_129	SARG|AAD51059	32.2	267	343	323	1.09e-20	90.1
k141_21219_129	SARG|AAD42183	31.8	267	343	322	1.58e-18	84.0
k141_21219_133	SARG|gb|AAK76137.1|ARO:3000024|patA	27.5	207	517	564	1.50e-09	59.3
k141_21219_155	CARD|gb|VWQ00850.1|ARO:3003843|leuO	25.3	182	299	314	1.83e-13	68.6
k141_21219_158	NCBI|WP_063856871.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	30.2	252	424	346	4.84e-17	80.9
k141_21219_158	NCBI|WP_063856854.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	30.2	268	424	356	5.96e-15	74.7
k141_21219_158	megares|MEG_7603|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	28.0	289	424	355	7.93e-15	74.3
k141_21219_158	SARG|BAE96115	28.0	289	424	355	7.93e-15	74.3
k141_21219_158	NCBI|WP_109545033.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	27.7	289	424	355	4.60e-14	72.0
k141_21219_158	megares|MEG_7602|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	27.7	289	424	355	4.60e-14	72.0
k141_21219_158	SARG|ACM47285	27.7	289	424	363	4.84e-14	72.0
k141_21219_158	NCBI|WP_049898469.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	28.8	264	424	356	1.49e-13	70.5
k141_21219_158	NCBI|WP_063856862.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	28.8	264	424	356	1.99e-13	70.1
k141_21219_158	megares|MEG_7604|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_2	30.0	200	424	209	6.72e-12	63.5
k141_21219_161	megares|MEG_5400|Drugs|beta-lactam|Penicillin_binding_protein|PBP2_1	93.4	632	634	633	0.0	1204
k141_21219_161	megares|MEG_3799|Drugs|beta-lactam|Penicillin_binding_protein|MECC_1	27.9	573	634	664	3.31e-43	164
k141_21219_161	NCBI|WP_128268231.1|1|1|mecC2|mecC2|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecC2|AMR|beta-lactam	27.1	580	634	665	1.54e-42	162
k141_21219_161	SARG|gb|CCC86795.1|ARO:3001209|mecC	27.7	574	634	665	2.08e-42	161
k141_21219_161	SARG|gi|2791908|emb|CAA73538.1|	27.9	513	634	666	9.59e-42	159
k141_21219_161	megares|MEG_3792|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	27.8	511	634	666	2.38e-41	158
k141_21219_161	NCBI|WP_069996660.1|1|1|mecC3|mecC3|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecC3|AMR|beta-lactam	28.1	437	634	665	3.96e-39	152
k141_21219_161	megares|MEG_3800|Drugs|beta-lactam|Penicillin_binding_protein|MECC_1	27.9	444	634	665	4.34e-38	149
k141_21219_168	megares|MEG_3295|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|ILES_1	23.1	899	861	1107	1.36e-15	80.5
k141_21219_168	SARG|gb|ADP36409.1|ARO:3003730|Bifidobacteria	23.1	899	861	1107	1.36e-15	80.5
k141_21219_172	SARG|gb|AEA37904.1|ARO:3003112|lsaC	25.5	208	242	492	1.31e-10	59.7
k141_21219_200	CARD|gb|AAC73788.1|ARO:3003841|kdpE	84.8	224	226	225	8.14e-139	387
k141_21219_200	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	85.1	222	226	225	2.33e-138	385
k141_21219_200	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	35.1	225	226	229	3.09e-44	147
k141_21219_200	CARD|gb|ATC67679.1|ARO:3000838|arlR	37.6	221	226	219	5.24e-43	143
k141_21219_200	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	34.4	227	226	232	7.50e-43	143
k141_21219_200	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	34.4	227	226	232	7.50e-43	143
k141_21219_200	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	32.7	226	226	231	1.28e-40	137
k141_21219_200	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	32.7	226	226	231	1.28e-40	137
k141_21219_200	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	33.2	226	226	231	5.08e-40	136
k141_21219_200	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	33.2	226	226	231	1.43e-39	135
k141_21219_201	CARD|gb|CYF42523.1|ARO:3004047|kdpD	27.0	878	896	885	2.16e-94	316
k141_67841_21	CARD|gb|ALH22601.1|ARO:3000620|adeL	41.2	289	302	337	2.20e-77	238
k141_67841_42	CARD|gb|CAA79966.1|ARO:3003665|NmcR	43.0	79	297	295	1.83e-08	53.5
k141_67841_116	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	36.2	224	224	225	2.27e-39	134
k141_67841_116	CARD|gb|AAC73788.1|ARO:3003841|kdpE	36.2	224	224	225	2.27e-39	134
k141_67841_116	CARD|gb|ATC67679.1|ARO:3000838|arlR	32.6	218	224	219	3.22e-34	120
k141_67841_116	CARD|gb|AAG06465.1|ARO:3005063|cprR	33.8	219	224	223	7.13e-30	109
k141_67841_116	NCBI|XSG12259.1|1|1|drcR|drcR||1|||daptomycin_efflux_response_regulator_transcription_factor_DrcR|AMR|peptide	29.0	224	224	223	1.98e-29	108
k141_67841_116	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	31.4	226	224	219	3.55e-29	107
k141_67841_116	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	31.4	226	224	219	4.99e-29	107
k141_67841_116	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	31.4	226	224	220	5.11e-29	107
k141_67841_116	NCBI|WP_063856729.1|1|1|vanR-O|vanR-O|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-O|AMR|glycopeptide	30.7	218	224	233	1.36e-28	106
k141_67841_116	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	31.4	226	224	220	1.42e-28	106
k141_67841_117	megares|MEG_7507|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	28.5	200	489	381	3.97e-16	79.0
k141_67841_117	NCBI|WP_063856738.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	28.5	200	489	381	3.97e-16	79.0
k141_67841_117	NCBI|WP_063856744.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	28.0	211	489	381	9.51e-16	77.8
k141_67841_117	NCBI|WP_028530133.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	29.5	200	489	381	9.51e-16	77.8
k141_67841_117	megares|MEG_7504|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	28.0	211	489	381	9.51e-16	77.8
k141_67841_117	megares|MEG_7505|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	29.5	200	489	381	9.51e-16	77.8
k141_67841_117	megares|MEG_7506|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	29.5	200	489	381	9.51e-16	77.8
k141_67841_117	NCBI|WP_063856730.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	29.5	200	489	381	9.51e-16	77.8
k141_67841_117	NCBI|WP_023042297.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	29.0	200	489	381	4.06e-15	75.9
k141_67841_117	megares|MEG_7509|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	29.0	200	489	381	4.06e-15	75.9
k141_67841_120	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	31.4	220	379	255	1.69e-29	113
k141_67841_120	SARG|gi|500448961|gb|EOP61695.1|	28.0	211	379	306	2.54e-23	97.8
k141_67841_120	SARG|gi|500465078|gb|EOP76697.1|	27.5	211	379	306	1.24e-22	95.9
k141_67841_120	SARG|gi|447195835|ref|WP_001273091.1|	26.9	216	379	306	6.49e-20	88.2
k141_67841_120	SARG|ZP_04081918	26.9	216	379	306	6.49e-20	88.2
k141_67841_120	SARG|gi|447195836|ref|WP_001273092.1|	26.4	216	379	306	1.65e-19	87.0
k141_67841_120	SARG|gi|500194536|ref|WP_011867743.1|	26.1	211	379	306	4.89e-18	82.8
k141_67841_120	SARG|gb|AAK76137.1|ARO:3000024|patA	28.3	230	379	564	1.09e-16	80.5
k141_67841_120	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	27.9	222	379	574	2.01e-12	67.4
k141_67841_120	SARG|gb|WP_082039181.1|ARO:3007028|salD	27.7	184	379	544	5.95e-11	62.8
k141_28773_4	CARD|gb|AAK37618.1|ARO:3005008|TxR	40.3	320	444	318	5.50e-69	221
k141_28773_5	CARD|gb|BAB38260.1|ARO:3000830|cpxA	30.0	237	465	457	1.82e-22	98.6
k141_28773_5	NCBI|WP_063856748.1|1|1|vanS-M|vanS-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-M|AMR|glycopeptide	28.2	227	465	370	2.33e-17	82.4
k141_28773_5	CARD|gb|CYF42523.1|ARO:3004047|kdpD	25.3	241	465	885	1.75e-16	81.3
k141_28773_5	NCBI|WP_006285582.1|1|1|vanS-F|vanS-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-F|AMR|glycopeptide	28.4	225	465	365	1.07e-13	71.2
k141_28773_5	NCBI|WP_222891058.1|1|1|vanS-P|vanS-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-P|AMR|glycopeptide	24.2	231	465	359	1.40e-12	67.8
k141_28773_25	CARD|gb|WP_041777404.1|ARO:3004480|Bado_rpoB_RIF	44.6	1369	1343	1186	0.0	1064
k141_28773_25	megares|MEG_8674|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB_1	44.6	1369	1343	1186	0.0	1064
k141_28773_25	CARD|gb|BAD59497.1|ARO:3000501|rpoB2	44.1	1362	1343	1162	0.0	1031
k141_85458_4	SARG|gi|985815823|ref|WP_060876116.1|	35.8	226	371	646	1.10e-26	110
k141_85458_4	SARG|gi|922960663|ref|WP_053388845.1|	33.2	232	371	648	1.10e-26	110
k141_85458_4	SARG|gi|757799695|ref|WP_043016897.1|	33.2	232	371	648	1.49e-26	110
k141_85458_4	SARG|gi|1045891604|ref|WP_065554100.1|	33.2	232	371	648	1.49e-26	110
k141_85458_4	SARG|gi|507082903|ref|WP_016153652.1|	33.2	232	371	648	1.49e-26	110
k141_85458_4	SARG|gi|507086196|ref|WP_016156937.1|	33.2	232	371	648	1.49e-26	110
k141_85458_4	SARG|gi|835233765|ref|WP_047410073.1|	33.6	232	371	648	2.71e-26	109
k141_85458_4	SARG|gi|740856590|ref|WP_038641842.1|	33.2	232	371	648	2.71e-26	109
k141_85458_4	SARG|gi|695840638|ref|WP_032753940.1|	35.0	226	371	646	3.64e-26	108
k141_85458_4	SARG|gi|829942568|ref|WP_047368199.1|	34.9	232	371	646	3.64e-26	108
k141_85458_23	SARG|BAH65866	100	394	395	394	6.15e-278	753
k141_85458_23	SARG|YP_002235907	99.7	394	395	394	2.50e-277	751
k141_85458_23	SARG|ACN65732	99.5	394	395	394	2.06e-276	749
k141_85458_23	SARG|gi|499527904|emb|CCI74263.1|	99.5	384	395	384	4.14e-269	730
k141_85458_23	SARG|CP000647.1.gene4115.p01	99.7	383	395	383	1.62e-268	728
k141_85458_23	SARG|CP001138.1.gene3995.p01	91.4	394	395	394	2.19e-255	696
k141_85458_23	SARG|YP_001572785	91.1	394	395	394	8.92e-255	694
k141_85458_23	SARG|YP_002043045	91.4	394	395	394	8.92e-255	694
k141_85458_23	SARG|YP_002639394	91.1	394	395	394	1.27e-254	694
k141_85458_23	SARG|CAD03195	91.1	394	395	394	1.27e-254	694
k141_85458_24	CARD|gb|CAA79966.1|ARO:3003665|NmcR	27.3	256	308	295	4.59e-22	92.8
k141_85458_47	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	34.3	848	805	703	6.81e-135	416
k141_85458_55	SARG|YP_001451669	78.0	386	393	390	2.16e-198	551
k141_85458_55	SARG|gi|391322939|gb|EIQ79610.1|	76.3	392	393	393	4.85e-198	550
k141_85458_55	SARG|gi|727765868|ref|WP_033870271.1|	76.0	387	393	391	1.05e-196	547
k141_85458_55	SARG|B7NF27	75.7	387	393	391	1.50e-196	546
k141_85458_55	SARG|YP_671782	75.7	387	393	391	2.12e-196	546
k141_85458_55	SARG|B1LL36	75.7	387	393	391	2.12e-196	546
k141_85458_55	SARG|YP_002331481	75.7	387	393	391	2.12e-196	546
k141_85458_55	SARG|gi|693055084|ref|WP_032223202.1|	76.0	387	393	391	3.01e-196	546
k141_85458_55	SARG|ACI75321	76.0	387	393	391	3.01e-196	546
k141_85458_55	SARG|gi|754720184|ref|WP_042093261.1|	75.7	387	393	391	4.28e-196	545
k141_85458_89	SARG|gi|507055561|ref|WP_016126482.1|	30.0	207	502	309	6.62e-20	89.4
k141_85458_89	SARG|gi|445996710|ref|WP_000074565.1|	31.9	207	502	309	1.21e-19	88.6
k141_85458_89	SARG|gi|488067981|ref|WP_002139378.1|	30.0	207	502	309	1.63e-19	88.2
k141_85458_89	SARG|gi|488130770|ref|WP_002201978.1|	30.0	207	502	309	1.63e-19	88.2
k141_85458_89	SARG|gi|487936534|ref|WP_002010000.1|	30.0	207	502	309	1.63e-19	88.2
k141_85458_89	SARG|gi|447057509|ref|WP_001134765.1|	30.0	207	502	309	2.21e-19	87.8
k141_85458_89	SARG|gi|445996719|ref|WP_000074574.1|	30.4	207	502	309	4.03e-19	87.0
k141_85458_89	SARG|gi|488120365|ref|WP_002191762.1|	30.0	207	502	309	4.03e-19	87.0
k141_85458_89	SARG|gi|488068784|ref|WP_002140181.1|	29.5	207	502	309	4.03e-19	87.0
k141_85458_89	SARG|gi|488053456|ref|WP_002124853.1|	29.5	207	502	309	5.45e-19	86.7
k141_85458_94	SARG|CP001918.1.gene3442.p01	44.4	459	466	457	7.06e-120	357
k141_85458_94	SARG|gi|780037362|ref|WP_045446599.1|	31.9	420	466	512	6.35e-47	168
k141_85458_94	SARG|gi|930176934|ref|WP_054177682.1|	31.9	420	466	512	3.23e-46	166
k141_85458_94	SARG|gi|491038386|ref|WP_004900055.1|	32.1	420	466	512	4.48e-46	166
k141_85458_94	SARG|gi|692126801|ref|WP_032082759.1|	32.1	420	466	512	6.19e-46	166
k141_85458_94	SARG|gi|924625749|ref|WP_053529696.1|	32.1	420	466	512	6.19e-46	166
k141_85458_94	SARG|gi|757697366|ref|WP_042927333.1|	31.9	420	466	512	6.19e-46	166
k141_85458_94	SARG|gi|555267544|ref|WP_023248992.1|	32.1	420	466	512	6.19e-46	166
k141_85458_94	SARG|gi|694065628|ref|WP_032412110.1|	32.1	420	466	510	8.29e-46	165
k141_85458_94	SARG|gi|506355393|ref|WP_015875112.1|	32.1	420	466	511	8.43e-46	165
k141_97328_1	SARG|gi|554684122|ref|WP_023184036.1|	27.8	288	381	343	1.84e-17	81.6
k141_97328_1	SARG|gi|803576054|ref|WP_046082052.1|	29.6	247	381	343	1.84e-17	81.6
k141_97328_1	SARG|YP_002385298	30.1	249	381	343	2.05e-16	78.6
k141_97328_1	SARG|gi|803562607|ref|WP_046076420.1|	30.1	249	381	343	2.05e-16	78.6
k141_97328_1	SARG|YP_001572361	27.4	288	381	343	1.23e-15	76.3
k141_97328_1	SARG|gi|446368539|ref|WP_000446394.1|	28.7	286	381	343	1.66e-15	75.9
k141_97328_1	SARG|gi|740511722|ref|WP_038341525.1|	28.6	294	381	343	3.02e-15	75.1
k141_97328_1	SARG|gi|754653900|ref|WP_042037551.1|	28.6	294	381	343	3.02e-15	75.1
k141_97328_1	SARG|gi|740611645|ref|WP_038397166.1|	27.1	288	381	343	3.02e-15	75.1
k141_97328_1	SARG|gi|1000943660|ref|WP_061182139.1|	28.6	294	381	343	3.02e-15	75.1
k141_97328_11	SARG|gi|507055561|ref|WP_016126482.1|	27.4	223	495	309	3.78e-16	78.2
k141_97328_11	SARG|gi|445996710|ref|WP_000074565.1|	30.0	223	495	309	9.22e-16	77.0
k141_97328_11	SARG|gi|445996719|ref|WP_000074574.1|	29.1	223	495	309	2.24e-15	75.9
k141_97328_11	SARG|gi|447195835|ref|WP_001273091.1|	29.4	228	495	306	5.27e-15	74.7
k141_97328_11	SARG|gi|447195836|ref|WP_001273092.1|	29.4	228	495	306	5.27e-15	74.7
k141_97328_11	SARG|gi|445996708|ref|WP_000074563.1|	29.1	223	495	309	5.45e-15	74.7
k141_97328_11	SARG|gi|445996722|ref|WP_000074577.1|	29.6	223	495	309	5.45e-15	74.7
k141_97328_11	SARG|gi|542061059|gb|ERI11611.1|	26.0	223	495	316	5.86e-15	74.7
k141_97328_11	SARG|P42332	30.4	204	495	306	7.09e-15	74.3
k141_97328_11	SARG|ABB80128	30.4	204	495	306	7.09e-15	74.3
k141_97328_47	SARG|gi|803568669|ref|WP_046077412.1|	42.9	219	229	648	6.05e-56	187
k141_97328_47	SARG|gi|446110352|ref|WP_000188207.1|	42.9	219	229	648	6.05e-56	187
k141_97328_47	SARG|YP_002382193	42.9	219	229	648	6.05e-56	187
k141_97328_47	SARG|gi|803575554|ref|WP_046081557.1|	42.9	219	229	648	6.05e-56	187
k141_97328_47	SARG|gi|446110351|ref|WP_000188206.1|	42.9	219	229	648	6.05e-56	187
k141_97328_47	SARG|gi|817104523|ref|WP_046477871.1|	42.5	219	229	648	8.42e-56	187
k141_97328_47	SARG|gi|1035670474|ref|WP_064517458.1|	42.9	219	229	648	8.42e-56	187
k141_97328_47	SARG|gi|502669352|ref|WP_012905216.1|	42.0	219	229	648	8.42e-56	187
k141_97328_47	SARG|gi|1035717981|ref|WP_064557480.1|	42.9	219	229	648	8.42e-56	187
k141_97328_47	SARG|gi|764278838|ref|WP_044327089.1|	42.5	219	229	648	8.42e-56	187
k141_97328_55	CARD|gb|AAL19308.1|ARO:3000504|golS	38.1	126	137	154	6.18e-28	99.8
k141_97328_60	SARG|YP_001477378	80.3	386	407	406	1.49e-215	596
k141_97328_60	SARG|ZP_04621517	78.0	386	407	404	3.76e-206	572
k141_97328_60	SARG|ZP_04631862	77.7	386	407	404	7.58e-206	571
k141_97328_60	SARG|ZP_04638972	76.6	394	407	404	1.08e-205	571
k141_97328_60	SARG|ZP_04612558	76.4	394	407	404	3.08e-205	570
k141_97328_60	SARG|YP_001605796	77.5	386	407	404	3.57e-204	567
k141_97328_60	SARG|YP_001401993	77.2	386	407	404	7.19e-204	566
k141_97328_60	SARG|ZP_04623896	77.4	380	407	380	1.73e-203	564
k141_97328_60	SARG|YP_001871501	77.2	386	407	404	2.92e-203	565
k141_97328_60	SARG|AAC60781	73.2	388	407	410	1.81e-184	517
k141_97328_61	SARG|gi|896190680|ref|WP_049199932.1|	80.3	554	559	563	3.52e-306	838
k141_97328_61	SARG|YP_001477377	80.7	548	559	563	4.09e-305	835
k141_97328_61	SARG|gi|1001786599|ref|WP_061324791.1|	80.5	548	559	563	3.89e-303	830
k141_97328_61	SARG|YP_001007250	80.1	548	559	563	4.98e-299	820
k141_97328_61	SARG|ZP_04638974	79.7	548	559	563	3.33e-297	815
k141_97328_61	SARG|gi|740410309|ref|WP_038243756.1|	79.0	548	559	563	6.71e-297	815
k141_97328_61	SARG|YP_001401994	79.6	548	559	563	5.49e-296	812
k141_97328_61	SARG|AAS61092	79.6	548	559	563	7.79e-296	812
k141_97328_61	SARG|YP_001605795	79.4	548	559	562	2.89e-293	805
k141_97328_61	SARG|gi|544012122|gb|ERK10884.1|	79.5	526	559	541	7.63e-286	786
k141_97328_75	CARD|gb|AAC76296.1|ARO:3000656|AcrS	36.0	203	217	220	1.72e-35	124
k141_97328_75	NCBI|CAA81047.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	31.9	207	217	210	5.04e-28	104
k141_97328_75	NCBI|ACF30254.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	31.9	207	217	210	9.96e-28	103
k141_97328_76	SARG|CP000647.1.gene444.p01	100	397	398	397	4.30e-275	746
k141_97328_76	SARG|gi|573042590|emb|CDI16885.1|	100	397	398	417	9.13e-275	746
k141_97328_76	SARG|YP_002240036	99.0	397	398	397	2.04e-273	741
k141_97328_76	SARG|CAC41008	95.2	399	398	398	2.21e-259	706
k141_97328_76	SARG|CAC35724	93.7	399	398	399	5.40e-258	702
k141_97328_76	SARG|gi|555116142|gb|ESM59081.1|	99.4	361	398	361	4.94e-247	673
k141_97328_76	SARG|gi|500615129|gb|EOQ55695.1|	99.2	361	398	361	1.41e-246	672
k141_97328_76	SARG|gi|555202465|gb|ESN44853.1|	98.9	361	398	361	5.75e-246	671
k141_97328_76	SARG|gi|524234431|emb|CDA04526.1|	98.9	361	398	361	1.65e-245	669
k141_97328_76	SARG|CP001918.1.gene1258.p01	88.2	397	398	397	1.81e-244	668
k141_97328_77	CARD|gb|AAC73564.1|ARO:3000216|acrB	91.5	1049	1049	1049	0.0	1837
k141_97328_77	SARG|BAC77251	81.9	1046	1049	1051	0.0	1648
k141_97328_77	SARG|gi|694076105|ref|WP_032421853.1|	81.3	1037	1049	1036	0.0	1617
k141_97328_77	SARG|gi|496667122|ref|WP_009309612.1|	81.4	1037	1049	1036	0.0	1616
k141_97328_77	SARG|CP000647.1.gene3710.p01	81.3	1037	1049	1036	0.0	1616
k141_97328_77	SARG|gi|447196024|ref|WP_001273280.1|	80.9	1034	1049	1037	0.0	1614
k141_97328_77	SARG|gi|556290479|ref|WP_023291164.1|	81.2	1037	1049	1036	0.0	1613
k141_97328_77	SARG|gi|817600095|ref|WP_046594084.1|	80.8	1034	1049	1037	0.0	1612
k141_97328_77	SARG|gi|487663012|ref|WP_001752778.1|	80.7	1034	1049	1037	0.0	1612
k141_97328_77	SARG|gi|817601660|ref|WP_046595348.1|	80.9	1034	1049	1037	0.0	1611
k141_97328_80	SARG|gb|AAF63432|ARO:3003744|vatF	60.8	51	189	221	2.01e-13	65.1
k141_97328_80	SARG|M58472.1.gene1.p01	56.9	51	189	209	3.26e-13	64.3
k141_97328_94	SARG|gb|AAK76137.1|ARO:3000024|patA	32.4	219	370	564	1.58e-19	89.0
k141_97328_94	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	29.3	208	370	343	1.97e-18	84.3
k141_97328_94	SARG|U82085.gene.p01	23.8	214	370	552	5.34e-09	56.6
k141_97328_108	SARG|gb|AAC74000.1|ARO:3003950|msbA	30.7	579	593	582	3.85e-70	236
k141_97328_108	SARG|gi|860594225|ref|WP_048475168.1|	28.8	577	593	620	2.07e-58	205
k141_97328_108	SARG|gi|496018010|ref|WP_008742581.1|	28.0	575	593	623	2.10e-57	202
k141_97328_108	SARG|gi|926351744|ref|WP_053683383.1|	28.2	579	593	648	1.57e-56	200
k141_97328_108	SARG|gi|917229923|ref|WP_051836635.1|	28.7	579	593	620	1.91e-56	199
k141_97328_108	SARG|gi|917203192|ref|WP_051809904.1|	28.3	575	593	620	3.65e-56	199
k141_97328_108	SARG|gi|926376632|ref|WP_053705806.1|	28.2	575	593	620	1.83e-55	197
k141_97328_108	SARG|gi|917127754|ref|WP_051734466.1|	28.0	575	593	620	3.48e-55	196
k141_97328_108	SARG|gi|772774655|ref|WP_045322518.1|	28.5	575	593	620	3.48e-55	196
k141_97328_108	SARG|gi|799286378|ref|WP_045936958.1|	28.0	575	593	620	4.80e-55	196
k141_97328_109	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	35.1	576	591	579	1.43e-102	321
k141_97328_109	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	34.9	576	591	579	1.56e-101	318
k141_97328_109	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	33.9	566	591	574	2.27e-90	289
k141_97328_109	SARG|gi|944152509|ref|WP_055644808.1|	32.6	487	591	616	2.88e-65	223
k141_97328_109	SARG|gb|AAK76137.1|ARO:3000024|patA	31.6	484	591	564	7.38e-64	218
k141_97328_109	SARG|gb|AYV52072.1|ARO:3002882|lmrD	30.2	494	591	664	1.60e-59	209
k141_97328_109	SARG|gb|WP_104671188.1|ARO:3003948|efrA	29.0	483	591	575	1.17e-56	199
k141_97328_109	SARG|gb|AAK76136.1|ARO:3000025|patB	27.0	597	591	588	1.81e-53	191
k141_97328_109	SARG|gb|CDO61516.1|ARO:3003949|efrB	36.2	271	591	362	4.49e-42	154
k141_97328_109	SARG|gb|AET10445.1|ARO:3004033|tetB(46)	30.6	386	591	578	1.95e-41	157
k141_97328_140	SARG|gb|AAD08227.1|ARO:3003964|hp1181	31.6	383	455	443	2.63e-42	154
k141_97328_140	megares|MEG_6987|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TET39_1	26.3	358	455	395	3.82e-13	69.7
k141_97328_140	SARG|AY743590.gene.p01	26.3	358	455	395	3.82e-13	69.7
k141_97328_140	ResF|tet(39)_2_CP044518_1	26.3	358	455	395	3.82e-13	69.7
k141_97328_140	SARG|BAC67142	27.9	172	455	401	1.64e-12	67.8
k141_97328_140	SARG|AAR14158	29.8	161	455	392	2.11e-12	67.4
k141_97328_140	SARG|CAQ51492	29.8	161	455	393	2.12e-12	67.4
k141_97328_140	SARG|gi|505141122|ref|WP_015328224.1|	29.8	161	455	393	2.12e-12	67.4
k141_97328_140	SARG|ZP_03063464	24.5	359	455	396	2.15e-12	67.4
k141_97328_140	SARG|CAA76069	29.8	161	455	400	2.18e-12	67.4
k141_97328_162	CARD|gb|TKW44661.1|ARO:3005040|YajC	47.8	113	111	112	2.17e-28	98.6
k141_97328_179	CARD|gb|ABD30512.1|ARO:3000839|arlS	27.2	228	432	451	1.73e-22	98.2
k141_97328_179	NCBI|WP_002305818.1|1|1|vanS-A|vanS-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-A|AMR|glycopeptide	24.4	275	432	384	1.48e-18	85.9
k141_97328_179	megares|MEG_7454|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	24.4	275	432	384	1.48e-18	85.9
k141_97328_179	NCBI|WP_063856741.1|1|1|vanS-Pt|vanS-Pt|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-Pt|AMR|glycopeptide	25.3	289	432	386	2.02e-18	85.5
k141_97328_179	megares|MEG_7488|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	25.3	289	432	386	2.02e-18	85.5
k141_97328_179	NCBI|WP_063856742.1|1|1|vanS-Pt|vanS-Pt|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-Pt|AMR|glycopeptide	25.3	289	432	388	2.05e-18	85.5
k141_97328_179	megares|MEG_7489|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	25.3	289	432	388	2.05e-18	85.5
k141_97328_179	megares|MEG_7487|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	24.3	288	432	386	6.60e-18	84.0
k141_97328_179	NCBI|WP_063856740.1|1|1|vanS-Pt2|vanS-Pt2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-Pt2|AMR|glycopeptide	24.3	288	432	386	6.60e-18	84.0
k141_97328_179	megares|MEG_7486|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	24.3	288	432	382	6.80e-17	80.9
k141_97328_180	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	40.4	225	230	228	4.76e-50	162
k141_97328_180	CARD|gb|ATC67679.1|ARO:3000838|arlR	36.4	220	230	219	9.34e-48	155
k141_97328_180	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	37.5	232	230	232	1.36e-44	148
k141_97328_180	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	37.1	232	230	232	3.83e-44	147
k141_97328_180	CARD|gb|AAD51348.1|ARO:3003066|smeR	38.1	223	230	229	7.02e-44	146
k141_97328_180	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	33.8	228	230	231	1.05e-43	145
k141_97328_180	NCBI|WP_034872470.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	38.5	231	230	231	2.09e-43	145
k141_97328_180	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	38.5	231	230	231	2.09e-43	145
k141_97328_180	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	38.5	231	230	231	4.16e-43	144
k141_97328_180	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	36.3	234	230	252	1.04e-42	144
k141_97328_195	CARD|gb|ABV18113.1|ARO:3001329|mdtG	61.2	381	400	408	7.92e-157	447
k141_97328_195	SARG|WP_000136147.1	42.1	378	400	399	1.89e-98	298
k141_97328_195	NCBI|EHE72460.1|1|1|pmrA|pmrA|efflux|1|quinolone|quinolone|multidrug_efflux_MFS_transporter_PmrA|AMR|quinolone	40.5	378	400	371	2.36e-89	273
k141_97328_195	SARG|YP_808159	27.0	348	400	387	6.36e-19	86.7
k141_97328_195	SARG|gi|446964022|ref|WP_001041278.1|	24.1	361	400	388	2.45e-16	79.0
k141_97328_195	SARG|gi|446964023|ref|WP_001041279.1|	24.1	361	400	388	3.29e-16	78.6
k141_97328_195	SARG|gi|446964029|ref|WP_001041285.1|	24.1	361	400	388	3.29e-16	78.6
k141_97328_195	SARG|gi|686391947|ref|WP_031906419.1|	24.1	361	400	388	3.29e-16	78.6
k141_97328_195	SARG|gi|686115864|ref|WP_031765718.1|	24.1	361	400	388	4.42e-16	78.2
k141_97328_195	SARG|gi|896351648|ref|WP_049308446.1|	24.1	361	400	388	4.42e-16	78.2
k141_97328_197	SARG|gi|752682279|ref|WP_041330231.1|	40.1	354	366	349	2.29e-83	256
k141_97328_197	SARG|DQ212986.1.gene8.p01	38.7	357	366	349	1.46e-81	251
k141_97328_197	SARG|gi|405945042|pdb|4FU0|A	38.7	357	366	357	1.85e-81	251
k141_97328_197	SARG|gi|765411304|ref|WP_044689514.1|	38.7	357	366	349	2.91e-81	251
k141_97328_197	SARG|AAF71281	38.4	357	366	349	8.20e-81	249
k141_97328_197	SARG|gi|1028100561|ref|WP_063856696.1|	39.3	354	366	349	1.16e-80	249
k141_97328_197	SARG|gb|ABX54687.1|ARO:3002910|vanL	38.0	358	366	349	4.62e-80	248
k141_97328_197	SARG|gi|1002798395|gb|AMN85478.1|	38.0	358	366	343	4.33e-79	245
k141_97328_197	SARG|ACM47287	36.5	359	366	343	8.64e-79	244
k141_97328_197	SARG|ABS72058	36.2	359	366	343	1.93e-77	241
k141_97328_203	megares|MEG_730|Drugs|beta-lactam|Penicillin_binding_protein|AMPH_1	99.2	386	387	386	1.94e-286	773
k141_97328_203	megares|MEG_729|Drugs|beta-lactam|Penicillin_binding_protein|AMPH_1	84.9	385	387	385	1.18e-241	660
k141_97328_208	SARG|gi|746253210|ref|WP_039301529.1|	38.7	181	256	648	7.49e-29	113
k141_97328_208	SARG|Q83LR7	36.2	185	256	648	1.39e-28	112
k141_97328_208	SARG|gi|647325472|ref|WP_025760953.1|	36.2	185	256	648	1.39e-28	112
k141_97328_208	SARG|gi|647323678|ref|WP_025760497.1|	36.2	185	256	648	1.39e-28	112
k141_97328_208	SARG|gi|495736522|ref|WP_008461101.1|	38.1	181	256	648	2.57e-28	112
k141_97328_208	SARG|gi|746243059|ref|WP_039291473.1|	38.1	181	256	648	2.57e-28	112
k141_97328_208	SARG|gi|1001720867|ref|WP_061274204.1|	38.1	181	256	648	2.57e-28	112
k141_97328_208	SARG|gi|446110305|ref|WP_000188160.1|	35.7	185	256	648	4.75e-28	111
k141_97328_208	SARG|gi|974633183|ref|WP_059219858.1|	34.1	217	256	648	8.79e-28	110
k141_97328_208	SARG|gi|974684692|ref|WP_059267998.1|	34.1	217	256	648	8.79e-28	110
k141_97328_218	SARG|gb|AVI44920.1|ARO:3004470|poxtA	27.4	234	261	542	9.09e-16	75.5
k141_97328_218	NCBI|WP_209691075.1|1|1|poxtA2|poxtA|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA2|AMR|multidrug	27.4	234	261	544	9.10e-16	75.5
k141_97328_218	megares|MEG_8639|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT_1	24.6	236	261	543	1.35e-14	72.0
k141_97328_218	NCBI|WP_094899500.1|1|1|poxtA-Ef|poxtA-Ef|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA-Ef|AMR|multidrug	24.6	236	261	543	1.35e-14	72.0
k141_97328_218	ResF|poxtA-Ef_1_WP094899500.1_1	24.4	234	261	538	4.44e-14	70.5
k141_97328_218	SARG|M80346.gene.p01	28.0	232	261	551	8.16e-14	69.7
k141_97328_218	megares|MEG_1491|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|CARA_1	28.0	232	261	551	8.16e-14	69.7
k141_97328_218	SARG|X63451.gene.p01	25.3	229	261	550	4.18e-11	61.6
k141_97328_218	megares|MEG_6558|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SRMB_1	25.3	229	261	550	4.18e-11	61.6
k141_97328_218	SARG|AXF35727.1	25.3	225	261	497	1.85e-09	56.6
k141_97328_219	SARG|gb|AYV52072.1|ARO:3002882|lmrD	27.5	149	232	664	6.61e-07	48.5
k141_97328_222	SARG|gi|803568669|ref|WP_046077412.1|	42.1	235	273	648	2.21e-44	157
k141_97328_222	SARG|gi|446110352|ref|WP_000188207.1|	42.1	235	273	648	2.21e-44	157
k141_97328_222	SARG|YP_002382193	42.1	235	273	648	2.21e-44	157
k141_97328_222	SARG|gi|803575554|ref|WP_046081557.1|	42.1	235	273	648	2.21e-44	157
k141_97328_222	SARG|gi|446110351|ref|WP_000188206.1|	42.1	235	273	648	2.21e-44	157
k141_97328_222	SARG|gi|974588181|ref|WP_059178476.1|	45.0	209	273	646	4.15e-44	157
k141_97328_222	SARG|YP_001176128	44.8	210	273	646	4.15e-44	157
k141_97328_222	SARG|gi|502669352|ref|WP_012905216.1|	44.9	207	273	648	4.22e-44	157
k141_97328_222	SARG|gi|749017716|ref|WP_040076354.1|	45.2	210	273	646	1.09e-43	155
k141_97328_222	SARG|gi|968563772|ref|WP_058587854.1|	44.0	216	273	648	1.11e-43	155
k141_97328_231	SARG|YP_001571041	35.2	233	281	648	2.26e-29	115
k141_97328_231	SARG|gi|555258323|ref|WP_023240896.1|	33.1	239	281	648	2.26e-29	115
k141_97328_231	SARG|gi|960873409|ref|WP_058345546.1|	35.2	233	281	648	2.26e-29	115
k141_97328_231	SARG|gi|740610794|ref|WP_038396317.1|	35.2	233	281	648	5.69e-29	114
k141_97328_231	SARG|gi|1005616587|ref|WP_061695226.1|	34.8	233	281	648	1.05e-28	114
k141_97328_231	SARG|gi|555246906|ref|WP_023230855.1|	34.8	233	281	648	1.43e-28	113
k141_97328_231	SARG|YP_002044935	34.8	233	281	648	1.43e-28	113
k141_97328_231	SARG|gi|835666879|ref|WP_047606339.1|	34.8	233	281	648	1.43e-28	113
k141_97328_231	SARG|gi|922019548|ref|WP_053299973.1|	34.8	233	281	648	1.43e-28	113
k141_97328_231	SARG|gi|685236936|ref|WP_031605176.1|	34.8	233	281	648	1.43e-28	113
k141_97328_239	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	60.3	375	351	374	1.20e-154	438
k141_97328_239	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	51.4	354	351	357	5.49e-112	329
k141_97328_264	SARG|YP_001444376	67.1	149	153	154	1.83e-77	226
k141_97328_264	SARG|BAB59035	67.1	149	153	154	3.02e-76	223
k141_97328_264	SARG|BAC58936	64.4	149	153	154	6.09e-76	222
k141_97328_264	SARG|ZP_02197344	65.1	149	153	154	6.09e-76	222
k141_97328_264	SARG|YP_002666586	65.8	149	153	154	8.65e-76	221
k141_97328_264	SARG|Q8DF90	64.4	149	153	154	1.74e-75	221
k141_97328_264	SARG|ZP_00990220	64.4	149	153	154	5.00e-75	219
k141_97328_264	SARG|YP_002418004	64.4	149	153	154	7.09e-75	219
k141_97328_264	SARG|ZP_01813310	64.4	149	153	154	1.01e-74	219
k141_97328_286	NCBI|WP_256875606.1|1|1|blaNWM-1|blaNWM|hydrolase|2|CARBAPENEM|beta-lactam|subclass_B3_metallo-beta-lactamase_NWM-1|AMR|beta-lactam	24.8	133	252	310	8.27e-06	45.1
k141_97328_290	NCBI|WP_063844229.1|1|1|cmlV|cmlV|efflux|2|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_MFS_transporter_CmlV|AMR|phenicol	35.8	388	397	412	2.83e-68	220
k141_97328_290	SARG|U09991.1.gene2.p01	35.8	388	397	436	5.27e-68	220
k141_97328_290	SARG|NP_044444	34.7	389	397	391	2.43e-59	196
k141_97328_290	SARG|AF024666.2.gene33.p01	34.7	389	397	391	2.43e-59	196
k141_97328_290	SARG|YP_251195	34.7	389	397	391	4.79e-59	196
k141_97328_290	SARG|gi|2708772|gb|AAB96371.1|	34.4	389	397	391	2.00e-57	191
k141_97328_290	SARG|gb|CAA78046.1|ARO:3002701|Rfas_cmr	32.2	376	397	391	7.92e-51	174
k141_97328_290	megares|MEG_1781|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	31.9	376	397	391	3.04e-50	172
k141_97328_290	SARG|NP_631702	34.0	385	397	392	2.43e-48	167
k141_97328_290	SARG|X59968.1.gene1.p01	34.0	385	397	392	2.43e-48	167
k141_97328_291	CARD|gb|ALH22601.1|ARO:3000620|adeL	34.6	286	302	337	2.35e-42	147
k141_101602_28	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	30.0	317	309	343	9.45e-41	144
k141_101602_28	SARG|gi|542061059|gb|ERI11611.1|	31.5	308	309	316	2.34e-37	134
k141_101602_28	SARG|gi|447057509|ref|WP_001134765.1|	32.3	303	309	309	2.95e-36	131
k141_101602_28	SARG|gi|507035724|ref|WP_016107411.1|	32.7	303	309	309	4.12e-36	130
k141_101602_28	SARG|gi|445996697|ref|WP_000074552.1|	32.7	303	309	309	5.77e-36	130
k141_101602_28	SARG|gi|445996696|ref|WP_000074551.1|	32.7	303	309	309	5.77e-36	130
k141_101602_28	SARG|gi|445996698|ref|WP_000074553.1|	32.7	303	309	309	8.07e-36	130
k141_101602_28	SARG|YP_001373621	32.2	304	309	318	9.78e-36	130
k141_101602_28	SARG|gi|488067981|ref|WP_002139378.1|	30.9	307	309	309	3.08e-35	128
k141_101602_28	SARG|gi|488053456|ref|WP_002124853.1|	31.3	307	309	309	3.08e-35	128
k141_101602_30	SARG|Q8DF90	33.9	115	179	154	1.34e-06	45.1
k141_101602_30	SARG|BAC58936	37.9	95	179	154	1.84e-06	44.7
k141_101602_30	SARG|BAB59035	35.1	111	179	154	1.84e-06	44.7
k141_101602_30	SARG|ZP_01813310	34.2	111	179	154	4.77e-06	43.5
k141_101602_30	SARG|YP_002418004	34.2	111	179	154	4.77e-06	43.5
k141_101602_30	SARG|ZP_00990220	34.2	111	179	154	4.77e-06	43.5
k141_101602_67	SARG|DQ212986.1.gene8.p01	38.2	249	307	349	9.84e-47	159
k141_101602_67	SARG|gi|405945042|pdb|4FU0|A	38.2	249	307	357	1.19e-46	159
k141_101602_67	SARG|gi|765411304|ref|WP_044689514.1|	38.2	249	307	349	1.94e-46	159
k141_101602_67	SARG|gi|752682279|ref|WP_041330231.1|	37.8	249	307	349	3.82e-46	158
k141_101602_67	SARG|JF802084.2.gene1.p01	33.5	346	307	343	4.66e-46	157
k141_101602_67	SARG|AAF71281	37.8	249	307	349	5.36e-46	157
k141_101602_67	SARG|FJ872411.1.gene41.p01	31.7	341	307	352	8.07e-46	157
k141_101602_67	SARG|gi|1028100561|ref|WP_063856696.1|	36.5	249	307	349	2.08e-45	156
k141_101602_67	SARG|gi|257803688|gb|EEV32510.1|	33.6	342	307	344	3.90e-44	152
k141_101602_67	SARG|gi|498467695|ref|WP_010773051.1|	30.8	341	307	352	4.67e-44	152
k141_101602_75	ResF|penA_1_AF515059_1	37.3	565	589	581	2.42e-128	387
k141_101602_75	megares|MEG_3790|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	22.4	554	589	666	7.06e-23	102
k141_101602_75	NCBI|WP_063852700.1|1|1|mecA2|mecA2|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecA2|AMR|beta-lactam	22.5	551	589	668	9.41e-23	101
k141_101602_75	SARG|CAA70425	21.9	534	589	666	1.65e-22	100
k141_101602_75	SARG|AAX35723	22.3	584	589	665	2.19e-22	100
k141_101602_75	NCBI|WP_063852694.1|1|1|mecA2|mecA2|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecA2|AMR|beta-lactam	22.4	544	589	668	6.81e-22	99.0
k141_101602_75	megares|MEG_3793|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	22.9	541	589	668	1.20e-21	98.2
k141_101602_75	megares|MEG_3789|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	22.7	541	589	668	2.11e-21	97.4
k141_101602_75	SARG|gi|686322767|ref|WP_031876626.1|	22.7	541	589	668	2.11e-21	97.4
k141_101602_75	SARG|gi|686196719|ref|WP_031807381.1|	22.7	541	589	668	2.11e-21	97.4
k141_101602_82	CARD|gb|VWQ00850.1|ARO:3003843|leuO	83.4	302	317	314	2.57e-189	522
k141_101602_98	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	34.0	212	234	255	2.57e-30	112
k141_101602_98	SARG|gb|AAK76136.1|ARO:3000025|patB	26.6	207	234	588	5.01e-11	60.8
k141_101602_98	SARG|gb|AYV52072.1|ARO:3002882|lmrD	25.0	224	234	664	2.31e-10	58.9
k141_101602_98	SARG|gb|CDO61516.1|ARO:3003949|efrB	29.6	162	234	362	2.07e-08	52.8
k141_101602_112	CARD|gb|AIA35096.1|ARO:3005059|LptD	99.9	771	772	782	0.0	1582
k141_101602_115	SARG|AY234334.1.orf0.gene.p01	24.6	260	274	281	1.42e-16	76.6
k141_101602_115	SARG|NC_007792.3912746.p01	28.6	182	274	244	2.37e-13	67.0
k141_101602_115	SARG|NP_040462	28.0	182	274	244	1.54e-12	64.7
k141_101602_115	SARG|P13978	28.0	182	274	244	2.10e-12	64.3
k141_101602_115	NCBI|WP_011276921.1|1|1|erm(C)|erm(C)|target_modification|2|CLINDAMYCIN/ERYTHROMYCIN/STREPTOGRAMIN_B/TYLOSIN|LINCOSAMIDE/MACROLIDE/STREPTOGRAMIN|23S_rRNA_(adenine(2058)-N(6))-methyltransferase_Erm(C)|AMR|multidrug	28.0	182	274	244	2.10e-12	64.3
k141_101602_115	SARG|gi|157058876|gb|ABV03165.1|	28.0	182	274	244	2.10e-12	64.3
k141_101602_115	SARG|NC_010686.6295746.p01	28.0	182	274	244	2.10e-12	64.3
k141_101602_115	SARG|gi|353127769|gb|AEQ67361.1|	28.0	182	274	244	2.10e-12	64.3
k141_101602_115	SARG|NC_007209.3523503.p01	28.0	182	274	244	2.10e-12	64.3
k141_101602_115	SARG|gi|700659240|gb|AIU96746.1|	28.0	182	274	253	2.32e-12	64.3
k141_101602_118	SARG|gb|AAA25550.1|ARO:3003105|dfrA3	52.5	160	160	162	3.35e-53	165
k141_101602_118	SARG|gb|ABO40886.1|ARO:3004645|dfrI	46.0	161	160	191	7.98e-43	139
k141_101602_118	SARG|gb|CBL80435.1|ARO:3002869|dfrK	41.5	159	160	163	2.30e-41	135
k141_101602_118	NCBI|WP_031775848.1|1|1|dfrK|dfrK|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrK|AMR|diaminopyrimidine	41.5	159	160	163	2.30e-41	135
k141_101602_118	NCBI|WP_012779617.1|1|1|dfrK|dfrK|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrK|AMR|diaminopyrimidine	41.5	159	160	163	9.25e-41	133
k141_101602_118	SARG|gb|BAE15963.1|ARO:3002868|dfrG	39.6	159	160	165	2.79e-40	132
k141_101602_118	NCBI|WP_434062363.1|1|1|dfrA53|dfrA53|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrA53|AMR|diaminopyrimidine	41.9	160	160	166	4.65e-39	129
k141_101602_118	SARG|gb|ASF80997.1|ARO:3005164|dfrA35	42.4	139	160	170	1.36e-36	123
k141_101602_118	SARG|gb|AAA85213.1|ARO:3002866|dfrD	38.0	158	160	162	1.99e-34	117
k141_101602_118	megares|MEG_2575|Drugs|Trimethoprim|Dihydrofolate_reductase|DFRD_1	38.0	158	160	162	1.99e-34	117
k141_101602_119	SARG|gi|740410309|ref|WP_038243756.1|	30.2	517	622	563	8.93e-51	183
k141_101602_119	SARG|ZP_04615639	30.1	511	622	543	1.20e-50	182
k141_101602_119	SARG|YP_001401994	29.4	506	622	563	1.57e-49	180
k141_101602_119	SARG|gi|1001786599|ref|WP_061324791.1|	29.7	516	622	563	2.16e-49	179
k141_101602_119	SARG|ZP_04631861	30.6	509	622	543	1.05e-48	177
k141_101602_119	SARG|ZP_04630103	29.8	524	622	543	1.05e-48	177
k141_101602_119	SARG|AAS61092	29.2	506	622	563	1.45e-48	177
k141_101602_119	SARG|YP_001007250	30.3	515	622	563	5.17e-48	176
k141_101602_119	SARG|ZP_04635128	30.3	509	622	543	7.08e-48	175
k141_101602_119	SARG|gi|896190680|ref|WP_049199932.1|	29.6	513	622	563	7.09e-48	175
k141_101602_137	CARD|gb|ALH22601.1|ARO:3000620|adeL	25.5	290	310	337	2.21e-32	121
k141_101602_153	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	30.0	407	435	429	1.23e-50	176
k141_101602_163	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	35.5	242	239	252	3.56e-46	153
k141_101602_163	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	36.1	227	239	229	8.23e-42	141
k141_101602_163	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	35.7	227	239	231	5.39e-40	136
k141_101602_163	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	35.2	227	239	231	1.07e-39	135
k141_101602_163	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	34.8	227	239	231	8.41e-39	133
k141_101602_163	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	33.9	230	239	239	4.08e-38	132
k141_101602_163	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	33.0	227	239	231	6.58e-38	131
k141_101602_163	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	33.0	227	239	231	6.58e-38	131
k141_101602_163	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	33.2	226	239	228	1.33e-36	127
k141_101602_163	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	32.5	234	239	231	2.03e-36	127
k141_101602_165	CARD|gb|AEX49906.1|ARO:3003583|basS	30.1	282	475	477	5.93e-25	106
k141_101602_165	NCBI|WP_002368696.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	26.8	272	475	447	2.94e-14	73.6
k141_101602_165	NCBI|WP_002382867.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	27.6	272	475	447	3.91e-14	73.2
k141_101602_165	NCBI|WP_012579101.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	27.6	272	475	447	3.91e-14	73.2
k141_101602_165	NCBI|WP_063856739.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	27.6	272	475	447	3.91e-14	73.2
k141_101602_165	NCBI|WP_063856751.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	29.1	203	475	454	3.91e-13	70.1
k141_101602_165	NCBI|WP_063856737.1|1|1|vanS-B-Delta|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|VanB-type_glycopeptide_resistance_histidine_kinase_VanS-B-Delta|AMR|glycopeptide	27.0	270	475	441	6.64e-13	69.3
k141_101602_166	CARD|gb|AAD51348.1|ARO:3003066|smeR	45.0	222	230	229	2.63e-55	175
k141_101602_166	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	39.5	223	230	228	8.56e-48	156
k141_101602_166	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	41.7	218	230	225	4.43e-47	154
k141_101602_166	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	39.1	230	230	233	3.13e-46	152
k141_101602_166	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	38.2	233	230	235	2.63e-45	150
k141_101602_166	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	39.6	227	230	231	1.32e-44	148
k141_101602_166	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	39.6	227	230	231	1.32e-44	148
k141_101602_166	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	38.3	227	230	232	5.40e-44	146
k141_101602_166	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	38.3	227	230	232	5.40e-44	146
k141_101602_166	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	36.4	231	230	232	1.08e-43	145
k141_101602_168	megares|MEG_7070|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TETD_1	60.6	104	290	138	5.03e-39	132
k141_101602_168	CARD|gb|BAA15221.2|ARO:3000263|marA	51.0	98	290	127	2.12e-30	110
k141_101602_168	CARD|gb|AFK13828.1|ARO:3000823|ramA	47.1	102	290	124	4.78e-27	101
k141_101602_173	SARG|gb|APB03219.1|ARO:3003986|TaeA	40.7	509	556	648	1.42e-115	355
k141_101602_173	megares|MEG_4322|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.4	534	556	655	1.01e-66	227
k141_101602_173	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.2	538	556	655	3.75e-66	226
k141_101602_173	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.0	534	556	655	3.75e-66	226
k141_101602_173	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.2	538	556	655	3.75e-66	226
k141_101602_173	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.2	538	556	655	3.75e-66	226
k141_101602_173	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.0	534	556	655	3.75e-66	226
k141_101602_173	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.2	538	556	655	3.75e-66	226
k141_101602_173	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.2	538	556	655	3.75e-66	226
k141_101602_173	SARG|gb|AKA86814|ARO:3003746|optrA	32.2	538	556	655	3.75e-66	226
k141_101602_188	SARG|gi|672386269|gb|AIJ27535.1|	26.0	453	530	639	1.76e-36	142
k141_101602_188	SARG|AAR29485	26.0	453	530	639	2.39e-36	142
k141_101602_188	SARG|gi|544707441|ref|WP_021137831.1|	26.0	453	530	639	2.39e-36	142
k141_101602_188	megares|MEG_7165|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	25.3	451	530	639	5.45e-34	135
k141_101602_188	SARG|Q02652	27.9	451	530	639	2.43e-33	133
k141_101602_188	megares|MEG_7164|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	25.3	451	530	639	4.42e-33	132
k141_101602_188	SARG|AJ295238.gene.p01	25.3	455	530	639	5.96e-33	132
k141_101602_188	NCBI|WP_032490535.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	26.3	453	530	639	5.96e-33	132
k141_101602_188	SARG|WP_002857791.1	26.4	454	530	639	1.08e-32	131
k141_101602_188	SARG|ZP_04668102	26.0	453	530	639	1.08e-32	131
k141_101602_201	SARG|gi|769934495|ref|WP_045068423.1|	26.3	339	395	483	8.40e-14	71.6
k141_101602_201	SARG|gi|702654850|ref|WP_033232517.1|	26.3	339	395	483	1.99e-13	70.5
k141_101602_201	SARG|gi|837892000|ref|WP_047890276.1|	26.0	335	395	475	2.60e-13	70.1
k141_101602_201	SARG|gi|757693251|ref|WP_042923498.1|	25.9	336	395	478	6.20e-13	68.9
k141_101602_201	SARG|gi|755098695|ref|WP_042449655.1|	25.4	323	395	478	6.20e-13	68.9
k141_101602_201	SARG|gi|544923113|ref|WP_021332509.1|	25.6	336	395	478	8.26e-13	68.6
k141_101602_201	SARG|gi|518577471|ref|WP_019747678.1|	25.6	336	395	478	1.10e-12	68.2
k141_101602_201	SARG|gi|495001339|ref|WP_007727353.1|	25.7	323	395	478	1.10e-12	68.2
k141_101602_201	SARG|gi|814567055|ref|WP_046378300.1|	25.7	335	395	475	1.46e-12	67.8
k141_101602_201	SARG|gi|656323931|ref|WP_029254989.1|	25.7	335	395	478	1.46e-12	67.8
k141_101602_215	CARD|gb|AAK37618.1|ARO:3005008|TxR	31.9	213	922	318	3.06e-21	94.7
k141_101602_236	SARG|WP_000345069.1	36.4	426	453	434	4.28e-94	290
k141_101602_251	SARG|gi|851982891|ref|WP_048241697.1|	77.2	403	414	413	3.98e-226	623
k141_101602_251	SARG|gi|447111665|ref|WP_001188921.1|	76.5	408	414	413	2.29e-225	621
k141_101602_251	SARG|gi|1002473661|ref|WP_061389473.1|	76.5	408	414	413	3.26e-225	621
k141_101602_251	SARG|gi|447111661|ref|WP_001188917.1|	76.5	408	414	413	3.26e-225	621
k141_101602_251	SARG|CP001138.1.gene4809.p01	76.5	408	414	413	3.26e-225	621
k141_101602_251	SARG|Q7CP73	76.5	408	414	413	3.26e-225	621
k141_101602_251	SARG|gi|487593373|ref|WP_001727641.1|	76.5	408	414	413	3.26e-225	621
k141_101602_251	SARG|gi|491276012|ref|WP_005134118.1|	76.7	403	414	413	4.62e-225	620
k141_101602_251	SARG|gi|554958315|ref|WP_023203355.1|	77.4	403	414	413	4.62e-225	620
k141_101602_251	SARG|gi|553877911|ref|WP_023139226.1|	76.5	408	414	413	6.57e-225	620
k141_101602_257	SARG|YP_001572361	29.8	339	356	343	3.90e-22	94.7
k141_101602_257	SARG|gi|554684122|ref|WP_023184036.1|	29.8	339	356	343	3.90e-22	94.7
k141_101602_257	SARG|gi|740611645|ref|WP_038397166.1|	29.8	339	356	343	5.34e-22	94.4
k141_101602_257	SARG|gi|518557085|ref|WP_019727292.1|	25.7	206	356	414	1.27e-09	58.2
k141_101602_257	SARG|gi|571153128|emb|CDH71753.1|	26.8	205	356	381	1.56e-09	57.8
k141_101602_257	SARG|gi|392319457|gb|AFM64837.1|	26.8	205	356	381	1.56e-09	57.8
k141_101602_257	SARG|gi|759552006|ref|WP_043271822.1|	27.5	207	356	410	1.68e-09	57.8
k141_101602_257	SARG|gi|497308478|ref|WP_009622695.1|	27.5	207	356	410	1.68e-09	57.8
k141_101602_257	SARG|gi|553795211|ref|WP_023125877.1|	26.8	205	356	414	1.69e-09	57.8
k141_101602_257	SARG|gi|553748318|ref|WP_023081313.1|	26.8	205	356	414	1.69e-09	57.8
k141_101602_262	NCBI|WP_004214174.1|1|1|fosA10|fosA5_fam|thiol_transferase|2|phosphonic	99.3	139	140	139	5.32e-102	286
k141_101602_262	NCBI|WP_114473955.1|1|1|fosA9|fosA5_fam|thiol_transferase|2|phosphonic	98.6	139	140	139	2.17e-101	285
k141_101602_262	SARG|gb|AJE60855.1|ARO:3003209|FosA5	99.3	139	140	139	3.08e-101	285
k141_101602_262	NCBI|WP_004146118.1|1|1|fosA5_fam|fosA5_fam|thiol_transferase|2|phosphonic	99.3	137	140	139	1.26e-100	283
k141_101602_262	SARG|gb|AMQ12811.1|ARO:3004111|FosA6	98.5	137	140	139	2.09e-99	280
k141_101602_262	NCBI|WP_009486251.1|1|1|fosA5_fam|fosA5_fam|thiol_transferase|2|phosphonic	97.8	137	140	139	2.96e-99	280
k141_101602_262	NCBI|WP_004857515.1|1|1|fosA_gen|fosA_gen|thiol_transferase|2|phosphonic	90.6	139	140	139	6.46e-94	266
k141_101602_262	SARG|gb|AEG78825.1|ARO:3002872|FosA3	80.3	137	140	138	1.91e-79	229
k141_101602_262	SARG|gb|BAP18892.1|ARO:3003210|FosA4	79.6	137	140	138	4.49e-78	226
k141_101602_262	SARG|gi|754494458|ref|WP_041911353.1|	72.7	139	140	141	1.93e-75	219
k141_101602_263	CARD|gb|VWQ00850.1|ARO:3003843|leuO	27.5	302	303	314	7.64e-22	92.4
k141_101602_267	SARG|gi|504542119|ref|WP_014729221.1|	28.8	233	495	647	6.04e-13	70.1
k141_101602_267	SARG|gi|1001720867|ref|WP_061274204.1|	28.3	233	495	648	6.05e-13	70.1
k141_101602_267	SARG|gi|981224618|ref|WP_059445588.1|	27.9	251	495	646	1.06e-12	69.3
k141_101602_267	SARG|gi|695722592|ref|WP_032649220.1|	28.3	251	495	646	1.06e-12	69.3
k141_101602_267	SARG|gi|658546960|ref|WP_029739484.1|	28.3	251	495	646	1.06e-12	69.3
k141_101602_267	SARG|gi|696411918|ref|WP_032982657.1|	28.3	233	495	647	1.06e-12	69.3
k141_101602_267	SARG|gi|696402390|ref|WP_032974230.1|	28.3	233	495	647	1.06e-12	69.3
k141_101602_267	SARG|gi|696423952|ref|WP_032993748.1|	28.3	233	495	647	1.06e-12	69.3
k141_101602_267	SARG|gi|556487375|ref|WP_023335108.1|	27.9	251	495	646	1.40e-12	68.9
k141_101602_267	SARG|gi|495067432|ref|WP_007792257.1|	28.3	233	495	647	1.40e-12	68.9
k141_101602_271	SARG|gi|542061059|gb|ERI11611.1|	37.1	221	915	316	1.52e-41	154
k141_101602_271	SARG|P42332	35.4	229	915	306	4.02e-39	146
k141_101602_271	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	35.4	229	915	306	4.02e-39	146
k141_101602_271	SARG|gi|510143239|gb|AGN36970.1|	35.4	229	915	313	4.77e-39	146
k141_101602_271	SARG|ABB80128	35.4	229	915	306	1.01e-38	145
k141_101602_271	SARG|YP_001373621	35.2	219	915	318	2.48e-38	144
k141_101602_271	SARG|AAD21213	34.9	229	915	306	2.52e-38	144
k141_101602_271	SARG|gi|447057509|ref|WP_001134765.1|	37.6	213	915	309	3.68e-38	144
k141_101602_271	SARG|gi|447057510|ref|WP_001134766.1|	37.1	213	915	309	5.00e-38	143
k141_101602_271	SARG|gi|488068784|ref|WP_002140181.1|	37.1	213	915	309	1.25e-37	142
k141_9686_18	SARG|gb|AYV52072.1|ARO:3002882|lmrD	30.2	461	707	664	1.28e-47	177
k141_9686_18	SARG|gi|496018010|ref|WP_008742581.1|	27.3	557	707	623	1.66e-44	168
k141_9686_18	SARG|gi|921231571|ref|WP_053176464.1|	28.0	528	707	620	4.01e-44	167
k141_9686_18	SARG|gi|695842130|ref|WP_032755430.1|	27.3	523	707	603	4.42e-44	166
k141_9686_18	SARG|gi|917172177|ref|WP_051778889.1|	28.0	528	707	620	5.44e-44	166
k141_9686_18	SARG|gi|926376632|ref|WP_053705806.1|	27.8	525	707	620	1.00e-43	166
k141_9686_18	SARG|gi|664458452|ref|WP_030980047.1|	26.4	518	707	601	1.08e-43	165
k141_9686_18	SARG|gi|662129758|ref|WP_030081404.1|	27.2	534	707	605	1.13e-43	165
k141_9686_18	SARG|gi|919568551|ref|WP_052871170.1|	26.9	527	707	620	1.36e-43	165
k141_9686_18	SARG|gi|917229923|ref|WP_051836635.1|	26.5	524	707	620	1.36e-43	165
k141_9686_25	SARG|gi|489421661|ref|WP_003327389.1|	45.5	101	106	105	2.39e-17	70.1
k141_9686_25	SARG|gi|489246601|ref|WP_003154765.1|	41.2	102	106	104	1.06e-15	65.9
k141_9686_25	SARG|ABS73654	40.2	102	106	104	4.25e-15	64.3
k141_9686_25	SARG|gi|1044625135|gb|OCB99622.1|	44.1	102	106	163	5.53e-15	65.5
k141_9686_25	SARG|gi|291483835|dbj|BAI84910.1|	44.7	103	106	105	6.16e-15	63.9
k141_9686_25	SARG|gi|489311091|ref|WP_003218500.1|	44.7	103	106	105	8.72e-15	63.5
k141_9686_25	SARG|gi|320021335|gb|ADV96321.1|	44.7	103	106	105	8.72e-15	63.5
k141_9686_25	NCBI|EAC4468893.1|1|1|emrC_Lis|emrC_Lis||1|QUATERNARY_AMMONIUM|QUATERNARY_AMMONIUM|multidrug_efflux_transporter_outer_membrane_subunit_EmrC|AMR|quaternary	35.3	102	106	128	1.05e-14	63.9
k141_9686_25	SARG|ABS73653	44.1	102	106	112	1.46e-14	63.2
k141_9686_25	SARG|gi|515503150|ref|WP_016936404.1|	40.2	102	106	104	1.70e-14	62.8
k141_9686_26	megares|MEG_497|Drugs|beta-lactam|Class_C_betalactamases|ACT_1	66.2	77	178	77	4.07e-33	112
k141_9686_97	SARG|gi|983405167|ref|WP_060572706.1|	30.4	230	501	646	2.09e-22	99.8
k141_9686_97	SARG|gi|782756348|ref|WP_045630015.1|	30.9	230	501	646	2.78e-22	99.4
k141_9686_97	SARG|gi|754493745|ref|WP_041910640.1|	30.4	230	501	646	3.71e-22	99.0
k141_9686_97	SARG|gi|498115003|ref|WP_010429159.1|	30.2	235	501	646	4.94e-22	98.6
k141_9686_97	SARG|gi|740633514|ref|WP_038419019.1|	32.0	206	501	646	8.76e-22	97.8
k141_9686_97	SARG|gi|779958642|ref|WP_045406003.1|	31.9	213	501	646	8.76e-22	97.8
k141_9686_97	SARG|gi|895898290|ref|WP_048999361.1|	30.0	230	501	646	1.17e-21	97.4
k141_9686_97	SARG|gi|896106549|ref|WP_049136608.1|	30.4	230	501	646	1.17e-21	97.4
k141_9686_97	SARG|gi|659669327|ref|WP_029883000.1|	32.0	206	501	646	1.17e-21	97.4
k141_9686_97	SARG|gi|998245120|ref|WP_061098715.1|	31.9	213	501	646	1.17e-21	97.4
k141_9686_137	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	22.5	883	952	1024	4.69e-50	191
k141_9686_137	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	22.5	883	952	1024	4.69e-50	191
k141_9686_137	megares|MEG_4091|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPB_1	21.1	893	952	1033	8.52e-50	190
k141_9686_137	SARG|gb|AEY83581|ARO:3000510|mupB	21.1	893	952	1033	8.52e-50	190
k141_9686_137	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	22.5	883	952	1024	1.46e-49	189
k141_9686_137	SARG|gb|CAA53189|ARO:3000521|mupA	22.5	883	952	1024	1.46e-49	189
k141_100653_6	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	34.5	432	501	429	3.33e-78	250
k141_100653_14	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	30.7	225	253	343	1.36e-20	88.2
k141_100653_14	SARG|gi|542061059|gb|ERI11611.1|	26.6	244	253	316	1.31e-19	85.1
k141_100653_14	SARG|gi|446026113|ref|WP_000103968.1|	26.1	222	253	306	2.21e-19	84.3
k141_100653_14	SARG|gi|507035724|ref|WP_016107411.1|	27.5	222	253	309	8.26e-19	82.8
k141_100653_14	SARG|gi|445996695|ref|WP_000074550.1|	27.5	222	253	309	8.26e-19	82.8
k141_100653_14	SARG|gi|445996698|ref|WP_000074553.1|	27.5	222	253	309	8.26e-19	82.8
k141_100653_14	SARG|gi|445996708|ref|WP_000074563.1|	27.0	222	253	309	1.56e-18	82.0
k141_100653_14	SARG|gi|507055561|ref|WP_016126482.1|	27.0	222	253	309	1.56e-18	82.0
k141_100653_14	SARG|gi|445996697|ref|WP_000074552.1|	27.5	222	253	309	2.15e-18	81.6
k141_100653_14	SARG|gi|445996696|ref|WP_000074551.1|	27.5	222	253	309	2.15e-18	81.6
k141_100653_15	SARG|gi|860594225|ref|WP_048475168.1|	31.4	210	227	620	6.70e-13	66.2
k141_100653_15	SARG|gi|516795764|ref|WP_018105258.1|	31.9	210	227	601	1.81e-11	62.0
k141_100653_15	SARG|gi|926351744|ref|WP_053683383.1|	31.4	210	227	648	1.85e-11	62.0
k141_100653_15	SARG|gb|AAK76137.1|ARO:3000024|patA	29.9	194	227	564	4.36e-11	60.8
k141_100653_15	SARG|gi|664170108|ref|WP_030704355.1|	32.6	190	227	603	6.01e-11	60.5
k141_100653_15	SARG|gi|501350226|ref|WP_012381861.1|	32.6	190	227	603	6.01e-11	60.5
k141_100653_15	SARG|gi|490068471|ref|WP_003970646.1|	32.6	190	227	603	6.01e-11	60.5
k141_100653_15	SARG|gi|648667297|ref|WP_026359044.1|	32.0	194	227	605	6.01e-11	60.5
k141_100653_15	SARG|gi|517787730|ref|WP_018957938.1|	32.6	190	227	610	6.03e-11	60.5
k141_100653_15	SARG|gi|926400371|ref|WP_053728483.1|	32.1	190	227	603	8.10e-11	60.1
k141_100653_21	SARG|gi|639209604|ref|WP_024547784.1|	31.9	229	507	648	3.85e-21	95.9
k141_100653_21	SARG|gi|542061059|gb|ERI11611.1|	27.8	230	507	316	2.37e-16	79.0
k141_100653_21	SARG|gi|447195835|ref|WP_001273091.1|	28.8	215	507	306	2.84e-16	78.6
k141_100653_21	SARG|gi|447195836|ref|WP_001273092.1|	28.8	215	507	306	2.84e-16	78.6
k141_100653_21	SARG|gb|AAC74000.1|ARO:3003950|msbA	30.4	207	507	582	2.94e-16	80.5
k141_100653_21	SARG|ZP_04081918	28.8	215	507	306	6.91e-16	77.4
k141_100653_21	SARG|gi|500194536|ref|WP_011867743.1|	29.6	206	507	306	2.26e-15	75.9
k141_100653_21	SARG|gi|445996719|ref|WP_000074574.1|	29.6	203	507	309	7.64e-15	74.3
k141_100653_21	SARG|gi|447057509|ref|WP_001134765.1|	29.6	203	507	309	1.38e-14	73.6
k141_100653_21	SARG|gi|507044560|ref|WP_016115614.1|	28.6	206	507	306	1.79e-14	73.2
k141_100653_27	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	38.4	237	243	252	2.89e-49	161
k141_100653_27	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	40.0	230	243	228	8.75e-39	133
k141_100653_27	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	36.8	228	243	225	3.52e-37	129
k141_100653_27	CARD|gb|AAG05188.1|ARO:3005068|ParR	34.2	228	243	235	5.00e-36	126
k141_100653_27	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	34.2	225	243	229	5.13e-34	121
k141_100653_27	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	34.7	236	243	231	2.29e-32	117
k141_100653_27	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	34.5	232	243	231	8.93e-32	115
k141_100653_27	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	33.9	236	243	231	1.76e-31	114
k141_100653_27	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	33.9	227	243	230	2.60e-30	111
k141_100653_27	CARD|gb|AAD51348.1|ARO:3003066|smeR	35.0	234	243	229	2.08e-28	106
k141_100653_46	CARD|gb|AAG05661.1|ARO:3004107|Paer_soxR	64.5	141	153	156	3.25e-62	187
k141_100653_47	CARD|gb|AFK13828.1|ARO:3000823|ramA	49.5	101	110	124	4.10e-33	110
k141_100653_53	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	30.7	215	344	343	4.92e-23	97.1
k141_100653_53	SARG|gb|AAK76137.1|ARO:3000024|patA	29.9	211	344	564	2.49e-20	90.9
k141_100653_53	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	30.8	221	344	579	2.73e-19	87.8
k141_100653_53	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	30.3	211	344	579	1.61e-18	85.5
k141_100653_53	SARG|gi|1045390184|ref|WP_065479071.1|	31.5	222	344	605	2.23e-18	85.1
k141_100653_53	SARG|gi|764446018|ref|WP_044369325.1|	31.5	222	344	605	5.40e-18	84.0
k141_100653_53	SARG|gi|695865802|ref|WP_032778631.1|	31.5	222	344	605	5.40e-18	84.0
k141_100653_53	SARG|gi|695887424|ref|WP_032788534.1|	31.5	222	344	605	7.25e-18	83.6
k141_100653_53	SARG|gi|664180077|ref|WP_030714054.1|	31.5	222	344	605	7.25e-18	83.6
k141_100653_53	SARG|gi|664556405|ref|WP_031071225.1|	32.4	210	344	602	9.70e-18	83.2
k141_100653_60	megares|MEG_7070|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TETD_1	34.0	106	123	138	2.62e-16	68.9
k141_100653_60	CARD|gb|BAA15221.2|ARO:3000263|marA	33.3	93	123	127	1.39e-13	61.6
k141_100653_64	SARG|gi|446048013|ref|WP_000125868.1|	34.6	104	942	648	2.89e-11	66.2
k141_100653_64	SARG|gi|654544841|ref|WP_028012549.1|	36.4	99	942	646	1.14e-10	64.3
k141_100653_64	SARG|gi|829908959|ref|WP_047362283.1|	36.4	99	942	646	1.14e-10	64.3
k141_100653_64	SARG|gi|1015876944|ref|WP_062856780.1|	36.4	99	942	646	1.14e-10	64.3
k141_100653_64	SARG|gi|504644166|ref|WP_014831268.1|	36.4	99	942	646	1.14e-10	64.3
k141_100653_64	SARG|gi|522181382|ref|WP_020689930.1|	36.4	99	942	646	1.14e-10	64.3
k141_100653_64	SARG|gi|896106549|ref|WP_049136608.1|	36.4	99	942	646	1.14e-10	64.3
k141_100653_64	SARG|gi|829942568|ref|WP_047368199.1|	36.4	99	942	646	1.14e-10	64.3
k141_100653_64	SARG|gi|1006477526|ref|WP_061771940.1|	36.4	99	942	646	1.14e-10	64.3
k141_100653_64	SARG|gi|742827468|ref|WP_038984467.1|	36.4	99	942	646	1.14e-10	64.3
k141_100653_69	NCBI|WP_063856758.1|1|1|vanTc2|vanTc2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT|AMR|glycopeptide	34.9	370	360	706	1.33e-45	164
k141_100653_69	NCBI|WP_063856759.1|1|1|vanTc3|vanTc3|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT|AMR|glycopeptide	34.6	370	360	700	3.30e-45	163
k141_100653_69	NCBI|WP_063856756.1|1|1|vanT-C|vanT-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-C|AMR|glycopeptide	34.3	367	360	700	1.17e-44	162
k141_100653_69	NCBI|WP_063856755.1|1|1|vanT-C|vanT-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-C|AMR|glycopeptide	33.3	369	360	700	2.78e-43	158
k141_100653_69	SARG|JF802084.2.gene3.p01	32.4	361	360	700	2.52e-42	155
k141_100653_69	SARG|gb|ABA71733.1|ARO:3002972|vanTG	30.9	363	360	712	3.71e-42	155
k141_100653_69	SARG|gb|ABX54690.1|ARO:3002974|vanTrL	33.1	363	360	366	3.99e-40	144
k141_100653_69	SARG|AF162694.1.gene4.p01	31.6	367	360	698	1.32e-39	147
k141_100653_69	SARG|gi|657686198|ref|WP_029487032.1|	31.6	367	360	698	1.32e-39	147
k141_100653_69	SARG|AAY67970	31.3	367	360	698	4.58e-39	146
k141_100653_85	SARG|gi|912614197|ref|WP_050196089.1|	34.4	221	370	648	2.41e-27	112
k141_100653_85	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	31.4	220	370	343	2.82e-23	98.2
k141_100653_85	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	28.2	220	370	307	2.88e-22	94.7
k141_100653_85	SARG|gi|953808775|ref|WP_058042812.1|	33.8	222	370	608	8.38e-22	95.9
k141_100653_85	SARG|gb|AAK76137.1|ARO:3000024|patA	27.9	233	370	564	1.33e-16	80.1
k141_100653_85	NCBI|WP_011116970.1|1|1|tetAB_B|tetAB_B|efflux|2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_TetAB_subunit_B|AMR|tetracycline	27.9	208	370	528	6.91e-09	56.2
k141_51093_8	SARG|gb|AYV52072.1|ARO:3002882|lmrD	27.4	234	357	664	3.63e-19	87.8
k141_51093_8	SARG|gb|WP_104671188.1|ARO:3003948|efrA	27.9	229	357	575	5.90e-19	87.0
k141_51093_8	SARG|gb|AAK76136.1|ARO:3000025|patB	25.0	208	357	588	6.95e-15	74.7
k141_51093_8	SARG|gb|CDO61516.1|ARO:3003949|efrB	26.5	181	357	362	1.38e-12	67.0
k141_51093_8	SARG|gi|640690880|ref|WP_025115215.1|	23.4	205	357	492	2.65e-11	63.5
k141_51093_8	SARG|gi|738272573|ref|WP_036227195.1|	23.4	205	357	492	6.28e-11	62.4
k141_51093_8	SARG|gi|495453058|ref|WP_008177752.1|	23.4	205	357	492	6.28e-11	62.4
k141_51093_8	NCBI|WP_172065992.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	24.9	185	357	461	5.30e-06	47.0
k141_66281_2	SARG|gi|694076105|ref|WP_032421853.1|	99.9	1036	1037	1036	0.0	1943
k141_66281_2	SARG|gi|496667122|ref|WP_009309612.1|	99.9	1036	1037	1036	0.0	1941
k141_66281_2	SARG|CP000647.1.gene3710.p01	99.8	1036	1037	1036	0.0	1941
k141_66281_2	SARG|gi|556290479|ref|WP_023291164.1|	99.5	1036	1037	1036	0.0	1937
k141_66281_2	SARG|gi|817600095|ref|WP_046594084.1|	91.6	1037	1037	1037	0.0	1809
k141_66281_2	SARG|gi|817604860|ref|WP_046598079.1|	91.6	1037	1037	1037	0.0	1808
k141_66281_2	SARG|gi|817600173|ref|WP_046594139.1|	91.6	1037	1037	1037	0.0	1808
k141_66281_2	SARG|gi|817601660|ref|WP_046595348.1|	91.6	1037	1037	1037	0.0	1807
k141_66281_2	SARG|gi|447196024|ref|WP_001273280.1|	91.5	1037	1037	1037	0.0	1807
k141_66281_2	SARG|gi|487663012|ref|WP_001752778.1|	91.3	1037	1037	1037	0.0	1804
k141_66281_3	SARG|gb|AAC76297.1|ARO:3000499|acrE	75.9	377	380	385	2.96e-196	545
k141_66281_3	SARG|CAC35724	71.1	374	380	399	1.73e-177	498
k141_66281_3	SARG|gi|489927712|ref|WP_003831044.1|	70.9	374	380	397	2.29e-177	498
k141_66281_3	SARG|gi|696364907|ref|WP_032939988.1|	71.1	374	380	397	2.29e-177	498
k141_66281_3	SARG|YP_002848373	70.9	374	380	414	1.19e-176	496
k141_66281_3	SARG|gi|749610452|ref|WP_040232688.1|	71.1	374	380	397	1.87e-176	495
k141_66281_3	SARG|YP_002240036	70.3	374	380	397	1.08e-175	493
k141_66281_3	SARG|CP000647.1.gene444.p01	70.1	374	380	397	1.08e-175	493
k141_66281_3	SARG|ZP_02656523	70.6	374	380	397	2.17e-175	493
k141_66281_3	SARG|gi|573042590|emb|CDI16885.1|	70.1	374	380	417	2.18e-175	493
k141_66281_4	CARD|gb|AAC76296.1|ARO:3000656|AcrS	53.5	198	218	220	3.68e-73	220
k141_66281_4	NCBI|CAA81047.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	29.9	197	218	210	2.10e-21	87.0
k141_66281_4	NCBI|ACF30254.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	29.9	197	218	210	2.93e-21	86.7
k141_66281_25	SARG|gi|979588572|ref|WP_059340812.1|	34.6	153	311	343	5.96e-18	82.0
k141_66281_25	SARG|YP_001572361	32.3	167	311	343	7.02e-17	79.0
k141_66281_25	SARG|gi|1039294627|ref|WP_064770825.1|	34.6	153	311	343	9.54e-17	78.6
k141_66281_25	SARG|gi|984670524|ref|WP_060773951.1|	34.6	153	311	343	9.54e-17	78.6
k141_66281_25	SARG|gi|949798405|ref|WP_057108582.1|	34.6	153	311	343	9.54e-17	78.6
k141_66281_25	SARG|YP_691420	34.0	153	311	323	1.09e-16	78.2
k141_66281_25	SARG|gi|332752007|gb|EGJ82400.1|	34.0	153	311	323	1.09e-16	78.2
k141_66281_25	SARG|NP_709857	34.0	153	311	343	1.30e-16	78.2
k141_66281_25	SARG|gi|765472015|ref|WP_044721456.1|	34.0	153	311	343	1.76e-16	77.8
k141_66281_25	SARG|gi|740611645|ref|WP_038397166.1|	31.7	167	311	343	1.76e-16	77.8
k141_66281_47	CARD|gb|AAC75429.1|ARO:3000833|evgS	27.6	525	780	1197	6.50e-51	192
k141_66281_47	CARD|gb|AEX49906.1|ARO:3003583|basS	25.0	228	780	477	9.46e-12	67.0
k141_66281_47	SARG|ZP_02848503	33.6	110	780	221	7.33e-09	55.8
k141_66281_47	CARD|gb|ATC67679.1|ARO:3000838|arlR	33.0	91	780	219	5.75e-08	53.1
k141_66281_47	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	34.7	121	780	228	6.82e-07	50.1
k141_66281_55	SARG|gi|500194536|ref|WP_011867743.1|	32.4	210	242	306	4.98e-28	107
k141_66281_55	SARG|gi|817536927|ref|WP_046586836.1|	20.9	196	242	492	3.96e-06	46.2
k141_66281_61	SARG|gb|ADZ12699.1|ARO:3005091|RanA	35.9	206	271	258	2.53e-36	129
k141_66281_61	SARG|gb|AAK76136.1|ARO:3000025|patB	25.0	236	271	588	1.89e-16	77.8
k141_66281_61	NCBI|AJP12342.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	25.1	219	271	550	3.78e-10	58.9
k141_66281_61	SARG|gb|AGN74946|ARO:3003749|salA	36.5	63	271	541	3.08e-07	50.1
k141_66281_79	SARG|AUI09862.1	42.0	269	283	287	3.53e-67	209
k141_66281_79	SARG|AJ459418.gene.p01	35.2	261	283	263	1.45e-44	150
k141_66281_79	SARG|gi|970263436|ref|WP_058647620.1|	35.2	261	283	263	2.87e-44	150
k141_66281_79	SARG|gi|553729091|ref|WP_023063817.1|	33.2	259	283	271	1.73e-36	130
k141_66281_79	SARG|gi|485778844|ref|WP_001402002.1|	33.2	259	283	271	3.41e-36	129
k141_66281_79	SARG|gi|499589362|ref|WP_011270145.1|	33.0	270	283	283	4.52e-36	129
k141_66281_79	SARG|gi|638947703|ref|WP_024439711.1|	33.2	259	283	271	4.79e-36	129
k141_66281_79	SARG|gi|916164813|ref|WP_050960181.1|	33.2	259	283	271	4.79e-36	129
k141_66281_79	SARG|gi|920213921|ref|WP_052970363.1|	33.2	259	283	271	4.79e-36	129
k141_66281_79	SARG|gi|835825825|ref|WP_047670793.1|	33.6	259	283	271	4.79e-36	129
k141_66281_140	SARG|WP_000345069.1	24.2	430	444	434	8.45e-24	102
k141_66281_173	SARG|gi|1035670474|ref|WP_064517458.1|	29.6	270	496	648	1.09e-19	91.3
k141_66281_173	SARG|gi|1035717981|ref|WP_064557480.1|	28.9	270	496	648	1.09e-19	91.3
k141_66281_173	SARG|gi|1035706844|ref|WP_064548272.1|	28.5	270	496	648	1.09e-19	91.3
k141_66281_173	SARG|gi|803568669|ref|WP_046077412.1|	30.9	223	496	648	1.45e-19	90.9
k141_66281_173	SARG|gi|446110352|ref|WP_000188207.1|	30.9	223	496	648	1.45e-19	90.9
k141_66281_173	SARG|YP_002382193	30.9	223	496	648	1.45e-19	90.9
k141_66281_173	SARG|gi|803575554|ref|WP_046081557.1|	30.9	223	496	648	1.45e-19	90.9
k141_66281_173	SARG|gi|446110351|ref|WP_000188206.1|	30.9	223	496	648	1.45e-19	90.9
k141_66281_173	SARG|gi|736472622|ref|WP_034494292.1|	28.5	270	496	648	8.00e-19	88.6
k141_66281_173	SARG|gi|446026113|ref|WP_000103968.1|	26.0	219	496	306	1.73e-14	73.2
k141_66281_200	CARD|gb|AAC75429.1|ARO:3000833|evgS	38.5	1161	1081	1197	4.93e-271	793
k141_66281_201	CARD|gb|BAB36671.1|ARO:3000832|evgA	66.7	204	205	204	9.57e-93	268
k141_66281_201	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	28.3	120	205	225	4.57e-10	56.2
k141_66281_201	CARD|gb|AAC73788.1|ARO:3003841|kdpE	28.3	120	205	225	4.57e-10	56.2
k141_66281_201	CARD|gb|ATC67679.1|ARO:3000838|arlR	31.3	112	205	219	3.46e-08	50.8
k141_66281_201	CARD|gb|AAC75429.1|ARO:3000833|evgS	28.9	97	205	1197	1.97e-07	49.7
k141_66281_201	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	28.6	112	205	225	4.27e-07	47.8
k141_66281_201	CARD|gb|AAD51348.1|ARO:3003066|smeR	23.7	118	205	229	5.95e-07	47.4
k141_66281_219	SARG|BAH65231	100	273	274	273	5.91e-190	520
k141_66281_219	SARG|YP_002236533	98.5	273	274	273	1.14e-187	514
k141_66281_219	SARG|A1AFX9	89.4	273	274	273	1.70e-173	478
k141_66281_219	SARG|CAS10898	89.4	273	274	273	1.70e-173	478
k141_66281_219	SARG|A8A4L2	89.4	273	274	273	1.70e-173	478
k141_66281_219	SARG|ZP_03064089	89.4	273	274	274	1.77e-173	478
k141_66281_219	SARG|gi|641685979|emb|CDN83808.1|	89.4	273	274	274	1.77e-173	478
k141_66281_219	SARG|B7NJS0	89.4	273	274	273	2.42e-173	478
k141_66281_219	SARG|gi|486204699|ref|WP_001551672.1|	89.0	273	274	273	4.88e-173	477
k141_66281_219	SARG|B7LQD5	89.0	273	274	273	9.84e-173	476
k141_66281_232	SARG|CP000647.1.gene3449.p01	100	490	491	492	0.0	894
k141_66281_232	SARG|gi|490278417|ref|WP_004174363.1|	100	490	491	490	0.0	894
k141_66281_232	SARG|gi|852051865|ref|WP_048271086.1|	99.8	490	491	490	0.0	894
k141_66281_232	SARG|gi|749556664|ref|WP_040188893.1|	99.8	490	491	490	0.0	893
k141_66281_232	SARG|gi|1031851380|ref|WP_064173626.1|	99.8	490	491	490	0.0	892
k141_66281_232	SARG|gi|852300918|ref|WP_048334428.1|	99.8	490	491	490	0.0	892
k141_66281_232	SARG|gi|504412163|ref|WP_014599265.1|	99.8	490	491	490	0.0	892
k141_66281_232	SARG|gi|414709877|emb|CCN31581.1|	99.8	490	491	492	0.0	892
k141_66281_232	SARG|gi|694088797|ref|WP_032433534.1|	99.8	490	491	490	0.0	892
k141_66281_232	SARG|gi|496082010|ref|WP_008806517.1|	99.6	490	491	490	0.0	892
k141_66281_237	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	37.9	651	632	703	3.10e-122	377
k141_66281_240	CARD|gb|AEX49906.1|ARO:3003583|basS	33.2	464	450	477	5.71e-56	191
k141_66281_241	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	37.9	219	220	219	8.55e-46	150
k141_66281_241	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	37.9	219	220	219	1.21e-45	150
k141_66281_241	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	37.9	219	220	220	1.24e-45	150
k141_66281_241	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	37.4	219	220	220	4.96e-45	148
k141_66281_241	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.1	219	220	220	2.49e-42	141
k141_66281_241	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	35.1	225	220	231	1.14e-36	127
k141_66281_241	CARD|gb|AAD51348.1|ARO:3003066|smeR	35.6	219	220	229	1.32e-34	122
k141_66281_241	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	33.8	222	220	228	3.34e-31	113
k141_66281_241	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	34.9	232	220	252	1.74e-29	109
k141_66281_241	CARD|gb|AAG05188.1|ARO:3005068|ParR	36.2	221	220	235	9.75e-28	104
k141_66281_269	CARD|gb|ALH22601.1|ARO:3000620|adeL	35.2	290	304	337	1.66e-43	150
k141_117435_11	CARD|gb|ALH22601.1|ARO:3000620|adeL	40.4	225	232	337	5.68e-54	175
k141_117435_13	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	69.6	385	382	374	3.71e-190	529
k141_117435_13	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	54.4	375	382	357	3.71e-128	371
k141_117435_29	SARG|gi|565651791|ref|WP_023899061.1|	42.2	237	251	647	1.18e-46	163
k141_117435_29	SARG|gi|516510995|ref|WP_017899433.1|	43.3	238	251	646	4.30e-46	161
k141_117435_29	SARG|gi|504542119|ref|WP_014729221.1|	40.0	255	251	647	1.15e-45	160
k141_117435_29	SARG|gi|655997348|ref|WP_029038923.1|	40.0	255	251	647	1.15e-45	160
k141_117435_29	SARG|gi|426326769|emb|CCK10228.1|	40.0	255	251	648	1.16e-45	160
k141_117435_29	SARG|gi|938461734|ref|WP_054625806.1|	41.8	237	251	647	1.59e-45	160
k141_117435_29	SARG|gi|1020141879|ref|WP_063264839.1|	41.8	237	251	647	1.59e-45	160
k141_117435_29	SARG|gi|696402390|ref|WP_032974230.1|	41.8	237	251	647	1.59e-45	160
k141_117435_29	SARG|gi|490522515|ref|WP_004387938.1|	41.8	237	251	647	1.59e-45	160
k141_117435_29	SARG|gi|696423952|ref|WP_032993748.1|	41.8	237	251	647	1.59e-45	160
k141_117435_30	CARD|gb|AAL20862.1|ARO:3000826|sdiA	66.7	240	241	240	2.86e-121	343
k141_117435_32	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	30.9	81	219	228	1.76e-06	46.2
k141_117435_41	SARG|CP001918.1.gene3442.p01	34.4	401	474	457	5.13e-81	257
k141_117435_41	SARG|YP_002188856	31.6	427	474	537	1.56e-34	134
k141_117435_41	SARG|YP_002196817	31.1	409	474	536	2.50e-33	131
k141_117435_41	SARG|YP_001486998	24.1	395	474	530	1.11e-32	129
k141_117435_41	SARG|ZP_03053667	23.5	395	474	506	2.21e-32	128
k141_117435_41	SARG|AAA67509	30.4	421	474	538	4.06e-32	127
k141_117435_41	SARG|gi|647263485|ref|WP_025711508.1|	26.7	401	474	512	8.07e-32	126
k141_117435_41	SARG|YP_002181880	30.0	407	474	536	1.00e-31	126
k141_117435_41	SARG|gi|507083411|ref|WP_016154159.1|	26.4	401	474	512	2.03e-31	125
k141_117435_41	SARG|gi|895960539|ref|WP_049043311.1|	26.4	401	474	512	2.03e-31	125
k141_117435_46	SARG|Q83LR7	31.1	225	505	648	9.16e-24	103
k141_117435_46	SARG|gi|647325472|ref|WP_025760953.1|	31.1	225	505	648	9.16e-24	103
k141_117435_46	SARG|gi|647323678|ref|WP_025760497.1|	31.1	225	505	648	9.16e-24	103
k141_117435_46	SARG|gb|CDO61516.1|ARO:3003949|efrB	25.7	202	505	362	3.94e-12	66.6
k141_117435_46	SARG|gi|542061059|gb|ERI11611.1|	25.9	216	505	316	2.96e-11	63.5
k141_117435_46	SARG|P42332	26.4	208	505	306	1.17e-10	61.6
k141_117435_46	SARG|ABB80128	26.4	208	505	306	1.17e-10	61.6
k141_117435_46	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	26.4	208	505	306	1.17e-10	61.6
k141_117435_46	SARG|gi|510143239|gb|AGN36970.1|	26.4	208	505	313	1.24e-10	61.6
k141_117435_46	SARG|gi|447057509|ref|WP_001134765.1|	26.8	209	505	309	1.61e-10	61.2
k141_117435_68	SARG|gi|445996719|ref|WP_000074574.1|	30.0	203	251	309	6.58e-22	91.3
k141_117435_68	SARG|gi|445996710|ref|WP_000074565.1|	29.6	203	251	309	1.74e-21	90.1
k141_117435_68	SARG|gi|542061059|gb|ERI11611.1|	29.6	203	251	316	1.91e-21	90.1
k141_117435_68	SARG|gi|895736250|emb|COF64653.1|	29.6	203	251	309	3.33e-21	89.4
k141_117435_68	SARG|gi|446110087|ref|WP_000187942.1|	29.6	203	251	309	3.33e-21	89.4
k141_117435_68	SARG|gi|445996714|ref|WP_000074569.1|	29.6	203	251	309	3.33e-21	89.4
k141_117435_68	SARG|gi|445996729|ref|WP_000074584.1|	29.6	203	251	309	4.60e-21	89.0
k141_117435_68	SARG|gi|1043490477|ref|WP_065382463.1|	29.6	203	251	309	4.60e-21	89.0
k141_117435_68	SARG|gi|445996726|ref|WP_000074581.1|	29.6	203	251	309	4.60e-21	89.0
k141_117435_68	SARG|gi|445996723|ref|WP_000074578.1|	29.6	203	251	309	4.60e-21	89.0
k141_117435_98	SARG|CP001581.1.gene725.p01	32.1	396	457	477	6.56e-57	194
k141_117435_98	SARG|YP_002181880	33.3	405	457	536	9.54e-44	160
k141_117435_98	SARG|YP_002196817	30.6	421	457	536	6.57e-43	157
k141_117435_98	SARG|YP_002193132	31.2	407	457	537	1.75e-42	156
k141_117435_98	SARG|NC_002951.3237948.p01	26.6	406	457	643	4.79e-34	134
k141_117435_98	SARG|AAD04032	31.8	415	457	563	7.11e-32	127
k141_117435_98	megares|MEG_4381|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|OTRB_1	31.8	415	457	563	7.11e-32	127
k141_117435_98	megares|MEG_4380|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|OTRB_1	31.8	415	457	563	1.31e-31	126
k141_117435_98	SARG|AAC15775	31.1	408	457	536	1.45e-31	125
k141_117435_98	SARG|gb|BAA11237.1|ARO:3000254|emrY	26.7	415	457	512	1.02e-30	123
k141_117435_103	ResF|penA_1_AF515059_1	34.0	556	582	581	2.98e-103	322
k141_117435_103	SARG|gb|AQX82857.1|ARO:3004185|mecD	21.6	546	582	678	2.36e-14	75.1
k141_117435_103	SARG|gb|BAI83385.1|ARO:3003440|mecB	21.6	407	582	674	2.03e-09	59.3
k141_117435_103	NCBI|WP_063852710.1|1|1|mecB|mecB|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecB|AMR|beta-lactam	21.0	404	582	674	3.53e-09	58.5
k141_117435_104	SARG|gb|AAS79458.1|ARO:3001302|chrB	37.8	246	265	280	1.13e-42	145
k141_117435_104	SARG|gb|AJD73064.1|ARO:3001301|RlmA(II)	35.1	239	265	282	1.66e-38	135
k141_117435_104	SARG|gb|CAB37345.2|ARO:3004592|erm(32)	35.5	242	265	280	5.44e-35	125
k141_117435_104	megares|MEG_4106|Drugs|MLS|23S_rRNA_methyltransferases|MYRA_1	35.2	256	265	295	4.11e-34	124
k141_117435_104	SARG|gb|BAA03674.1|ARO:3001300|myrA	35.2	256	265	295	4.11e-34	124
k141_117435_104	SARG|gb|AAD12162.1|ARO:3001299|tlrB	35.1	242	265	280	5.80e-34	123
k141_117435_134	SARG|gb|ABA71733.1|ARO:3002972|vanTG	28.7	366	357	712	1.01e-37	142
k141_117435_134	SARG|gb|ABX54690.1|ARO:3002974|vanTrL	29.2	356	357	366	2.04e-37	137
k141_117435_134	NCBI|CZR78671.1|1|1|vanT-Cd|vanT-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-Cd|AMR|glycopeptide	28.8	365	357	712	6.51e-35	134
k141_117435_134	SARG|JF802084.2.gene3.p01	28.7	356	357	700	7.10e-32	125
k141_117435_134	NCBI|WP_063856752.1|1|1|vanT-G|vanT-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-G|AMR|glycopeptide	27.4	368	357	711	6.82e-30	119
k141_117435_134	megares|MEG_7535|Drugs|Glycopeptide|VanN-type_resistance_protein|VANTN_1	29.7	283	357	656	1.41e-24	103
k141_117435_155	SARG|gi|500194536|ref|WP_011867743.1|	30.8	117	292	306	4.68e-14	70.1
k141_117435_155	SARG|gi|488042066|ref|WP_002113463.1|	26.7	165	292	309	1.20e-13	68.9
k141_117435_155	SARG|gi|500448961|gb|EOP61695.1|	33.3	96	292	306	1.59e-13	68.6
k141_117435_155	SARG|gi|500465078|gb|EOP76697.1|	33.3	96	292	306	1.59e-13	68.6
k141_117435_155	SARG|gi|447195835|ref|WP_001273091.1|	30.4	135	292	306	3.96e-13	67.4
k141_117435_155	SARG|gi|445996698|ref|WP_000074553.1|	26.7	165	292	309	4.04e-13	67.4
k141_117435_155	SARG|gi|542061059|gb|ERI11611.1|	28.1	135	292	316	4.24e-13	67.4
k141_117435_155	SARG|YP_001373621	30.5	105	292	318	4.30e-13	67.4
k141_117435_155	SARG|P42332	32.3	96	292	306	5.36e-13	67.0
k141_117435_155	SARG|ABB80128	32.3	96	292	306	5.36e-13	67.0
k141_117435_156	SARG|gi|695840638|ref|WP_032753940.1|	32.7	211	240	646	1.26e-17	80.5
k141_117435_156	SARG|gi|852138723|ref|WP_048293411.1|	32.2	211	240	646	4.22e-17	79.0
k141_117435_156	SARG|gi|1000904163|ref|WP_061155197.1|	32.2	211	240	646	4.22e-17	79.0
k141_117435_156	SARG|gi|765283866|ref|WP_044612790.1|	32.2	211	240	646	4.22e-17	79.0
k141_117435_156	SARG|gi|822022298|ref|WP_046882271.1|	32.2	211	240	646	4.22e-17	79.0
k141_117435_156	SARG|gi|496081332|ref|WP_008805839.1|	32.2	211	240	646	4.22e-17	79.0
k141_117435_156	SARG|gi|1016530977|ref|WP_063106245.1|	32.2	211	240	646	4.22e-17	79.0
k141_117435_156	SARG|gi|556337683|ref|WP_023297316.1|	32.2	211	240	646	4.22e-17	79.0
k141_117435_156	SARG|gi|1031862522|ref|WP_064180366.1|	32.2	211	240	646	4.22e-17	79.0
k141_117435_156	SARG|gi|757718708|ref|WP_042946953.1|	32.2	211	240	646	4.22e-17	79.0
k141_117435_161	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	28.0	403	432	429	4.46e-49	171
k141_117435_161	megares|MEG_6990|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TET39_1	35.6	149	432	373	1.56e-06	48.9
k141_117435_161	megares|MEG_6987|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TET39_1	35.6	149	432	395	1.64e-06	48.9
k141_117435_161	SARG|AY743590.gene.p01	35.6	149	432	395	1.64e-06	48.9
k141_117435_161	ResF|tet(39)_2_CP044518_1	35.6	149	432	395	1.64e-06	48.9
k141_117435_206	SARG|gi|895865878|ref|WP_048974758.1|	30.4	230	263	646	1.56e-22	95.5
k141_117435_206	SARG|gi|447057510|ref|WP_001134766.1|	29.5	200	263	309	1.13e-20	88.2
k141_117435_206	SARG|gi|445996719|ref|WP_000074574.1|	28.5	200	263	309	2.97e-20	87.0
k141_117435_206	SARG|gi|445996710|ref|WP_000074565.1|	28.5	200	263	309	2.97e-20	87.0
k141_117435_206	SARG|gi|445996695|ref|WP_000074550.1|	29.4	201	263	309	4.10e-20	86.7
k141_117435_206	SARG|gi|488042066|ref|WP_002113463.1|	29.1	196	263	309	7.79e-20	85.9
k141_117435_206	SARG|gi|507023808|ref|WP_016095885.1|	29.5	200	263	309	7.79e-20	85.9
k141_117435_206	SARG|gi|447057509|ref|WP_001134765.1|	29.5	200	263	309	7.79e-20	85.9
k141_117435_206	SARG|gi|488068784|ref|WP_002140181.1|	30.0	200	263	309	7.79e-20	85.9
k141_117435_206	SARG|gi|507035724|ref|WP_016107411.1|	29.4	201	263	309	1.48e-19	85.1
k141_117435_210	CARD|gb|BAB36671.1|ARO:3000832|evgA	24.6	207	217	204	5.86e-24	93.6
k141_117435_210	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	30.5	167	217	228	5.35e-13	64.7
k141_117435_210	CARD|gb|ADM92605.1|ARO:3000553|adeR	39.3	84	217	247	3.26e-12	62.8
k141_117435_210	CARD|gb|ATC67679.1|ARO:3000838|arlR	23.5	200	217	219	7.15e-10	55.8
k141_117435_210	CARD|gb|AAG05188.1|ARO:3005068|ParR	31.9	69	217	235	1.79e-06	46.2
k141_117435_222	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	32.7	104	338	228	2.31e-12	64.7
k141_117435_222	CARD|gb|ATC67679.1|ARO:3000838|arlR	34.5	116	338	219	1.74e-11	62.0
k141_117435_224	CARD|gb|BAB35162.1|ARO:3000676|H-NS	89.6	135	136	137	1.57e-79	229
k141_117435_231	SARG|gi|1032819400|ref|WP_064325534.1|	31.7	252	338	646	1.46e-23	100
k141_117435_231	SARG|gi|779861244|ref|WP_045352062.1|	32.1	240	338	646	1.19e-22	97.8
k141_117435_231	SARG|gi|823326845|ref|WP_047080664.1|	31.3	259	338	648	1.19e-22	97.8
k141_117435_231	SARG|gi|1022688710|ref|WP_063443532.1|	31.3	259	338	648	1.19e-22	97.8
k141_117435_231	SARG|gi|505180394|ref|WP_015367496.1|	31.3	259	338	648	1.19e-22	97.8
k141_117435_231	SARG|gi|823302270|ref|WP_047057473.1|	31.3	259	338	648	2.16e-22	97.1
k141_117435_231	SARG|gi|1022664304|ref|WP_063420886.1|	31.3	259	338	648	2.16e-22	97.1
k141_117435_231	SARG|gi|823309640|ref|WP_047064288.1|	31.3	259	338	648	2.16e-22	97.1
k141_117435_231	SARG|gi|518923394|ref|WP_020079269.1|	31.3	259	338	648	2.16e-22	97.1
k141_117435_231	SARG|gi|851931792|ref|WP_048222288.1|	32.1	240	338	646	2.90e-22	96.7
k141_117435_232	SARG|Q83LR7	30.4	224	335	648	1.78e-20	91.3
k141_117435_232	SARG|gi|647325472|ref|WP_025760953.1|	30.4	224	335	648	1.78e-20	91.3
k141_117435_232	SARG|gi|647323678|ref|WP_025760497.1|	30.4	224	335	648	1.78e-20	91.3
k141_117435_232	SARG|gi|445996719|ref|WP_000074574.1|	29.6	216	335	309	5.37e-20	87.8
k141_117435_232	SARG|gi|446110305|ref|WP_000188160.1|	30.4	224	335	648	5.85e-20	89.7
k141_117435_232	SARG|gi|507055561|ref|WP_016126482.1|	28.5	214	335	309	7.35e-20	87.4
k141_117435_232	SARG|gi|488042066|ref|WP_002113463.1|	28.8	219	335	309	7.35e-20	87.4
k141_117435_232	SARG|gi|447057509|ref|WP_001134765.1|	28.2	220	335	309	7.35e-20	87.4
k141_117435_232	SARG|gi|447195835|ref|WP_001273091.1|	29.7	212	335	306	9.68e-20	87.0
k141_117435_232	SARG|gi|488120365|ref|WP_002191762.1|	29.0	217	335	309	1.01e-19	87.0
k141_117435_265	SARG|gb|APB03222.1|ARO:3003992|rphB	35.6	331	793	884	5.34e-44	170
k141_117435_265	NCBI|WP_087348261.1|1|1|rphD|rphD||2|rifamycin|rifamycin|rifamycin-inactivating_phosphotransferase_RphD|AMR|rifamycin	35.7	336	793	872	3.84e-43	167
k141_117435_265	NCBI|WP_087347987.1|1|1|rphC|rphC||2|rifamycin|rifamycin|rifamycin-inactivating_phosphotransferase_RphC|AMR|rifamycin	35.1	333	793	868	1.20e-42	166
k141_117435_265	SARG|gb|AIA08936.1|ARO:3000444|rphA	37.0	327	793	865	2.81e-42	164
k141_117435_273	SARG|gi|920267901|ref|WP_052974235.1|	29.0	390	411	402	2.91e-33	127
k141_117435_273	SARG|gi|898303707|ref|WP_049581793.1|	28.8	396	411	401	3.95e-33	127
k141_117435_273	SARG|gi|1043549336|ref|WP_065392391.1|	29.0	396	411	401	5.45e-33	127
k141_117435_273	SARG|gi|738927516|ref|WP_036814260.1|	28.8	396	411	401	1.04e-32	126
k141_117435_273	SARG|gi|446014366|ref|WP_000092221.1|	28.7	390	411	402	1.05e-32	126
k141_117435_273	SARG|gi|499458880|ref|WP_011146344.1|	28.5	396	411	401	2.71e-32	125
k141_117435_273	SARG|gi|510899407|ref|WP_016231666.1|	28.5	390	411	402	2.75e-32	125
k141_117435_273	SARG|gi|1036101407|ref|WP_064670261.1|	28.7	390	411	402	2.75e-32	125
k141_117435_273	SARG|gi|486274174|ref|WP_001568721.1|	28.7	390	411	402	2.75e-32	125
k141_117435_273	SARG|YP_310046	28.7	390	411	402	2.75e-32	125
k141_117435_274	SARG|gb|APB03219.1|ARO:3003986|TaeA	24.1	241	254	648	6.34e-16	75.9
k141_117435_274	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	24.5	245	254	574	2.71e-15	73.9
k141_117435_274	SARG|gb|SOX29786.1|ARO:3004730|tva(A)	25.5	196	254	505	6.92e-14	69.7
k141_117435_274	NCBI|WP_014936356.1|1|1|tva(B)|tva(B)|target_protection|2|TIAMULIN|PLEUROMUTILIN|ABC-F_type_ribosomal_protection_protein_Tva(B)|AMR|pleuromutilin	24.9	197	254	504	8.19e-12	63.5
k141_117435_274	NCBI|WP_002294513.1|1|1|lsa(E)|lsa(E)|target_protection|2|LINCOSAMIDE/STREPTOGRAMIN|LINCOSAMIDE/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_Lsa(E)|AMR|multidrug	23.9	205	254	494	1.47e-11	62.8
k141_117435_274	SARG|gb|AVI44920.1|ARO:3004470|poxtA	29.8	168	254	542	6.76e-11	60.8
k141_117435_274	NCBI|WP_209691075.1|1|1|poxtA2|poxtA|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA2|AMR|multidrug	29.8	168	254	544	6.77e-11	60.8
k141_117435_274	ResF|poxtA-Ef_1_WP094899500.1_1	27.8	194	254	538	1.22e-10	60.1
k141_117435_274	megares|MEG_8639|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT_1	27.8	194	254	543	1.22e-10	60.1
k141_117435_274	NCBI|WP_094899500.1|1|1|poxtA-Ef|poxtA-Ef|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA-Ef|AMR|multidrug	27.8	194	254	543	1.22e-10	60.1
k141_117435_280	CARD|gb|AAG03547.1|ARO:3003680|TriB	30.6	350	370	356	4.05e-25	103
k141_117435_281	SARG|gb|AAG07064.1|ARO:3003693|mexK	42.4	1021	1031	1025	5.75e-260	757
k141_117435_281	CARD|gb|AAG03548.1|ARO:3003681|TriC	39.3	1016	1031	1015	4.34e-229	677
k141_117435_281	NCBI|WP_034065037.1|1|1|tmexD3|tmexD|efflux|2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_RND_transporter_permease_subunit_TMexD3|AMR|tetracycline	24.7	1048	1031	1044	2.67e-53	201
k141_117435_281	NCBI|WP_027591160.1|1|1|tmexD2|tmexD|efflux|2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_RND_transporter_permease_subunit_TMexD2|AMR|tetracycline	24.3	1080	1031	1044	6.27e-53	200
k141_117435_281	ResF|tmexD3_1_LC633285_1	24.7	1048	1031	1044	6.27e-53	200
k141_117435_281	SARG|YP_001187672	22.6	1056	1031	1059	6.61e-53	200
k141_117435_281	SARG|gi|852273548|ref|WP_048328542.1|	24.9	1052	1031	1043	8.30e-53	200
k141_117435_281	ResF|tmexD4_1_CP091084_1	24.8	1047	1031	1044	8.33e-53	200
k141_117435_281	SARG|gi|951185348|ref|WP_057663064.1|	25.0	1046	1031	1045	3.45e-52	198
k141_117435_281	NCBI|WP_118842627.1|1|1|tmexD1|tmexD|efflux|2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_RND_transporter_permease_subunit_TMexD1|AMR|tetracycline	24.6	1048	1031	1044	8.05e-52	197
k141_117435_288	SARG|gb|AYV52072.1|ARO:3002882|lmrD	24.9	217	249	664	2.34e-13	68.2
k141_117435_288	SARG|gi|974588181|ref|WP_059178476.1|	26.9	197	249	646	1.06e-07	51.2
k141_117435_288	SARG|YP_001176128	26.9	197	249	646	1.06e-07	51.2
k141_117435_288	SARG|gi|446048013|ref|WP_000125868.1|	25.0	248	249	648	1.90e-07	50.4
k141_117435_298	SARG|gi|1039291348|ref|WP_064768701.1|	25.1	383	441	511	2.65e-06	48.5
k141_117435_298	SARG|gi|1039004533|ref|WP_064760451.1|	24.8	383	441	511	6.12e-06	47.4
k141_117435_298	NCBI|WP_112021705.1|1|1|qepA9|qepA|efflux|2|quinolone|quinolone|quinolone_efflux_MFS_transporter_QepA9|AMR|quinolone	24.6	382	441	511	8.09e-06	47.0
k141_117435_301	SARG|AXF35727.1	28.6	199	250	497	7.62e-12	63.5
k141_117435_301	SARG|gi|921979807|ref|WP_053271336.1|	33.0	185	250	648	2.78e-11	62.0
k141_117435_305	SARG|gi|544923113|ref|WP_021332509.1|	30.8	451	555	478	2.72e-38	145
k141_117435_305	NCBI|WP_015031687.1|1|1|rox_sv|rox_sv||2|rifamycin|rifamycin|rifampin_monooxygenase_Rox|AMR|rifamycin	31.0	400	555	476	1.08e-28	118
k141_117435_305	SARG|gi|754504368|ref|WP_041915032.1|	25.0	364	555	378	3.40e-08	54.7
k141_117435_315	CARD|gb|ALH22601.1|ARO:3000620|adeL	32.4	108	298	337	8.65e-10	57.8
k141_117435_321	SARG|gi|974588181|ref|WP_059178476.1|	37.1	210	258	646	6.79e-28	110
k141_117435_321	SARG|YP_001176128	37.1	210	258	646	1.26e-27	110
k141_117435_321	SARG|YP_002850060	35.3	241	258	648	1.26e-27	110
k141_117435_321	SARG|gi|696368937|ref|WP_032943949.1|	35.3	241	258	648	1.71e-27	109
k141_117435_321	SARG|gi|851913025|ref|WP_048215946.1|	35.3	241	258	648	1.71e-27	109
k141_117435_321	SARG|gi|851922185|ref|WP_048218206.1|	34.2	240	258	648	1.71e-27	109
k141_117435_321	SARG|gi|696375069|ref|WP_032949617.1|	34.2	240	258	648	1.71e-27	109
k141_117435_321	SARG|gi|489936909|ref|WP_003840216.1|	34.2	240	258	648	1.71e-27	109
k141_117435_321	SARG|gi|489127020|ref|WP_003036815.1|	34.2	240	258	648	1.71e-27	109
k141_117435_321	SARG|gi|507079862|ref|WP_016150620.1|	34.2	240	258	648	1.71e-27	109
k141_117435_323	SARG|GQ205627.2.gene1.p01	27.1	214	274	525	4.93e-11	61.6
k141_117435_323	SARG|U82085.gene.p01	22.3	215	274	552	2.35e-08	53.5
k141_117435_323	SARG|gb|CBL58195.1|ARO:3002831|vgaC	26.0	192	274	522	3.07e-08	53.1
k141_117435_323	SARG|AAG08983	25.7	191	274	524	1.76e-07	50.8
k141_117435_323	NCBI|WP_063856937.1|1|1|vga(A)|vga(A)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(A)|AMR|lincosamide	22.5	200	274	522	3.15e-06	47.0
k141_117435_323	NCBI|WP_032492560.1|1|1|vga(A)|vga(A)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(A)|AMR|lincosamide	22.5	200	274	522	4.20e-06	46.6
k141_117435_323	SARG|DQ823382.1.gene1.p01	22.5	200	274	522	4.20e-06	46.6
k141_117435_323	megares|MEG_7687|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|VGA_1	22.5	200	274	522	4.20e-06	46.6
k141_117435_323	megares|MEG_7686|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|VGA_1	22.5	200	274	522	4.20e-06	46.6
k141_117435_323	SARG|KC539823.1.gene1.p01	27.7	83	274	522	4.20e-06	46.6
k141_117435_330	SARG|gi|974588181|ref|WP_059178476.1|	37.2	218	241	646	2.02e-38	140
k141_117435_330	SARG|YP_001176128	37.2	218	241	646	2.02e-38	140
k141_117435_333	SARG|gi|555231380|ref|WP_023218596.1|	62.4	391	411	413	9.79e-179	503
k141_117435_333	SARG|gi|554960030|ref|WP_023204860.1|	62.4	391	411	413	3.97e-178	501
k141_117435_333	SARG|gi|851910511|ref|WP_048215018.1|	62.1	391	411	413	5.63e-178	501
k141_117435_333	SARG|gi|555220864|ref|WP_023213580.1|	62.1	391	411	413	7.98e-178	501
k141_117435_333	SARG|gi|851940702|ref|WP_048227152.1|	62.1	391	411	413	7.98e-178	501
k141_117435_333	SARG|gi|491276012|ref|WP_005134118.1|	62.4	391	411	413	7.98e-178	501
k141_117435_333	SARG|gi|554958315|ref|WP_023203355.1|	62.4	391	411	413	7.98e-178	501
k141_117435_333	SARG|gi|554963100|ref|WP_023207486.1|	62.1	391	411	413	1.13e-177	500
k141_117435_333	SARG|gi|447111661|ref|WP_001188917.1|	62.1	391	411	413	1.13e-177	500
k141_117435_333	SARG|CP001138.1.gene4809.p01	62.1	391	411	413	1.13e-177	500
k141_117435_341	SARG|gb|QNR09092.1|ARO:3007042|msr(G)	25.5	196	357	485	1.45e-09	58.2
k141_117435_346	SARG|gb|WP_096809342.1|ARO:3007029|salE	25.0	180	208	543	2.20e-11	61.2
k141_117435_346	SARG|U82085.gene.p01	25.6	172	208	552	3.27e-07	48.9
k141_117435_346	SARG|gb|AVI44920.1|ARO:3004470|poxtA	26.2	191	208	542	4.38e-07	48.5
k141_117435_346	NCBI|WP_209691075.1|1|1|poxtA2|poxtA|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA2|AMR|multidrug	26.2	191	208	544	4.38e-07	48.5
k141_117435_346	ResF|poxtA-Ef_1_WP094899500.1_1	23.8	189	208	538	7.92e-07	47.8
k141_117435_346	megares|MEG_8639|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT_1	23.8	189	208	543	7.94e-07	47.8
k141_117435_346	NCBI|WP_094899500.1|1|1|poxtA-Ef|poxtA-Ef|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA-Ef|AMR|multidrug	23.8	189	208	543	7.94e-07	47.8
k141_117435_346	SARG|AXF35727.1	24.3	177	208	497	1.04e-06	47.4
k141_117435_346	SARG|gi|514904648|ref|WP_016630030.1|	26.3	160	208	498	1.04e-06	47.4
k141_117435_346	SARG|gi|895818174|ref|WP_048942695.1|	25.6	160	208	498	2.54e-06	46.2
k141_117435_357	CARD|gb|ADM92606.1|ARO:3000549|adeS	35.5	341	354	361	2.35e-67	215
k141_117435_358	CARD|gb|ADM92605.1|ARO:3000553|adeR	47.9	215	246	247	4.33e-65	201
k141_117435_358	CARD|gb|AAD51348.1|ARO:3003066|smeR	43.3	215	246	229	1.66e-46	153
k141_117435_358	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	38.9	226	246	228	9.04e-36	125
k141_117435_358	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	34.5	229	246	229	2.59e-35	124
k141_117435_358	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	35.4	223	246	231	1.07e-34	123
k141_117435_358	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	34.1	226	246	252	3.81e-33	119
k141_117435_358	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	36.2	221	246	230	6.22e-33	118
k141_117435_358	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	38.2	220	246	231	1.26e-32	117
k141_117435_358	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	34.4	218	246	231	1.26e-32	117
k141_117435_358	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	35.4	223	246	232	7.07e-32	115
k141_117435_360	CARD|gb|AAL14440.1|ARO:3000775|adeB	60.0	1022	1039	1035	0.0	1138
k141_117435_360	ResF|tmexD4_1_CP091084_1	52.7	1025	1039	1044	0.0	992
k141_117435_360	SARG|YP_348488	53.3	1025	1039	1043	0.0	991
k141_117435_360	NCBI|WP_118842627.1|1|1|tmexD1|tmexD|efflux|2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_RND_transporter_permease_subunit_TMexD1|AMR|tetracycline	52.6	1024	1039	1044	0.0	991
k141_117435_360	NCBI|WP_034065037.1|1|1|tmexD3|tmexD|efflux|2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_RND_transporter_permease_subunit_TMexD3|AMR|tetracycline	52.7	1025	1039	1044	0.0	989
k141_117435_360	ResF|tmexD3_1_LC633285_1	52.6	1025	1039	1044	0.0	988
k141_117435_360	NCBI|WP_027591160.1|1|1|tmexD2|tmexD|efflux|2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_RND_transporter_permease_subunit_TMexD2|AMR|tetracycline	52.5	1025	1039	1044	0.0	986
k141_117435_360	SARG|YP_001668663	53.2	1025	1039	1043	0.0	985
k141_117435_360	SARG|gi|499256187|ref|WP_010953727.1|	53.0	1025	1039	1042	0.0	984
k141_117435_360	SARG|gi|852273548|ref|WP_048328542.1|	53.2	1022	1039	1043	0.0	983
k141_117435_373	CARD|gb|ALH22601.1|ARO:3000620|adeL	27.8	133	297	337	2.29e-12	65.5
k141_117435_379	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	30.7	225	277	255	1.32e-32	119
k141_117435_379	SARG|gi|895865878|ref|WP_048974758.1|	33.5	227	277	646	1.28e-26	107
k141_117435_379	SARG|gb|AAK76137.1|ARO:3000024|patA	27.1	203	277	564	9.18e-16	75.9
k141_117435_379	SARG|gb|CDO61516.1|ARO:3003949|efrB	21.3	150	277	362	6.30e-07	48.9
k141_117435_394	SARG|Q83LR7	36.1	244	327	648	2.66e-24	102
k141_117435_394	SARG|gi|647325472|ref|WP_025760953.1|	36.1	244	327	648	2.66e-24	102
k141_117435_394	SARG|gi|647323678|ref|WP_025760497.1|	36.1	244	327	648	2.66e-24	102
k141_117435_394	SARG|gi|696368937|ref|WP_032943949.1|	36.7	237	327	648	6.56e-24	101
k141_117435_394	SARG|gi|851913025|ref|WP_048215946.1|	36.7	237	327	648	6.56e-24	101
k141_117435_394	SARG|gi|446110305|ref|WP_000188160.1|	36.1	244	327	648	6.56e-24	101
k141_117435_394	SARG|gi|489930965|ref|WP_003834285.1|	36.7	237	327	648	6.56e-24	101
k141_117435_394	SARG|YP_002850060	36.7	237	327	648	8.85e-24	100
k141_117435_394	SARG|gi|696361545|ref|WP_032936694.1|	36.7	237	327	648	8.85e-24	100
k141_117435_394	SARG|gi|489936909|ref|WP_003840216.1|	36.7	237	327	648	8.85e-24	100
k141_117435_407	NCBI|WP_256875606.1|1|1|blaNWM-1|blaNWM|hydrolase|2|CARBAPENEM|beta-lactam|subclass_B3_metallo-beta-lactamase_NWM-1|AMR|beta-lactam	28.8	212	279	310	1.95e-10	59.3
k141_117435_407	SARG|EU408347.1.gene9.p01	27.4	135	279	302	5.67e-06	45.8
k141_117435_407	SARG|gi|896534788|ref|WP_049437465.1|	27.8	169	279	290	7.30e-06	45.4
k141_117435_409	megares|MEG_1992|Drugs|beta-lactam|Class_C_betalactamases|CMY_1	29.3	287	295	291	1.24e-21	91.3
k141_117435_415	SARG|gi|694089948|ref|WP_032434648.1|	99.1	457	458	457	7.44e-311	841
k141_117435_415	SARG|BAH63712	99.8	457	458	457	2.13e-310	840
k141_117435_415	SARG|YP_001335662	99.8	457	458	457	3.03e-310	840
k141_117435_415	SARG|gi|694065160|ref|WP_032411643.1|	99.8	457	458	457	3.03e-310	840
k141_117435_415	SARG|gi|490279918|ref|WP_004175850.1|	99.6	457	458	457	6.11e-310	839
k141_117435_415	SARG|gi|694102876|ref|WP_032446138.1|	99.8	457	458	457	1.23e-309	838
k141_117435_415	SARG|gi|556195453|ref|WP_023278941.1|	99.6	457	458	457	2.48e-309	837
k141_117435_415	SARG|gi|490245669|ref|WP_004143852.1|	99.6	457	458	457	2.48e-309	837
k141_117435_415	SARG|gi|694073028|ref|WP_032418890.1|	99.3	457	458	457	3.53e-309	837
k141_117435_415	SARG|gi|852089256|ref|WP_048279785.1|	99.6	457	458	457	3.53e-309	837
k141_117435_418	SARG|gb|ALV80601.1|ARO:3003801|bcr-1	33.4	332	412	402	3.50e-38	141
k141_117435_418	NCBI|WP_115421099.1|1|1|cml_Ensi|cml_Ensi|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	30.7	345	412	400	1.51e-33	128
k141_117435_418	megares|MEG_8021|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML_1	30.7	345	412	400	1.51e-33	128
k141_117435_418	SARG|gi|730661043|ref|WP_034065992.1|	30.2	387	412	404	8.01e-33	126
k141_117435_418	megares|MEG_8019|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML_1	29.4	344	412	411	1.69e-32	125
k141_117435_418	NCBI|WP_011552636.1|1|1|cml_Myxo|cml_Myxo|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	29.4	344	412	411	1.69e-32	125
k141_117435_418	NCBI|WP_031633255.1|1|1|cmlA_floR|cmlA_floR|efflux|2|CHLORAMPHENICOL|PHENICOL|CmlA/FloR_family_phenicol_efflux_MFS_transporter|AMR|phenicol	27.1	336	412	395	4.77e-32	124
k141_117435_418	NCBI|WP_061345584.1|1|1|cml_Ochro|cml_Ochro|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	29.2	336	412	397	1.20e-30	120
k141_117435_418	SARG|AF332662.1.gene1.p01	27.2	375	412	404	1.23e-29	117
k141_117435_418	SARG|gi|695688999|ref|WP_032634100.1|	27.4	376	412	404	1.68e-29	117
k141_117435_422	NCBI|WP_063844229.1|1|1|cmlV|cmlV|efflux|2|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_MFS_transporter_CmlV|AMR|phenicol	34.7	383	389	412	1.10e-60	200
k141_117435_422	SARG|U09991.1.gene2.p01	34.7	383	389	436	1.97e-60	200
k141_117435_422	megares|MEG_1780|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	33.0	379	389	391	2.48e-50	172
k141_117435_422	SARG|AF015087.1.gene1.p01	33.2	377	389	391	4.86e-50	172
k141_117435_422	megares|MEG_1781|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	33.2	371	389	391	5.10e-49	169
k141_117435_422	SARG|gb|CAA78046.1|ARO:3002701|Rfas_cmr	33.3	369	389	391	9.98e-49	168
k141_117435_422	SARG|AF024666.2.gene33.p01	30.2	387	389	391	8.06e-46	160
k141_117435_422	SARG|gi|2708772|gb|AAB96371.1|	30.0	387	389	391	1.13e-45	160
k141_117435_422	SARG|YP_251195	30.2	387	389	391	1.57e-45	160
k141_117435_422	SARG|NP_044444	30.0	387	389	391	3.06e-45	159
k141_117435_428	SARG|YP_001126889	28.1	121	136	140	4.93e-06	42.4
k141_117435_428	SARG|gi|679859930|gb|KFX31740.1|	28.1	121	136	139	6.75e-06	42.0
k141_117435_428	SARG|gi|489443058|ref|WP_003348511.1|	28.1	121	136	140	6.83e-06	42.0
k141_117435_428	SARG|gi|670458671|ref|WP_031407470.1|	28.1	121	136	140	6.83e-06	42.0
k141_117435_428	SARG|gi|917378394|ref|WP_051985106.1|	28.1	121	136	153	7.99e-06	42.0
k141_117435_435	NCBI|CAQ45063.1|1|1|emrA-sm|emrA-sm||1|EFFLUX|EFFLUX|multidrug_efflux_MFS_transporter_periplasmic_adaptor_subunit_EmrA|AMR|efflux	29.2	318	299	393	3.33e-25	102
k141_117435_435	SARG|gb|AAF40763.1|ARO:3003961|farA	28.3	290	299	384	6.07e-22	93.6
k141_117435_435	SARG|gi|1036665295|ref|WP_064719275.1|	25.9	324	299	391	1.47e-20	89.7
k141_117435_435	megares|MEG_3265|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_pumps|HLYD_1	24.8	314	299	391	2.81e-18	83.2
k141_117435_435	CARD|gb|AAC75135.2|ARO:3000792|mdtA	28.2	149	299	415	6.19e-08	52.4
k141_117435_460	CARD|gb|ABV18113.1|ARO:3001329|mdtG	26.7	359	406	408	6.48e-07	50.1
k141_117435_493	SARG|gi|895865878|ref|WP_048974758.1|	35.4	223	338	646	1.87e-31	123
k141_117435_493	SARG|gi|500194536|ref|WP_011867743.1|	29.4	214	338	306	4.03e-25	102
k141_117435_493	megares|MEG_4383|Drugs|Tetracycline|Tetracycline_resistance_ABC_efflux_pumps|OTRC_1	26.1	222	338	351	2.16e-15	75.1
k141_117435_493	SARG|gb|AAR96051.1|ARO:3002894|otrC	26.1	222	338	351	2.91e-15	74.7
k141_117435_523	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	31.5	232	260	325	5.58e-29	110
k141_117435_523	SARG|gb|AAA26793|ARO:3003748|oleC	31.5	232	260	325	1.08e-28	110
k141_117435_523	SARG|gi|817122037|ref|WP_046494699.1|	34.0	244	260	613	1.45e-24	101
k141_117435_523	megares|MEG_2670|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|DRRA_1	29.0	231	260	293	4.48e-21	89.0
k141_117435_523	megares|MEG_4383|Drugs|Tetracycline|Tetracycline_resistance_ABC_efflux_pumps|OTRC_1	27.0	237	260	351	4.44e-20	87.0
k141_117435_523	SARG|gb|AAR96051.1|ARO:3002894|otrC	27.0	237	260	351	8.37e-20	86.3
k141_117435_528	SARG|gi|694064328|ref|WP_032410816.1|	39.8	201	234	646	9.82e-31	118
k141_117435_528	SARG|gi|495067432|ref|WP_007792257.1|	36.8	204	234	647	2.50e-30	117
k141_117435_528	SARG|gb|WP_082039181.1|ARO:3007028|salD	22.9	223	234	544	3.62e-11	61.2
k141_117435_538	SARG|gb|ACQ82816.1|ARO:3004577|Acinetobacter	53.3	488	500	492	9.81e-162	466
k141_117435_538	NCBI|AMD83542.1|1|1|aadT|aadT||1|EFFLUX|EFFLUX|multidrug_efflux_MFS_transporter_AadT|AMR|efflux	44.5	488	500	504	2.62e-121	363
k141_117435_538	NCBI|BAE79899.1|1|1|smfY|smfY||1|EFFLUX|EFFLUX|multidrug_efflux_MFS_transporter_SmfY|AMR|efflux	41.6	486	500	490	4.50e-100	308
k141_117435_538	SARG|gb|AEZ36150.1|ARO:3000448|qepA	37.6	487	500	511	1.76e-74	243
k141_117435_538	SARG|gi|1039004533|ref|WP_064760451.1|	37.4	486	500	511	2.46e-74	242
k141_117435_538	NCBI|WP_109638756.1|1|1|qepA8|qepA|efflux|2|quinolone|quinolone|quinolone_efflux_MFS_transporter_QepA8|AMR|quinolone	37.9	486	500	513	2.59e-74	242
k141_117435_538	NCBI|WP_112021705.1|1|1|qepA9|qepA|efflux|2|quinolone|quinolone|quinolone_efflux_MFS_transporter_QepA9|AMR|quinolone	37.4	486	500	511	4.85e-74	241
k141_117435_538	NCBI|WP_096941464.1|1|1|qepA6|qepA|efflux|2|||quinolone_efflux_MFS_transporter_QepA6|AMR|quinolone	37.4	486	500	511	4.85e-74	241
k141_117435_538	SARG|gi|1028098233|ref|WP_063854778.1|	37.2	486	500	511	6.79e-74	241
k141_117435_538	SARG|NC_010558.1.6275948.p01	37.2	486	500	511	6.79e-74	241
k141_117435_555	NCBI|WP_063844229.1|1|1|cmlV|cmlV|efflux|2|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_MFS_transporter_CmlV|AMR|phenicol	29.5	373	385	412	3.16e-44	157
k141_117435_555	SARG|U09991.1.gene2.p01	29.5	373	385	436	5.04e-44	157
k141_117435_555	SARG|AF015087.1.gene1.p01	29.2	370	385	391	5.95e-41	147
k141_117435_555	megares|MEG_1780|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	29.2	366	385	391	1.61e-40	146
k141_117435_555	SARG|gb|CAA78046.1|ARO:3002701|Rfas_cmr	28.2	372	385	391	8.41e-38	139
k141_117435_555	megares|MEG_1781|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	28.3	368	385	391	2.25e-37	138
k141_117435_565	SARG|gb|NP_388442.1|ARO:3004476|vmlR	29.3	512	572	547	2.36e-47	172
k141_117435_565	SARG|gb|ABX00624.1|ARO:3002881|lmrC	31.5	546	572	550	1.61e-42	159
k141_117435_565	SARG|AAG08983	27.2	492	572	524	3.55e-41	155
k141_117435_565	SARG|gb|APB03219.1|ARO:3003986|TaeA	28.6	538	572	648	9.05e-40	152
k141_117435_565	SARG|FR772051.1.gene9.p01	26.8	508	572	524	4.06e-37	143
k141_117435_565	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	26.3	510	572	461	3.83e-36	139
k141_117435_565	SARG|gb|QNR09092.1|ARO:3007042|msr(G)	28.5	495	572	485	4.69e-35	137
k141_117435_565	NCBI|WP_172065992.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	25.7	510	572	461	6.26e-35	136
k141_117435_565	NCBI|WP_063856937.1|1|1|vga(A)|vga(A)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(A)|AMR|lincosamide	26.7	494	572	522	4.59e-34	134
k141_117435_565	SARG|GQ205627.2.gene1.p01	25.1	502	572	525	1.18e-33	133
k141_117435_604	megares|MEG_5400|Drugs|beta-lactam|Penicillin_binding_protein|PBP2_1	60.0	625	637	633	6.35e-273	760
k141_117435_613	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	66.8	238	247	252	2.67e-107	309
k141_117435_613	CARD|gb|AAG05188.1|ARO:3005068|ParR	35.7	230	247	235	4.52e-45	150
k141_117435_613	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	38.3	230	247	225	2.38e-42	142
k141_117435_613	CARD|gb|AAD51348.1|ARO:3003066|smeR	37.9	227	247	229	2.09e-41	140
k141_117435_613	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	35.3	232	247	228	8.06e-41	139
k141_117435_613	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	33.9	227	247	231	9.17e-37	128
k141_117435_613	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	34.3	236	247	232	9.41e-37	128
k141_117435_613	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	34.3	236	247	232	9.41e-37	128
k141_117435_613	CARD|gb|ATC67679.1|ARO:3000838|arlR	33.6	229	247	219	1.87e-36	127
k141_117435_613	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	32.9	231	247	235	3.99e-36	127
k141_117435_614	CARD|gb|ADM92606.1|ARO:3000549|adeS	30.0	203	448	361	3.71e-20	90.5
k141_117435_614	NCBI|WP_063856734.1|1|1|vanS-E|vanS-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-E|AMR|glycopeptide	25.4	209	448	357	1.73e-11	64.3
k141_117435_614	megares|MEG_7511|Drugs|Glycopeptide|VanE-type_regulator|VANSE_1	25.4	209	448	357	1.73e-11	64.3
k141_117435_614	NCBI|AXB64455.1|1|1|vanS-Cd|vanS-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|VanG-Cd-type_glycopeptide_resistance_histidine_kinase_VanS|AMR|glycopeptide	27.2	206	448	380	1.08e-10	62.0
k141_117435_614	megares|MEG_7498|Drugs|Glycopeptide|VanC-type_regulator|VANSC_1	27.2	206	448	380	1.08e-10	62.0
k141_117435_621	SARG|gb|AAK76137.1|ARO:3000024|patA	25.0	180	243	564	7.28e-07	48.5
k141_117435_644	NCBI|AAD54074.1|1|1|farB|farB||1|EFFLUX|EFFLUX|fatty_acid_resistance_MFS_efflux_transporter_permease_subunit_FarB|AMR|efflux	30.3	498	521	507	1.50e-73	241
k141_117435_644	SARG|gi|739061055|ref|WP_036932467.1|	33.2	422	521	505	7.74e-73	239
k141_117435_644	SARG|gb|AAF40764.1|ARO:3003962|farB	29.9	498	521	508	1.17e-72	238
k141_117435_644	SARG|gi|739067217|ref|WP_036938624.1|	33.4	422	521	505	4.18e-72	237
k141_117435_644	SARG|gi|857775940|emb|CRL64641.1|	33.2	422	521	505	5.85e-72	236
k141_117435_644	SARG|gi|739030888|ref|WP_036912019.1|	33.2	422	521	505	5.85e-72	236
k141_117435_644	SARG|gi|739101602|ref|WP_036972253.1|	32.9	422	521	505	5.85e-72	236
k141_117435_644	SARG|CP004022.1.gene546.p01	32.9	422	521	505	8.19e-72	236
k141_117435_644	SARG|gi|857587974|emb|CRL59874.1|	33.2	422	521	505	8.19e-72	236
k141_117435_644	SARG|gi|983379651|ref|WP_060556945.1|	32.9	422	521	512	9.70e-72	236
k141_117435_645	SARG|gi|896068623|ref|WP_049113239.1|	38.0	324	348	390	7.28e-47	162
k141_117435_645	SARG|gi|490225630|ref|WP_004123983.1|	38.0	324	348	390	7.28e-47	162
k141_117435_645	SARG|gi|896053843|ref|WP_049103497.1|	38.0	324	348	390	1.02e-46	162
k141_117435_645	SARG|gi|896019803|ref|WP_049082122.1|	38.0	324	348	390	1.02e-46	162
k141_117435_645	SARG|gi|490991731|ref|WP_004853464.1|	38.0	324	348	390	1.02e-46	162
k141_117435_645	SARG|gb|AAF40763.1|ARO:3003961|farA	37.8	307	348	384	1.25e-46	161
k141_117435_645	SARG|gi|695837578|ref|WP_032750955.1|	38.0	324	348	390	1.99e-46	161
k141_117435_645	SARG|gi|822016107|ref|WP_046877644.1|	37.7	324	348	390	2.79e-46	160
k141_117435_645	SARG|gi|896002933|ref|WP_049068984.1|	37.7	324	348	390	2.79e-46	160
k141_117435_645	SARG|gi|1033042764|ref|WP_064355128.1|	37.3	324	348	365	4.40e-46	159
k141_117435_657	SARG|gi|803568669|ref|WP_046077412.1|	37.5	256	246	648	2.27e-42	151
k141_117435_657	SARG|gi|446110352|ref|WP_000188207.1|	37.5	256	246	648	2.27e-42	151
k141_117435_657	SARG|YP_002382193	37.5	256	246	648	2.27e-42	151
k141_117435_657	SARG|gi|803575554|ref|WP_046081557.1|	37.5	256	246	648	2.27e-42	151
k141_117435_657	SARG|gi|446110351|ref|WP_000188206.1|	37.5	256	246	648	2.27e-42	151
k141_117435_657	SARG|gi|764278838|ref|WP_044327089.1|	38.7	235	246	648	2.14e-41	148
k141_117435_657	SARG|gi|446110301|ref|WP_000188156.1|	41.4	222	246	648	2.95e-41	148
k141_117435_657	SARG|gi|446110305|ref|WP_000188160.1|	41.4	222	246	648	4.06e-41	147
k141_117435_657	SARG|gi|545248218|ref|WP_021546584.1|	41.4	222	246	648	4.06e-41	147
k141_117435_657	SARG|gi|968563772|ref|WP_058587854.1|	41.8	201	246	648	5.60e-41	147
k141_117435_660	NCBI|WP_256875606.1|1|1|blaNWM-1|blaNWM|hydrolase|2|CARBAPENEM|beta-lactam|subclass_B3_metallo-beta-lactamase_NWM-1|AMR|beta-lactam	40.0	60	306	310	1.23e-06	48.1
k141_117435_660	NCBI|WP_219860712.1|1|1|blaB3SU1-1|blaB3SU1|hydrolase|2|CEPHALOSPORIN|beta-lactam|subclass_B3_metallo-beta-lactamase_B3SU1-1|AMR|beta-lactam	43.3	60	306	303	5.13e-06	46.2
k141_117435_661	CARD|gb|ALH22601.1|ARO:3000620|adeL	42.8	290	303	337	1.28e-87	264
k141_117435_671	SARG|gi|488395528|ref|WP_002464913.1|	23.7	215	411	389	4.96e-08	53.5
k141_117435_671	SARG|ZP_03592168	24.1	224	411	389	8.45e-07	49.7
k141_117435_671	SARG|P33449	24.1	224	411	389	1.49e-06	48.9
k141_117435_692	megares|MEG_1992|Drugs|beta-lactam|Class_C_betalactamases|CMY_1	30.3	234	303	291	1.46e-17	80.1
k141_117435_710	megares|MEG_2982|Drugs|Fosfomycin|Fosfomycin_thiol_transferases|FOSA_1	31.4	118	130	129	4.72e-09	50.1
k141_117435_710	NCBI|WP_010494170.1|1|1|fos_related|fos_related|thiol_transferase|2|phosphonic	31.4	118	130	129	4.72e-09	50.1
k141_117435_710	SARG|gi|661279466|ref|WP_029973156.1|	29.3	123	130	140	8.35e-07	44.3
k141_117435_710	SARG|gi|1008207798|ref|WP_061862621.1|	29.3	123	130	140	8.35e-07	44.3
k141_117435_710	SARG|gi|504230293|ref|WP_014417395.1|	29.3	123	130	147	9.18e-07	44.3
k141_117435_710	SARG|gi|982902851|ref|WP_060386859.1|	29.3	123	130	140	1.16e-06	43.9
k141_117435_710	SARG|gi|504070777|ref|WP_014304771.1|	29.3	123	130	140	2.24e-06	43.1
k141_117435_710	SARG|gi|489246926|ref|WP_003155086.1|	29.3	123	130	140	2.24e-06	43.1
k141_117435_715	SARG|WP_000345069.1	37.3	402	446	434	5.88e-89	276
k141_117435_746	SARG|gb|ARB93503.1|ARO:3004603|tet(56)	22.8	395	385	389	1.44e-10	61.2
k141_117435_746	SARG|gb|AKQ05894.1|ARO:3004584|tet(50)	21.7	322	385	388	4.46e-09	56.6
k141_117435_746	SARG|gb|AKQ05899.1|ARO:3004591|tet(55)	23.8	336	385	385	1.04e-08	55.5
k141_117435_750	SARG|NP_631702	32.3	378	413	392	9.99e-24	100
k141_117435_750	SARG|X59968.1.gene1.p01	32.3	378	413	392	9.99e-24	100
k141_117435_750	SARG|NP_044444	32.9	368	413	391	1.34e-23	100
k141_117435_750	SARG|AF024666.2.gene33.p01	32.6	368	413	391	3.38e-23	99.4
k141_117435_750	SARG|YP_251195	32.6	368	413	391	6.24e-23	98.6
k141_117435_750	SARG|gi|2708772|gb|AAB96371.1|	32.3	368	413	391	1.56e-22	97.4
k141_117435_750	megares|MEG_2614|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|DHAP_1	24.8	258	413	395	7.23e-11	62.4
k141_117435_757	SARG|gi|554685678|ref|WP_023185565.1|	41.3	223	264	648	6.60e-40	145
k141_117435_757	SARG|gi|923061916|ref|WP_053445667.1|	40.4	223	264	648	2.18e-38	140
k141_117435_757	SARG|gi|446048048|ref|WP_000125903.1|	41.3	223	264	648	5.63e-38	139
k141_117435_757	SARG|gi|959109145|ref|WP_058113944.1|	41.3	223	264	648	5.63e-38	139
k141_117435_757	SARG|gi|446048047|ref|WP_000125902.1|	41.3	223	264	648	5.63e-38	139
k141_117435_757	SARG|gi|487407385|ref|WP_001675419.1|	40.4	223	264	648	7.72e-38	139
k141_117435_757	SARG|gi|487661511|ref|WP_001751648.1|	40.4	223	264	648	7.72e-38	139
k141_117435_757	SARG|gi|555268367|ref|WP_023249730.1|	40.2	224	264	648	7.72e-38	139
k141_117435_757	SARG|gi|446048030|ref|WP_000125885.1|	40.4	223	264	648	7.72e-38	139
k141_117435_757	SARG|YP_002214869	40.4	223	264	648	7.72e-38	139
k141_117435_769	SARG|AF144880.1.gene1.p01	25.6	129	149	145	2.63e-08	48.9
k141_117435_769	SARG|gb|AAL20537.1|ARO:3002571|AAC(6')-Iaa	25.6	129	149	145	5.09e-08	48.1
k141_117435_769	NCBI|WP_010107623.1|1|1|aac(6')-III|aac(6')-III|acetyltransferase|2|TOBRAMYCIN|aminoglycoside|tobramycin_N-acetyltransferase_AAC(6')-III|AMR|aminoglycoside	31.6	95	149	156	2.14e-06	43.9
k141_117435_769	SARG|AB119105.1.gene1.p01	30.7	114	149	144	3.52e-06	43.1
k141_117435_769	NCBI|WP_104467712.1|1|1|aac(6')_E963|aac(6')_E963|acetyltransferase|2|KANAMYCIN/TOBRAMYCIN|aminoglycoside|aminoglycoside_6'-N-acetyltransferase_AAC(6')-E963|AMR|aminoglycoside	31.1	74	149	153	7.50e-06	42.4
k141_117435_784	SARG|CAB61228	33.6	271	317	322	7.45e-31	117
k141_117435_790	CARD|gb|BAA15221.2|ARO:3000263|marA	92.7	124	125	127	1.11e-83	239
k141_117435_795	SARG|gi|500194536|ref|WP_011867743.1|	29.8	215	233	306	5.61e-27	104
k141_117435_795	SARG|gi|446026113|ref|WP_000103968.1|	29.6	216	233	306	1.11e-25	100
k141_117435_795	SARG|gi|542061059|gb|ERI11611.1|	28.4	215	233	316	1.81e-25	100
k141_117435_795	SARG|P42332	28.4	215	233	306	2.15e-25	100
k141_117435_795	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	28.4	215	233	306	2.15e-25	100
k141_117435_795	SARG|gi|510143239|gb|AGN36970.1|	28.4	215	233	313	2.41e-25	100
k141_117435_795	SARG|gi|507044560|ref|WP_016115614.1|	27.9	215	233	306	3.00e-25	99.8
k141_117435_795	SARG|ABB80128	28.4	215	233	306	4.17e-25	99.4
k141_117435_795	SARG|gi|447195835|ref|WP_001273091.1|	28.4	215	233	306	1.12e-24	98.2
k141_117435_795	SARG|AAD21213	27.9	215	233	306	1.56e-24	97.8
k141_117435_810	SARG|CP000647.1.gene1607.p01	100	286	287	286	2.53e-202	552
k141_117435_810	SARG|AF467947.1.gene1.p1	99.7	286	287	286	3.60e-202	552
k141_117435_810	SARG|gb|WP_063864666.1|ARO:3003590|SHV-190	99.7	286	287	286	5.11e-202	551
k141_117435_810	SARG|DQ322460.1.gene1.p1	99.7	286	287	286	5.11e-202	551
k141_117435_810	megares|MEG_6493|Drugs|beta-lactam|Class_A_betalactamases|SHV_1	99.7	286	287	291	6.14e-202	551
k141_117435_810	SARG|gi|1008264053|gb|AMQ81151.1|	99.7	286	287	286	7.25e-202	551
k141_117435_810	SARG|EU586041.1.gene1.p01	99.7	286	287	286	7.25e-202	551
k141_117435_810	SARG|DQ013287.1.gene1.p1	99.7	286	287	286	7.25e-202	551
k141_117435_810	SARG|KF513177.1.gene1.p1	99.7	286	287	286	7.25e-202	551
k141_117435_810	SARG|gb|AJO16042.1|ARO:3001364|SHV-182	99.7	286	287	286	7.25e-202	551
k141_117435_817	megares|MEG_7070|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TETD_1	39.0	100	314	138	6.59e-17	75.1
k141_117435_832	megares|MEG_8019|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML_1	24.5	208	428	411	8.34e-12	65.5
k141_117435_832	NCBI|WP_011552636.1|1|1|cml_Myxo|cml_Myxo|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	24.5	208	428	411	8.34e-12	65.5
k141_117435_832	SARG|gi|896514456|ref|WP_049420414.1|	32.2	115	428	387	1.32e-09	58.5
k141_117435_832	SARG|gi|896534839|ref|WP_049437516.1|	32.2	115	428	387	1.32e-09	58.5
k141_117435_832	SARG|gi|881042407|ref|WP_048761349.1|	32.2	115	428	387	1.32e-09	58.5
k141_117435_832	SARG|gi|739700146|ref|WP_037554487.1|	32.2	115	428	387	1.32e-09	58.5
k141_117435_832	SARG|ZP_04060517	32.2	115	428	387	1.32e-09	58.5
k141_117435_832	SARG|gi|518673227|ref|WP_019834920.1|	32.2	115	428	387	1.32e-09	58.5
k141_117435_832	SARG|gi|896507999|ref|WP_049415454.1|	32.2	115	428	387	1.32e-09	58.5
k141_117435_832	SARG|gi|896396316|ref|WP_049335029.1|	32.2	115	428	387	1.32e-09	58.5
k141_108035_42	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	27.2	250	301	346	1.82e-17	80.5
